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Abstract 
 
This thesis presents a systematic study of how different types monolayer-protected AuNPs 
interact with amyloid fibers. We report a class of amphiphilic gold nanoparticles capable of 
adsorbing onto specific surface features on these types of protein fibers. A common disease-
associated protein fold is the amyloid state: it is characterized by a cross-beta sheet structure 
that forces proteins and peptides into a fibrillar state, commonly found in illnesses such as 
Alzheimer’s disease, Parkinson’s disease among many others. Amyloid diseases are typically 
chronic, correlated with ageing and have posed several challenges: the exact structure of the 
fibers is difficult to determine and their etiologic role is often unclear. This thesis shows, for 
the first time, that amphiphilic monolayer-protected AuNPs can discriminatively adsorb onto 
surface features of amyloid fibers made of A?1-40 and ?-synuclein in vitro and that 
hydrophobicity determines adsorption onto Tau fibers. Given an amyloid fiber that adopts a 
twisted ribbon morphology, AuNPs protected by a mixture of sulfonated and hydrophobic 
thiolate molecules adsorb onto specific features on the surface of the fiber, leaving other 
interfaces uncovered. This generates a novel supra-molecular assembly that directly interfaces 
an engineered nanomaterial with a biological structure, without using antibodies. Experiments 
and calculations demonstrated the importance of nanoparticle size and ligand-shell 
composition: a size cut-off around 4 nm was observed and other types of water soluble 
nanoparticles did not adsorb discriminatively. Small amphiphilic AuNPs act as surfactants and 
probably adsorb onto solvent-exposed beta sheets and small amyloidogenic oligomers. The 
results presented in this thesis provide a systematic framework to understand the interaction 
between nanoparticles and amyloid fibers. The particles can, moreover, become useful markers 
for amyloid research and possibly a cross-instrumental probe to reconcile spectroscopic and 
imaging techniques to help molecular structure determination. During this work, the synthesis 
and purification of large amounts of sulfonated thiolate molecules was systematized to generate 
libraries of differently coated water soluble gold nanoparticles (AuNPs). This helped elucidate 
how amphiphilic AuNPs fuse with lipid bilayers. 
 
 
Keywords: gold nanoparticles, amyloid, lipid bilayers, proteins, aggregation, monolayer-
protected, mixed-ligand, amphiphilic, beta sheets.  
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Kurzzusammenfassung 
 
In dieser Doktorarbeit wird eine systematische Untersuchung der Interaktion zwischen 
einschichtig beschichteten Gold-Nanopartikeln und Proteinaggregaten vorgestellt. Die am 
häufigsten mit Krankheiten assoziierte Proteinfaltung sind Amyloide. Diese sind durch eine 
beta-Faltblattstruktur gekennzeichnet, welche Proteine und Peptide in einen fibrillären Zustand 
zwingt. Diese Fibrillen werden gemeinhin in Krankheiten wie Alzheimer, Parkinson und vielen 
anderen gefunden. Amyloid-assoziierte Krankheiten sind in der Regel chronisch, korrelieren 
mit dem Altern und stellen mehrere Herausforderungen, da sowohl die genaue Struktur der 
Fasern schwierig zu bestimmen, als auch ihre Wirkung auf Organismen unklar ist. 
Diese Arbeit zeigt zum ersten Mal, dass amphiphile einschichtig beschichtete Gold-
Nanopartikel in vitro diskriminativ an Oberflächenmerkmalen von Amyloidfibrillen aus A?1-
40 und ?-Synuclein adsorbieren, sowie dass Hydrophobie die Absorption an Tau-fasern 
bestimmt. Während einschichtig, aus einer Mischung sulfonierter und hydrophober Thiole, 
beschichtete, wasserlösliche Gold-Nanopartikel an spezifischen Oberflächenmerkmalen der 
Fasern adsorbieren, bleiben andere mögliche Grenzflächen unbedeckt. Dies stellt eine neue 
direkte supramolekulare Schnittstelle zwischen einem synthetisch hergestellten Nanomaterial 
und einer biologischen Struktur dar, ohne Antikörper zu verwenden. 
Experimente und Berechnungen zeigten die Bedeutung der Nanopartikelgröße und 
Beschichtungszusammensetzung: es wurden sowohl eine Grenzgröße von circa 4 nm 
beobachtet, als auch dass andere Arten von wasserlöslichen Nanopartikeln nicht in der Lage 
sind, diskriminativ an den Fasern zu adsorbieren. Kleine amphiphile Gold-Nanopartikel wirken 
als Tenside und adsorbieren an Lösungsmittel-exponierten Beta-Faltblättern und kleinen 
Amyloid-Oligomeren. Die Ergebnisse dieser Arbeit bieten einen systematischen Rahmen, um 
die Wechselwirkung zwischen Nanopartikeln und Amyloid-Fasern zu verstehen. Die Partikel 
haben darüber hinaus Potential, als nützliche Marker für die Amyloid-Forschung und sowie als 
interdisziplinäres Werkzeug für spektroskopische und bildgebende Verfahren zur molekularen 
Strukturbestimmung genutzt zu werden. 
Weiterhin wurden in dieser Arbeit die Synthese und die Aufreinigung großer Mengen 
sulfonierter Thiole systematisiert, um Bibliotheken unterschiedlich beschichteter 
wasserlöslicher Gold-Nanopartikel zu erzeugen. Dies trug unter anderem dazu bei aufzuklären, 
wie amphiphile Gold-Nanopartikel mit Lipid-Doppelschichten verschmelzen. 
 
Stichwörter: Gold-Nanopartikel, Amyloid, Lipid-Doppelschichten, Proteine, Aggregation, 
einschichtig beschichtet, gemischte Liganden, amphiphil. 
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1? Protein aggregation and the amyloid fold 
The results presented in this thesis cannot be rationalized without appreciating the background 
on protein aggregation. Moreover, amyloid fiber structural determination has become a field 
in itself: this chapter reviews the basic developments of the past 15 years, and provides the 
background to interpret the cryo electron micrographs discussed in chapters 3 and 4. It 
emphasizes, in detail, the structural models for A? fibers, their variations and experimental 
constraints. ?-synuclein and Tau-441 fibers are briefly presented, and contextualized in the 
debate on amyloid pathogenicity, followed by a summary of what the surfaces of twisted ribbon 
amyloid fibers correspond to according to the literature.  
 
1.1? Protein folding and misfolding in disease. 
Living organisms are composed of a few classes of building blocks, such as lipids, nucleotides 
and amino acids. Despite the remarkable information-density and transmission reliability that 
nucleotides afford living organisms, life itself occurs as an expression of the coordinated 
functions encoded in the final shapes, forms and combinations of proteins. Unsurprisingly, the 
quest to understand protein structure to gain a glimpse of how they operate, and hope to correct 
their malfunction in disease, is a major undertaking in the scientific community1.  
 
Anfinsen’s dogma states that the primary structure of a polypeptide, in other words, the amino 
acid sequence, determines the final three-dimensional structure of the native protein2. This 
rationale implies a rugged funnel-shaped energy landscape, in which the native protein sits at 
the lowest free-energy state (Figure 1.1(a)). This landscape is evolutionarily favorable, because 
it allows multiple paths for the same ultimate function, which does not rule out potentially 
beneficial mutations. However, even under physiological conditions, proteins can adopt 
structures that depart from the native conformation. This observation does not contradict 
Anfinsen’s dogma, but reveals that, depending on the conditions, polypeptides can fold and 
aggregate outside the free-energy minimum, as depicted in Figure 1.1(b). This figure shows a 
different energy landscape, in which the free-energy minimum is the aggregated state, that is 
avoided by the action of chaperones3,4. Whichever the landscape, protein aggregation occurs 
and its repercussions can be devastating.  
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Figure 1.1 Proposed energy landscapes available for protein folding. (a) The rugged, multi-pathway landscape in which 
different paths lead to the native protein conformation depending only on the primary structure, regardless the route. Reused 
with permission from reference (1) Copyright© 2012 AAAS. (b) From reference (3) a different possibility for proteins prone 
to misfold, highlighting the role of chaperones to ensure correct folding, and the possibility of degradation for incorrectly 
arranged proteins.  
 
A polypeptide chain, in its path to the native conformation, can undergo several energy-
minimizing arrangements that deviate from the physiological route, placing it in front of a 
kinetic barrier. There are proteins called chaperones that act to correct and guide the 
polypeptide around kinetic barriers towards the native state (Figure 1.1(b)). The roles of 
chaperones go beyond navigating proteins through the rugged free-energy landscape, and 
include the redirection of faulty proteins to the proteasome system, where homeostatic 
degradation of discarded proteins take place5. Post-translational modifications add another 
layer of complexity to how proteins fold, and play a crucial role in establishing the native 
conformation6. Again, this does not directly contradict Anfisen’s dogma, because the primary 
sequence of amino acids still determines how the post-translationally modified proteins adopt 
their three-dimensional conformation, therefore, how they operate.  
 
Faulty protein causes disease through multifactorial pathophysiological mechanisms. The 
pathologies can be roughly categorized depending on the degree of known causality between 
misfolding and phenotype, in other words, how well-established the etiology is. First, 
mutations in the DNA sequence can lead to a loss of function or a gain of toxicity that deviates 
from homeostasis. In this category, Mendelian conditions such as Cystic Fibrosis (CB), a 
disease caused by a mutation in the gene for the chlorine channel Cystic Fibrosis 
Transmembrane Conductance Regulator (CFTR), culminates in a devastating condition 
marked by viscous secretions from epithelial tissues. The repercussions of this incorrect 
mucous production affects the respiratory and digestive systems, culminating in organ failure 
and death by obstructive lung failure in 80% of cases7. Despite a well-established etiology, 
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treatments for CB remain palliative. Sickle cell anemia is another example of an inherited 
faulty protein disease. When the ?6 glutamic acid in hemoglobin S (HbS) is replaced by valine, 
the solubility of deoxygenated HbS decreases, which causes the protein to aggregate inside the 
red blood cell8. These aggregates made of HbS fibers distort the shape of the erythrocyte into 
an elongated cell, hence the name of the disease, that causes a variety of vascular 
complications, and depending on the severity, culminates in death. Other Mendelian 
“misfolding” disorders include Huntington’s disease and phenylketonuria9. The latter has 
recently been proposed to culminate in fibrous phenylalanine aggregation in the brain10 which 
can be one mechanism of toxicity. This finding illustrates that protein aggregation, and the 
damage it causes, can be downstream from a simple mutation in an enzyme.  
 
In addition to these causally well-established genetic conditions that express faulty pathogenic 
proteins, a collection of other syndromes correlated to protein malfunction has been described. 
They can be triggered by defects in the chaperoning system and culminate in cataracts, 
retinopathy, inclusion-body myositis among other diseases11. Or they can be age-related 
multifactorial syndromes, often neurodegenerative, such as Alzheimer’s disease12,13 and 
Parkinson’s disease14. Other neurodegenerative conditions are also related to protein 
malfunction, including progressive supranuclear palsy (PSP), frontotemporal dementia15 and 
multiple-system atrophy16. Notably, the archetypical protein aggregation diseases are the 
Transmissible Spongiform Encephalopathies (TSEs) caused by aggregation of prion protein 
(PrP), that is capable of propagating its noxious aggregates across tissues, individuals and even 
species17.  
 
Most of these diseases share one characteristic: the presence of proteins in the amyloid state. 
This type of protein fold is a common, stable structure correlated with about 50 human 
diseases18, and has become a field of study in itself. Difficulties to crystallize and determine 
high-resolution structural models for the amyloid state led to several attempts using Nuclear 
Magnetic Resonance (NMR) techniques in combination with Electron Microscopy (EM). This 
thesis shows, for the first time, that gold nanoparticles ranging from 1 to 4 nm in core diameter 
can discriminatively adsorb onto features of the amyloid fiber, depending on the type of 
monolayer that protects the particles.  
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1.2? Definition of the amyloid fold 
In 1854, Rudolph Virchow reported iodine-positive inclusions in brain samples that he believed 
were made of a starchy material, hence the name Amyloid, from the Latin and Greek words for 
sugar: amylum and amylon respectively19. Later, the proteinaceous nature of the inclusions was 
established, and currently, pathologists impose a stringent definition for amyloids. They are 
body tissue deposits of non-branching protein filaments, that bind the Congo-Red dye, and 
exhibit green-yellow birefringence under polarized light microscopy when stained20. The 
International Society of Amyloidosis (ISA) suggests the term amyloid-like for fibers prepared 
in vitro from natural or synthetic precursors20.  
 
On the other hand, the biophysical definition of amyloid encompasses fundamental structural 
features common to all fibers, and is summarized as: protein fibers that display a cross-beta 
fiber diffraction pattern. Astbury first reported this structure in 1935, observing the diffraction 
pattern of stretched egg-white that showed ~4.7 Å and ~10 Å meridional and equatorial 
scattering respectively21. Similar diffraction patterns were later observed for fibers extracted 
from disease tissue deposits22, thus consolidating the definition of amyloids. Segments of the 
proteins (or entire peptides) adopt an extended beta-sheet conformation that stack parallel to 
one another and perpendicular to the fiber, giving rise to the ~4.7-4.8 Å meridional reflection. 
Identical layers of these beta-sheet supra-assemblies stack onto one another, producing the 6-
11 Å equatorial diffraction bands, as illustrated in Figure 1.2.  
 
 
Figure 1.2 On the left, negatively stained TEM image of amyloid fibers. In the center, schematic view of how beta-sheet 
segments arrange in space, in the fiber core, followed by a typical fiber X-Ray diffraction pattern. From reference (23) reprinted 
with permission Copyright © 2010 Elsevier Ltd. All rights reserved. 
 
Despite a constitutively simple motif, amyloid fibers pose a challenge for protein structure 
determination. High-resolution models of fibers made from disease-related proteins are 
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difficult to obtain: such polydisperse helical fibers have not yet been crystallized for X-ray 
diffraction. Most models rely on complex NMR approaches and mass density maps from EM 
images. This generates a gap between biological properties and the underlying fiber structures. 
Furthermore, it has been recognized that proteins correlated with devastating diseases, such as 
amyloid beta (A?) in the case of Alzheimer’s disease, exist in several morphologies24, 
analogous to the different strains found in prion diseases. Recently, the crystallization of small 
peptide fragments, that also form amyloid fibers, has revealed a set of structural constraints, 
that likely underpin the fundamental design rules dictating how longer peptides and full 
proteins self-assemble into fibers25,26.  
 
1.3? Amyloid-like microcrystals 
Amyloid fibers are unbranched twisted ribbons, 5 to 20 nm wide that span from tens of 
nanometers to a few microns in length. Different shapes, helical pitches, widths and symmetries 
can reflect all the possible ways the constitutive polypeptide monomers fold and subsequently 
arrange with respect to one another. To understand the different detailed molecular structural 
models proposed for amyloid fibers, it is convenient to begin with the reductionist approach 
taken by David Eisenberg’s group. They have performed X-ray diffraction crystallography on 
short peptides that form both fibrils and microcrystals. A set of intermolecular arrangements 
was revealed by microcrystal X-ray crystallography which coincides with the basic fiber 
structure: care must be exercised to translate these findings to the fibers25-27.  
 
The first microcrystal structure was determined for the 7-residue fragment derived from Sup35 
yeast prion protein, GNNQQNY25. The microcrystal matched fundamental aspects of the cross-
beta motif found in the fibers: the heptapeptides adopt a Pauling-Corey beta-sheet 
conformation, perpendicular to the long axis of the crystal, spaced by 4.87 Å. The unit cell is 
formed by complementary pairs of anti-parallel monomers (two heptapeptides) bound together 
by a dry interface of self-complementary, interdigitating side chains, termed steric zippers. 
These unit cells are related via a 21 screw axis, bound together by extended hydrogen bonds in 
the long axis (b axis in Figure 1.3(a)). Despite not being the structure of a full-length amyloid 
fiber, these results provide molecular insight to understand the lower resolution models 
proposed for fibers. Not all properties seen in the microcrystals translate to the fibers: for 
example, the facets and beta-sheets of the crystals are flatter than those reported on fibers28. 
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Nevertheless, the microcrystal structures offer invaluable insight to understand fiber 
polymorphisms and prion strains. 
 
 
Figure 1.3 1.8 Å resolution crystal structure of a GNNQQNY microcrystal: space group P21. Carbon atoms in purple or 
grey/white, oxygen red and nitrogen blue (a) Lateral view of the crystal highlighting the beta-sheet stacking in agreement with 
the biophysical definition of the amyloid fold. (b) A cross-sectional view of the peptide pair, highlighting the antiparallel 
nature, the self-complementary interdigitating side-groups coined steric zippers that form a dry interface (c) A view along the 
b axis on how the units in (b) pack in the a-c plane: note the wet interfaces between the faces of the peptides not committed to 
steric zipper (d) The hydrogen bonding network between adjacent in-register parallel beta sheets. Adapted with permission 
from reference (25) Copyright© 2005, Rights Managed by Nature Publishing Group. 
 
To date, dozens of amyloid-like microcrystal structures have been determined by X-ray 
crystallography26,29,30. These structures reveal how short amyloid-forming peptides can self-
associate in different patterns, giving rise to the possible root of amyloid polymorphism and 
prion strains26. Briefly, as depicted in Figure 1.4(a), a peptide pair can undergo a shift in 
registry, in other words, how two neighboring peptides stack relative to one another, which 
creates different steric zippers. They can also combine in a parallel or antiparallel fashion, 
depending on the crystal-formation conditions. These possibilities have been aptly named 
packing polymorphisms, whereby the relative arrangement between the two monomers varies 
in orientation and registry. When different segments of the peptide form steric zippers, as in 
Figure 1.4(b), the polymorphism is called segmental. So far, only these two types of 
polymorphisms have been described in amyloid-like microcrystals. If different segments from 
two separate molecules (Figure 1.4(c)), or within the same polypeptide chain (Figure 1.4(d)) 
form heterosteric zippers, in other words, non-homologous interdigitations, the variations are 
called combinatorial and single-chain registration polymorphism respectively. The latter 
constitutes the ubiquitous U-shaped monomer found in several detailed structural models 
derived from multidimensional NMR techniques28,31,32. 
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Figure 1.4 Schematic view of molecular scale polymorphisms. (a) Packing polymorphism. (b) Segmental polymorphism. (c) 
Combinatorial polymorphism. (d) Single-chain registration polymorphism. The last two types of polymorphisms have never 
been determined at high resolution, but (d) is commonly reported in amyloid fibers made of long peptides. Reprinted with 
permission from reference (26) Copyright © 2009, Rights Managed by Nature Publishing Group. 
 
The microcrystals cannot capture all aspects of the amyloid state and prion propagation. 
Nonetheless, they offer crucial guidelines that might underlie the formation of the spines that 
define the fibrous species. The decrease in entropy upon formation of ordered fibers and 
microcrystals poses a barrier to their formation. The enthalpic gain upon formation of the 
extended beta-sheet hydrogen bonding network is not sufficient to offset the entropic loss. The 
new hydrogen bonds do not significantly outnumber the water-amide bonds in the soluble form, 
however, the complementary interdigitation between the amino acid side groups confer a 
significant decrease in enthalpy through van der Waals forces. In other words, the formation 
of the steric zippers may be the main driving force for the nucleation and propagation of 
amyloid-like structures. Once formed, the hydrogen bonding network on the amyloid fiber is 
remarkably robust because of dipole induction: however, unlike the steric zippers, this added 
strength is not considered a driving force to form the amyloid structure25.  
 
The steric zipper may also be the molecular mechanism behind protein-encoded inheritance, 
whereby different conformations of prion proteins can propagate their own strain29. An 
analogous observation has been made for amyloid fibers of A?1-40 extracted from cadaveric 
brain tissue of AD patients. Different polymorphs were found in separate patients, and the 
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correlation between disease severity and amyloid morphology, a well-known phenomenon for 
prion strains, is now under close scrutiny for non-prion amyloid diseases as well33. The idea 
that molecular information can be encoded and transmitted by a protein conformation is new, 
and has even led to an intriguing speculation of a pre-biotic world, when prion-based life 
existed through the selection of sequences that fit a given conformation. In other words, the 
cross beta sheet motif would be an “ancestor” fold under this hypothesis, and the steric zipper 
acts as the information propagating unit in such ‘amyloid world’34. The recent reports of 
functional amyloids35, for example the storage of pituitary peptide hormones in this 
conformation36 reveal that organisms do take advantage of what was otherwise considered a 
mere pathognomonic finding. 
 
1.4? Structural models of amyloid fibers 
Despite the enormous contributions that microcrystal atomic resolution models have warranted 
the field, full length fibers lack the same level of structural resolution. Amyloid fibers have not 
yet been crystallized, and even if a crystal is obtained, it will likely contain only a particular 
polymorph. Amyloid fibrils tend to be polydisperse, that is, vary in length and width, and also 
polymorphic through diverse self-associations between the building blocks. Furthermore, they 
are inherently non-crystalline and insoluble, which render them recalcitrant to structural 
determination, not only via conventional crystallography, but also through standard 
multidimensional solution NMR techniques. Figure 1.5 shows fibers made in vitro from three 
different polypeptides associated with neurodegenerative diseases. Figures 1.5(a) and (b) 
depict A?1-40 fibers imaged under Atomic Force Microscopy (AFM) and negatively stained 
EM respectively. Figure 1.5(c) is an EM image of Tau-441 in the fibrillar state and Figure 
1.5(d) shows ?-synuclein fibers. Different types of fibers clearly co-exist in the same sample.  
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Figure 1.5 (a) Atomic Force Microscopy (AFM) image of mature A?1-40 fiber (Bruker, 40 N/m cantilever) (b) The same fibers 
imaged under negatively stained preparation for Transmission Electron Microscopy (TEM) (c) Wild-type full Tau-441. (d) ?-
synuclein fibers. EM scale bars represent 200 nm and AFM 2 μm. All EM images were obtained in an FEI TALOSTM Electron 
Microscope in bright-field mode.  
 
1.4.1? Detailed molecular models of A? 
 
Several groups have used solid state NMR (ssNMR) and EM as constraints to propose detailed 
structural models of A? fibers, which are strongly correlated with Alzheimer’s disease37. Other 
techniques including X-ray diffraction, electron paramagnetic resonance (EPR) and hydrogen-
deuterium (H/D) exchange in solution NMR along with mass spectrometry have helped 
produce detailed models. Nevertheless, ssNMR has yielded the most precise structural models, 
and is a powerful technique to study, not only amyloids, but also membrane proteins and 
dynamic aspects of these macromolecules38. A detailed technical background on ssNMR 
escapes the goal of this thesis, however the different detailed models proposed by NMR groups 
are essential to interpret the data in chapters 3 and 4. Therefore, it is imperative to briefly 
review these results and how they relate to the fundamental rules established by the amyloid-
like microcrystal structures. The nomenclature for models established via X-ray diffraction and 
ssNMR varies: when the term structure is used, it denotes atomic resolution models derived 
from X-ray diffraction patterns. Because the resolution of ssNMR models is lower, the term 
detailed structural model is preferred. The resolution of these models span from 2.1 to 2.7 Å 
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based on root mean squared deviations of backbones and heavy atoms39. Ultimately, both 
approaches produce models that differ in their proximity to reality: henceforth the term model 
will be used interchangeably throughout this text.  
 
Similar to microcrystal structural determination, early ssNMR studies focused on fragments of 
disease-related amyloid-forming proteins and peptides. In the early 90’s, Griffin and then 
Lansbury published the first ssNMR of A?34-42, a nonapeptide from the A? sequence40,41. Their 
results confirmed the cross beta sheet motif revealed by fiber X-ray diffraction, and showed 
that these nonapeptides adopt an anti-parallel conformation. As ssNMR researchers increased 
the length of the polypeptides, the cross beta sheet arrangement was consolidated, but different 
organizations between the monomers were found. For example, the model obtained for A?10-
35 revealed parallel beta-sheets42, which became the most common arrangement found in A?1-
40 and A?1-4231,32,43. These different arrangements found by early ssNMR studies fall under the 
category of packing polymorphisms, shown in Figure 1.4(a).  
 
After initial attempts to determine key aspects on how polypeptides self-associate to form 
amyloid fibers, 3D detailed molecular models for these materials were proposed. Notably, 
Robert Tycko’s group published a model for A?1-4044, and later revealed that, depending on 
experimental conditions, different morphologies can self-propagate31. This finding 
demonstrated the existence of polymorphs that can recruit monomers to adopt a particular 
three-dimensional conformation through a mechanism similar to prion strains. When A?1-40 
monomers were prepared under quiescent or agitated conditions, 3-fold or 2-fold symmetric 
structures were obtained, respectively28. Figure 1.6 illustrates the quiescently grown 3-fold 
symmetric fibers and the agitated 2-fold ribbons. These ssNMR models established the U-
shaped or hairpin monomer model, in which the A?1-40 chain has two domains in a beta-sheet 
conformation, linked by a loop, establishing the the beta-turn-beta unit. Further studies showed 
that monomers can form multiple beta-sheet domains in the primary sequence and fold in a 
serpentine-like fashion alternating multiple beta-turn-beta segments: this superpleated 
structure is likely obligatory for larger amyloid-forming proteins45 and has been described for 
certain preparations of A?1-4246. 
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Figure 1.6 (a) The sequence of A?1-40 and the segments that adopt an extended beta-sheet conformation: beta-1 from residues 
12 to 24 and beta-2 from 30 to 40. Possible segmental polymorphisms can cause variation in these domains. (b) Beta-turn-
beta hairpin schematic model for monomers prepared under quiescent (top) and agitated (bottom) conditions. The 3-fold 
symmetric rendition is plausibly the accurate combinatorial geometry of the monomers, whereas the 2-fold symmetric shows 
only one layer, which is denoted protofilament. (c) Transection of the molecular backbone for both quiescently prepared fibrils 
(top) and possible lateral interactions for 2-fold symmetric protofilaments, with the first 10 N-terminal residues in a random 
coil conformation. Reproduced and adapted from references (44) and (28) Copyright© by the National Academy of Sciences.  
 
Solid state NMR provides constraints that, combined with EM, enable the calculation of an 
energy-minimizing model of the peptides in 3D. Materials that cannot be characterized via 
conventional crystallography can be determined using this approach. Moreover, protein 
crystallography reveals the state of the macromolecule in its crystalline form, whereas 
spectroscopic techniques can capture the thermal fluctuations and less ordered native 
components. In the models proposed in Figure 1.6, residues 1 through 8 were deemed 
disordered, therefore omitted from the simulation. The loop is stabilized by a salt bridge 
between the positively charged lysine at position 28 (K28) and aspartic acid at 23 (D23). Other 
polar residues sit in the omitted N-terminal tail, on the outside of the beta-1 strand (notably 
another lysine at position 16) and on the outside of the loop. The remaining residues are 
hydrophobic (green in Figure 1.6(a)), especially in the beta-2 strand (residues 30 to 40) that 
can establish strong hydrophobic pairings with a homologous strand44. The amino acid side 
chain contacts in the interior of the hairpin model is reminiscent of the steric zippers described 
for amyloid-like microcrystals. For example, glutamine at position 15 (Q15) establishes a 
contact with the hydrophobic pocket formed by glycines 37 and 38 (G37 and 38): this, along 
with all contacts inside the hairpin, constitute a heterostatic steric zipper as defined for 
amyloid-like microcrystals (Figure 1.4(d)).  
 
Despite the structural difference between 3 and 2-fold symmetric A?1-40 fibers (Figures 1.6(b) 
and (c)) the basic building block is, to a first approximation, identical. Subtle differences in 
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residue-residue interactions were reported: for example, the salt bridge between D23 and K28 
for the 2-fold symmetric monomer occurs inside the hairpin at a 0.37 nm distance, whereas this 
gap is 0.5 nm for the monomers sitting on a 3-fold fiber. Nonetheless, both polymorphs are 
made of remarkably similar hairpin monomers that self-associate in-register with a cross-beta 
motif. The main differences are the overall symmetry, the contacts established between the 
homologous beta-strands and perhaps the disordered segments28.  
 
The 3-fold symmetric species has a higher mass-per-length value (~27 kDa/nm) than the 2-fold 
type (18 kDa/nm), however, the rate of monomer addition to the ends of the different fibrils 
does not scale in a 3:2 ratio. On the contrary, the elongation and shrinkage rates (ke and ks) are 
indistinguishable at 37°C, but the elongation rate at 24°C is higher for 2-fold symmetric fibers. 
Therefore, a direct correlation between structure and kinetic properties may not exist47. At 24°C 
the 2-fold species is more stable than the 3-fold by 0.8 kcal/mol, but this difference is below 
the detection limit at 37°C47. So far, the only properties that seem to be structure-dependent are 
the higher propensity of 2-fold fibers to fragment under shear stresses47 and the higher in vitro 
toxicity of 3-fold fibers31. The former can explain the prevalence of 2-fold species in agitated 
preparations and the interconversion towards this morphology when both species co-exist. 
During sample preparation, the 2-fold symmetric fibers break and form nuclei that outnumber 
the 3-fold species, eventually becoming the dominant morphology via monomer exchange. 
Structural interconversion from one morphology to another has not been reported and is an 
unlikely phenomenon due to the high energy penalty to reorganize the structure. It is unlikely 
that the minor thermodynamic stability of the 2-fold morphology is the driving force behind its 
prevalence in experimental preparations.  
 
Other groups have published different detailed structural models of A?1-40 using the same 
approach48,49, and reported slightly different models. Given that the same group obtains 
controllably different polymorphs at 24°C by tuning agitation, it is not surprising that different 
sample preparations produce distinct molecular arrangements. Figure 1.7 summarizes the 
relevant detailed molecular structures of A?1-40 obtained by two groups using ssNMR, 
highlighting their distinct intra and intermolecular contacts. Figure 1.7(c) depicts the model 
obtained by Bertini et. al. that, in addition to the beta-turn-beta monomer, has a segment of the 
otherwise disordered N-terminal in a beta-sheet conformation. This segmental polymorphism 
involves residues 4 through 7 that form a beta sheet (?n), followed by a kink prior to beta-1 that 
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starts at residue 11. The ?n segment might be related to the biological relevance of the N-
terminal portion of A?48. These models can be found in the protein database under 2LMN, 
2LMO, 2LMP, 2LMQ.  
 
 
Figure 1.7 White dots represent hydrophobic residues, black acidic or basic and grey other types (a) Detailed molecular 
structure of A?1-40 in which position 35 methionine (M35) points into the hairpin space. Two protofibrils associate via parallel 
contacts between C-terminal beta-2 strands44. (b) The 2006 A?1-40 model, with M35 facing outwards, and defining the contacts 
in the 3-fold symmetric polymorph, whereas the 2-fold stacks two homologous beta-2 strands anti-parallel to one another. 
While G37-I31 contacts define the 2-fold polymorph beta-2 contacts, V39-I31 stabilizes the beta-2 contacts in the 3-fold 
version28. (c) An A?1-40 model for an agitated preparation at 37°C reveals different beta-2-beta-2 contacts and a beta-sheet 
segment on the N-terminal, otherwise, amorphous segment. Adapted with permission from reference (48) Copyright © 2011, 
American Chemical Society. 
 
Unlike in vitro preparations, different parts of a single human brain did not present A?1-40 fiber 
polymorphism, but fibers obtained from two different AD patients did33. A?1-40 fibers were 
extracted from different parts of cadaveric brain tissue of two patients with different clinical 
presentations. Each fiber morphology depended on the patient and not on the anatomical origin 
within the brain. In other words, at that stage of the disease, the mature fibers had a uniform 
morphology throughout the organ, which may be due to a common nucleation instance that 
imposed a particular structure. Both samples showed the hallmarks of 3-fold symmetric fibers, 
but the seeded fibers from only one patient had a good enough ssNMR spectrum for the 
calculation of a 3D detailed structural model. The resulting model, shown in Figure 1.8(c), 
differs from those obtained in vitro, but contains an overall 3-fold symmetry and a 28 kDa/nm 
mass per length density. The D23-K28 salt bridge is present with a 0.35 nm distance, similar 
to the 2-fold symmetric in vitro fiber. However, the N-terminal contains a beta-stretch, similar 
to Bertini’s ?n, and the conformation of the beta-1 and 2 segments is more intricate than its in 
vitro counterparts. Nonetheless, the peptide adopts roughly a hairpin conformation instead of 
a serpentine-like superpleated structure.  
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Figure 1.8 Differences between in vitro and human brain derived A?1-40 fibers: the D23-K28 salt bridge is tight both in the 2-
fold symmetric in vitro fibers and in the human derived fibers. (a) Detailed molecular structure of A?1-40 prepared in vitro at 
24°C with agitation (PDB 2LMN): (b) Quiescently grown fibers displaying a 3-fold symmetry (PDB 2LMP). (c) Detailed 
model for fibers produced by seeding with brain derived tissue from an AD patient. Notably, no polymorphisms were found 
inside the same brain, but between two different brains, the ssNMR spectra revealed structural differences that can correlate 
with clinical presentation. Adapted with permission from references (24) Copyright © 2015 Elsevier Inc. All rights reserved 
and (33) Copyright © 2013 Elsevier Inc. All rights reserved. 
 
This cross-patient polymorphism reveals a complex landscape for A? toxicity. Not only the 
aggregation process and its associated oligomers can be toxic, but also specific conformations 
may respond for different clinical presentations. In addition to wild type A?, the strong 
correlation between certain mutations and early onset familial types of AD (FAD) ties a close 
link between A? and the disease. Several mutations have been described, many of them 
surrounding the glutamic acid (E) at position 22 of the A? sequence. For example, the Arctic, 
Dutch and Italian mutations replace E22 with a glycine, glutamine and a lysine respectively.  
 
Recently, a model of the Osaka mutant50 fiber containing a deletion of E22 (E22?A?1-40) has 
been proposed using ssNMR51. Figure 1.9 depicts the proposed structure, in which K28, instead 
of establishing a salt bridge with D23, does so with the glutamic acid at position 3 (E3) of its 
homologous pair. In this morphology isoleucine 32 interacts with valine 40 (I32-V40), which 
disrupts the otherwise beta-2 stretch forcing it to kink outwards. Therefore, instead of a U-
shaped monomer, the peptide adopts a serpentine-like conformation that pairs with its 
homologous counterpart. The distinctive morphology of in vitro E22?A?1-40 fibers is not 
necessarily due only to the E22 deletion, but may also result from sample preparation 
conditions: it is most likely a consequence of both.  
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Figure 1.9 Detailed structural model for Osaka mutant E22?A?1-40 fibers. (a) Backbone model showing important inter and 
intramolecular contacts. Notice the departure from the simple U-shaped monomer as the I32-V40 contact forces the otherwise 
beta-2 strand in wild type A?1-40 fibers to bend inwards. Residues from 30 to 40 are then broken into three beta sheet segments, 
connected by kinks. (b) Configuration of 20 monomers of E22?A?1-40 in 3D defining the protofibril of this mutant. A mature 
fiber is likely made of multiple intertwined structures like this one. Reproduced and adapted with permission from reference 
(51) Copyright© 2014 The Authors. Published by Wiley-VCH Verlag GmbH & Co.  
 
Another important mutation that contributes to the current understanding of detailed structural 
models for A?1-40 is the replacement of aspartic acid at position 23 with an asparagine 
(D23NA?1-40). This substitution known as the Iowa mutation was found in kindred patients 
who presented severe brain lesions, marked by a devastating cerebral amyloid beta-protein 
angiopathy (CAA)52. This mutant revealed the existence of anti-parallel beta sheets along the 
fibril axis, which can be called an intermolecular registration polymorphism, following the 
nomenclature established for amyloid-like microcrystals53. Figure 1.10 shows the detailed 
structural model obtained for this fiber, in which hydrophobic contacts inside the U-shaped 
monomer stabilize the peptide. Up to residue 16, the peptide is disordered, followed by beta-
sheet stretches between residues 17-21 and 31-35: these rigid segments are united in a U-
shaped monomer via hydrophobic contacts of residues 17, 19, 21, 30, 32, 34 and 3654.  
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Figure 1.10 (a) On the left, a schematic view of a D23NA?1-40 protofibril in antiparallel stacking. On the right, a rough model 
of the typical parallel protofibril found for wild type A?1-40. Green boxes represent hydrophobic contacts, analogous to the 
heterosteric zippers proposed for amyloid-like microcrystals (b) (PDB 2LNQ) Molecular view of two (front orange, back blue) 
Iowa mutant monomers and the orientations of amino acid side groups. (c) A molecular backbone rendition of how the 
monomers pack relative to one another on a mature fiber: four monomers associate to form the fiber. Two layers are shown; 
therefore 8 monomers are depicted in 3D. Adapted from reference (54) with permission from the authors.  
 
The Iowa mutant structure raises profound questions on how full length proteins and peptides 
pack along the fiber axis in the amyloid state. It is commonly held that amyloid fibers are 
defined by an in-register, parallel beta-sheet conformation, in which rigid segments are spaced 
by ~4.8 Å. The satisfaction of hydrophobic interactions that drive amyloid formation was 
proposed to be maximized in this parallel in register arrangement43. However, antiparallel 
intermolecular packing has been described for short peptides in the crystalline form55,56 and for 
fibers made of short A? fragments41,57. The argument for parallel arrangements rests largely 
on a two-dimensional interpretation of beta-sheet interconnectivity43, and contradicts the anti-
parallel findings of short segments which are, to a first approximation, two-dimensional (i.e. 
flat). Nonetheless, this argument has agreed with all models proposed for several larger 
proteins and peptides58,59 until the model proposed for D23NA?1-40 was published. The authors 
propose that the antiparallel version is thermodynamically metastable, because mixtures of 
both fibers culminate in the parallel conformation, via monomer exchange. It also indicates 
that the nucleation rate of less structured, anti-parallel D23NA?1-40 oligomers is higher than 
that of parallel structures. This suggests that certain nuclei or oligomers can have an anti-
parallel conformation, which are challenging to isolate and study, but can be related to 
oligomeric toxicity54. Regardless the intricacies, this finding questions the paradigm of in 
register parallel beta sheets in mature fibers, and points towards less structured oligomers with 
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a degree of antiparallel arrangement56, which in turn can have higher surface tension following 
classical nucleation and growth theory.  
 
In addition to A?1-40 fibers, several other amyloidogenic peptides have been carefully studied. 
Each system poses its own experimental challenges: for example, two additional residues, 
isoleucine and alanine at positions 41 and 42, extend the A? molecule to its A?1-42 version that 
is less water soluble, thus more prone to aggregation. It is safe to assume that A?1-42 presents 
the same, if not greater, polymorphic behavior as the 40-residue species. The attempts to 
determine detailed structural models of A?1-42 fibers confirm this trend. Although hairpin U-
shaped monomers32,60 have been observed for A?1-42 fibers, recent works reveal superpleated 
serpentine-like monomeric arrangement61 (Figure 1.11(a) and (b) respectively).  
 
The earliest, and perhaps best-known A?1-42 model was not obtained from ssNMR, but rather 
through quenched hydrogen-deuterium (H/D) exchange in solution-based NMR, along with 
mutagenesis and careful cryo-electron microscopy (cryo-EM). The model proposed by Lührs 
et al. revealed a disordered N-terminal up to residue 17, followed by two beta-sheet stretches 
(beta 1 and 2) connected by a loop that spans residues 26 to 30. This model resembles the A?1-
40 models, but displays key differences: namely the K28-D23 salt bridge that stabilizes the turn 
is intermolecular. In other words, the lysine 28 in molecule i establishes a salt bridge with the 
aspartic acid 23 of the neighboring molecule i+1. Figure 1.11(b) shows a remarkable image 
obtained in this work: a 3D model of a mature fiber, made of 4 protofilaments was built to 
scale, and the image was rendered in a blurred grey scale with 2 nm resolution. Then, they 
acquired negatively stained cryo-EM images of the fibers using ammonium molybdate to 
increase the electron density of the aqueous medium. The images obtained (Figure 1.11(b)) 
reveal discrete intertwined lines that the authors interpret as single protofilaments32.  
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Figure 1.11 Different detailed structural models for A?1-42. (a) (PDB 2BEG) A U-shaped model obtained through H/D 
exchange in solution NMR, mutagenesis and EM. (b) Simulation of a full fiber made of four protofibrils and the corresponding 
gray-scale rendition, and two examples of negatively-stained cryo-EM images showing remarkable similarity (scale bar 50 
nm) (c) (PDB 2MXU) van der Walls surface rendition of S-shaped A?1-42 structure showing intramolecular contacts. Green 
side chains are hydrophobic. (d) View of in register parallel S-shaped monomers down the fibril axis, highlighting the unique 
K28-A42 salt bridge. Adapted with permission from references (32) Copyright© by the National Academy of Sciences and 
(61) Copyright© 2015, Rights Managed by Nature Publishing Group.  
 
Detailed structural models of A?1-42 have been proposed using ssNMR by other groups46,60,61. 
Similar to A?1-40, separate groups have found different structures, however polymorphs were 
not reproducibly created and distinguished form one another, as done by Tycko and co-
workers28. A recent model shows A?1-42 in a conformation that resembles the Osaka mutant 
shown in Figure 1.9: instead of the usual U-shaped monomer, the peptide adopts an S-like 
superpleated shape61. Three beta-sheet domains encompass residues 12-18 (?1), 24-33 (?2) and 
36-40 (?3), which adopt a serpentine-like conformation relative to one another. Figures 1.11(c) 
and (d) show different representations of this structure, next to the U-shaped conformation 
proposed by Lührs et al. for comparison. The distinguishing feature of this configuration rests 
on the salt bridge between lysine 28 and the C-terminal carboxyl group of alanine 42. Such 
interaction has never been reported for A?1-40 and is somewhat surprising given the availability 
of other negative charges such as glutamic acid 3 in the disordered N-terminal. All other 
intramolecular stabilizing hydrophobic contacts are shown in Figure 1.11(c) with dotted lines.  
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A?1-42 fibers that adopted this conformation could not seed the growth of A?1-40 fibers with the 
same structure. The authors concluded that a structural requirement prevents cross-seeding 
between the two different types of A?: once a structure is formed, only peptides exactly 
congruent with the constitutive fiber monomers are able to join the conformation, which can 
explain the self-recognition of the amyloid state as discussed in the common ancestor 
hypothesis34. However, cross-seeding between E22?A?1-40 (Osaka mutation) fibers and wild 
type A?1-40 showed that fibers made of the 39-residue mutant can seed the growth of wild-type 
A?1-4062. Whether the wild-type peptide adopts the 3D structure of the mutated version remains 
unknown.  
In summary, the polymorphic nature of beta-amyloid (A?) peptides has been exhaustively 
characterized in the literature, and its structure-property relationships are far from being 
resolved. Rather than experimental error or inaccurate data interpretation, these different 
conformations for the same molecule reflect a complex energy landscape with several local 
minima. Depending on the exact conditions of sample preparation, the peptides adopt 
conformations with marginally different free energies47. Figure 1.12 illustrates several different 
in vitro detailed structural models for A?1-40 and A?1-42. The arrows indicate the segments in a 
beta-sheet conformation, and as described in the amyloid-like microcrystal section, 
independent groups have studied different segmental polymorphism available to this sequence. 
Different segmental polymorphs can translate into markedly distinct 3D structures, which 
explains the diversity of fibers observed in a sample.  
 
 
Figure 1.12 List of important segmental polymorphisms proposed by different groups in the past 15 years for the A? sequence. 
All models are established by modelling the peptide under the constraints imposed by ssNMR and EM, except the Lührs et al. 
2005 model that relied on a H/D exchange experiment.  
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1.4.2? A structural model for ?-synuclein  
 
Synucleins (?, ?, and ?) are abundant in the pre-synaptic terminals of the central nervous 
system63,64. Their exact function is not fully understood, but they may play a role in synaptic 
plasticity and vesicle recycling65. ?-synuclein is the most abundant fibrillar species in the Lewy 
bodies found in dopaminergic neurons (and other types of neurons) of Parkinson’s disease (PD) 
patients14. Mutations and overexpression of ?-synuclein results if familial, early-onset forms 
of PD, which reveals the possible causative role of this protein66. ?-synuclein is also found as 
an amyloid in the senile plaques of AD patients, and is correlated to different diseases, such as 
dementia with Lewy bodies, multiple system atrophy among others, collectively grouped as 
synucleopathies67.  
 
The amino acid sequence of ?-synuclein can be separated into three regions: (i) the N-terminal 
region from residues 1 to 60 is amphipathic; (ii) the central region between 61 and 95, called 
the non-amyloid beta component (NAC), consists of a hydrophobic segment prone to beta sheet 
formation; and (iii) the C-terminal that contains several acidic amino acids, which gives ?-
synuclein a net-negative charge in neutral pH. Figure 1.13(a) schematically depicts the 
sequence of ?-synuclein, showing these three main subdivisions. Although idiopathic PD 
remains unclear, several mutations, mostly in the N-terminal segment, have been reported to 
correlate with familial early-onset PD: for example, as shown in Figure 1.13(a), if threonine 
replaces alanine at position 5368, the disease manifests early, as an autosomal dominant trait in 
the families that carry the mutation. Several other point mutations in addition to gene 
duplication and even triplication renders the syndrome an autosomal dominant trait of how ?-
synuclein is expressed14.  
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Figure 1.13 Possible structural constraints for ?-synuclein. (a) Schematic subdivisions of the primary structure of ?-synuclein, 
highlighting: the amphipathic N-terminal; the hydrophobic central part (NAC); and the negatively charged acidic C-terminal. 
The site of a mutation A53T is shown: most reported pathogenic mutations occur in the N-terminal. Two segmental 
polymorphisms for ?-synuclein fibers reported by different laboratories are shown. (b) In a third model for ?-synuclein in the 
amyloid state, the authors proposed a 3D model for the fiber. (c) Cryo-EM of twisted filaments and a 3 nm resolution model 
of it. The mature fiber structure was proposed using constraints from, H/D exchange experiments, ssNMR and cryo-EM. The 
cross-section of one of their proposed structures contains 4 beta-arcade monomers: in this model, the edge of the twisted fiber, 
which also corresponds to the thinnest diameter at the node (5 ± 1 nm) is made of solvent exposed beta sheets. This figure is 
adapted with permission from references: (30) Copyright © 2015, Rights Managed by Nature Publishing Group and (69) 
Copyright© by the National Academy of Sciences. 
 
Figure 1.13 shows the general structural features that have been reported for ?-synuclein. 
Several groups have used the same techniques described for A? molecular structure 
determination for ?-synuclein fibers with some degree of success59,69-71. Due to its length, 
several segments can adopt a beta sheet conformation, interconnected by loops, giving rise to 
a beta-arcade superpleated monomer. Figure 1.13(b) shows the structure proposed by Vilar et. 
al69, containing five beta-strands, that fold onto one another, establishing four heterosteric 
zippers that hold the monomer together. They found that the amino acid side-chains in the beta-
1 and beta-5 strands were more solvent-exposed than those sitting at beta-2, 3 and 4. They 
proposed a 3D model of a mature fiber, in which the cross-section contains four beta-arcade 
monomers in several possible arrangements. Through careful cryo-EM analysis, they observed 
both flat fibers that did not twist and the ribbon-like structures depicted in figure 1.13(c). The 
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largest width of a twisted fiber was 11±1 nm, and the narrowest knot 5±1 nm (see Figure 
1.13(c)). The peptide used to obtain the data that support this model is the fragment from 
residues 30 to 110: it contains the core fiber forming domain of ?-synuclein, and likely 
represents how the full-length ?-synuclein arranges in the amyloid state. Although segmental 
polymorphisms have been shown by other groups, the way beta-arcade monomers self-
assemble to form a twisted fiber probably follows a structure similar to Figure 1.13(b).  
 
If we approximate the object imaged under cryo-EM in Figure 1.13(c) to a twisted ribbon, 
according to their model, the edges of this ribbon correspond to solvent-exposed beta sheets. 
In other words, the smallest dimension of the twisting object is the length of two combined 
beta sheet surfaces: beta-1 and beta-5 (blue and red in Figure 1.13) establish an extended 
surface 5.5 nm wide. These two surfaces are always separated by about 11 nm, which means 
that the other, longer surface, of the twisted ribbon is made of loops and the disordered 
segments that protrude outwards from the fiber core.  
 
1.4.3? Amyloid fibers made of large proteins: the example of Tau 
 
Another pathognomonic amyloid is found in the paired helical filaments (PHFs) formed by 
Tau, a microtubule-associated protein that plays an important role in axonal growth and 
function15,72. The PHFs are intracellular amyloids that aggregate as neurofibrillary tangles 
(NFTs), one of the hallmarks of AD, along with the senile plaques and cerebral amyloid 
angiopathy73. Like ?-synuclein, Tau is associated with a collection of neurodegenerative 
diseases that include Pick’s disease, sporadic corticobasal degeneration, progressive 
supranuclear palsy among others, grouped as tauopathies74. Tau is found in the amyloid state 
and can form fibers in vitro, but the detailed structural models for the core of Tau fibers are not 
as well-established as reviewed for A?: the main difficulty is sample heterogeneity, because a 
given fragment of Tau forms polymorphic fibers in a single preparation, which gives poor 
spectroscopic data75. Nonetheless, structural considerations for the complex interfaces 
generated by Tau in the amyloid state are shown in Figure 1.14. 
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Figure 1.14 Considerations on Tau protein fiber structure. (a) Schematic depiction of the primary structure of Tau-441 and a 
truncated version, TauRD that lacks the disordered segments. It highlights the polyelectrolyte nature of the disordered tails 
that form the fuzzy coat. (b) A ssNMR model of a 99-residue core-forming fragment of Tau (K19), that includes R1, R3 and 
R4 from the scheme shown of the primary structure. It reveals an in register parallel beta sheet formed by the R3 segment: 
V306-S324. Two types of cysteine disulfide bridges are proposed: one that joins beta strands along the axis of the protofibrils, 
and another that unites two different layers. Reproduced from reference (75) Copyright © 2012, American Chemical Society 
(c) A schematic depiction of how the fuzzy coat surrounds Tau fibers, similar to a polyelectrolyte brush (d) Anti-Tau labeled 
nanoparticles (Immunogold) show a diffuse distribution surrounding the fibril core, consistent with binding to the disordered 
segments that constitute the fuzzy coat. On the right, the fibers were digested with Pronase, which the authors claim removed 
the disordered segments, thus eliminating immunogold labeling. Measurements in white show the distances between 
nanoparticles that associate to the fuzzy coat, and in red, the core of the fiber. Reproduced from reference (76). (a) and (c) are 
reproduced with permission from reference (77).  
 
Similar to A? and ?-synuclein, Tau can form an amyloid fiber with a twisted ribbon 
morphology. Because of its long disordered protruding segments, the surface of the amyloid 
fold is buried within a polyelectrolyte brush formed by the N-terminal domain that can be 
subdivided in two segments: (i) the negatively charged ND segment from residues 1 to 120, 
and (ii) the positively charged MD portion from 121 to 243. Figures 1.14(a) and (c) show how 
the N-terminal forms radially protruding disordered segments that can be approximated to a 
polyelectrolyte brush77. Figure 1.14(d) shows immunogold labeling that targeted regions of the 
disordered segments: when the fiber is treated with Pronase, the immunogold labeling no 
longer forms a cloud of particles around the fiber core76. The center-to-center interparticle 
distances in these images range from ~20 nm to ~50 nm, whereas the widest portion of the 
twisted ribbon measures ~15 nm, and the width at the knot is ~6.5 nm. The fuzzy coat may 
likely mediate how Tau fibers interact with other objects such as cell membranes77 but it also 
provides an ‘extreme’ type of amyloid fiber that displays long disordered domains, to test 
whether our nanoparticles interact with the core of the amyloid fibers or if they scatter around 
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the disordered tails, as seen in Figure 1.14(d). The other two amyloid precursors reviewed so 
far (A? and ?-synuclein) also have disordered protrusions, albeit much shorter.  
 
1.5?  Structural considerations on the twisted ribbon morphology 
 
The proposed detailed structural models discussed in the previous sections reveal that a single 
building block can adopt different morphologies in the amyloid state23,24,27. How these 
morphologies associate in 3D to form the mature amyloid fiber is not trivial to establish. In this 
thesis, we rely on several experiments, including cryo-EM images, to determine how the size 
and ligand shell of gold nanoparticles dictate their interaction with amyloid fibers. If an EM 
image is analyzed and compared to a model from the previous sections, one can arrive at 
somewhat straightforward conclusions. For example, when three strings of nanoparticles 
intertwine in space around an A?1-40 fiber, the phenomenon is likely an adsorption onto an 
object that follows the 3-fold symmetric model, illustrated in Figures 1.6, 1.7 and 1.828,78. On 
the other hand, we commonly observed two-fold symmetric fibers with a twisted ribbon 
morphology. Different groups have ascribed to these surfaces distinct components of the 
monomeric building blocks32,79,80. For example, the A?1-42 and ?-synuclein models, shown 
respectively in Figures 1.11(b) and 1.13, predict a twisted ribbon morphology, in which the 
edges (that we define as the smallest cross-sectional length), are made of extended solvent-
exposed beta sheets. Other groups that used cryo-EM images to propose structural models for 
A?1-40 and A?1-42, have indicated that the edges are made of amorphous N-terminal segments79-
83. If all models are taken into account, three types of structure can sit at edges: solvent exposed 
beta sheets, loops and transitions between beta sheet segments and disordered tails and the 
partially disordered N-terminals proposed by cryo-EM. The latter were prepared in 
considerably different ways, for example, using 50 mM sodium borate at 4°C and pH 7.839. 
The dry TEM images reported by these papers differ from the morphologies observed in the 
fibers used for ssNMR experiments, which means different objects were studied and reported. 
Figure 1.15(a) and (b) show the findings from cryo-EM reconstruction studies and the proposed 
structural models for A?1-40 and A?1-42.  
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Figure 1.15 (a) Cryo-EM and reconstructed fibers for 4 or the 12 polymorphs observed in the same sample. Reproduced with 
permission from reference (79) Copyright © 2008 Elsevier Ltd. All rights reserved. (b) The proposed arrangement of the 
monomers in the twisted ribbon structures: on the top, a recent proposal for A?1-42 obtained from mass density analysis of 
cryo-EM images. On the bottom, the comparison to structures obtained by the same group for A?1-40 fibers. Adapted from 
reference (80) (c) Same image as in Figure 1.10(b) to compare the proposed arrangement of protofilaments in a twisted ribbon 
morphology under cryo-EM. While the models in (b) propose partially disordered N-terminals on the edges, the model in this 
image attributes solvent exposed beta sheets to these sites. These are dramatically different structures for the same peptide. (d) 
Stable zippers that can hold the A? monomers together: six combinations of four protofibrils are shown, four of which 
culminate in twisted ribbon morphologies that have solvent exposed beta sheets on the edges. The bottom two predict a 
combination of loops (or kinks) and ‘open ends’ on the edges. Reproduced from reference (26). 
 
Figure 1.15 summarizes the different ways in which A? protofibrils can assemble to form a 
mature amyloid fiber. The protofilament is defined here as the sequence of folded monomers 
that form a single layer (a lamina), of the amyloid fiber: it is the unit with a ~4.7 Å meridional 
X-ray signal. In the protofilament, the beta sheet segments of the monomers are stacked in 
register and parallel to one another. The exception to this rule was shown in the Iowa mutant 
model (Figure 1.10), that showed an antiparallel inter-monomer arrangement in the mature 
fiber54. The way different protofilaments associate with one another in 3D establishes the 
mature amyloid fiber (a single protofilament can be the amyloid fiber itself). Figures 1.15(a)-
(c) and (d) show different interpretations to the molecular nature of the surface on the edges of 
the twisted ribbon fibers. They are not mutually exclusive, and are probably accurate 
interpretations of the data acquired for their experiments. However, each experiment was done 
in different conditions: notably, the cryo-EM images in Figure 1.15(a)-(c) were acquired from 
samples prepared at lower pHs and high monomer concentration compared to all the ssNMR 
reviewed here, which can affect the structure of the fibers and cause the reported differences.  
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The A? sequence establishes several types of steric zippers that can reconcile these different 
observations. The group of Prof. Eisenberg determined the structure of microcrystals made of 
different sequences from the A? peptide, with the same approach described in section 1.326. 
Figure 1.15(e) shows the repertoire of accessible morphologies when the steric zippers are used 
to tie together the detailed structural models for A?1-40 and A?1-4232,78. Four protofibrils are 
united via the favorable steric zippers in the A? sequence, showing that both interpretations for 
the cryo-EM images in Figure 1.15(a)-(c) are possible. Most commonly, the smallest cross-
sectional dimension, i.e. the edge of the ribbon, is a solvent-exposed beta sheet, as in the case 
proposed for ?-synuclein in Figure 1.13.  
 
Although this reductionist approach can reconcile and provide a mechanism for 
polymorphisms, it does not ‘predict’ the 3-fold symmetric fibers shown in Figure 1.6. The 
landscape for amyloid polymorphisms remains vast, and no single mechanism seems capable 
of explaining all possible variations. The only complete amyloid fiber that has a high-resolution 
structural model is the prion-forming domain of HET-s(218-289)58, precisely because it shows 
little polymorphism, which enabled the determination of a high-quality structural model. Most 
disease-related amyloids come from proteins meant to adopt a native conformation that differs 
significantly from the amyloid fold, whereas the HET-s(218-289) protein belongs to a 
functional amyloid, that has been selected by evolution to adopt a particular amyloid 
conformation: this likely homogenizes samples of these fibers to a dominant morphology. 
Therefore, it is not surprising that in the amyloid state, several energetically equivalent 
morphologies are observed for disease-associated amyloids, which in turn causes different 
structures to exist47. 
 
1.6? Summary of proposed amyloid structures 
 
This thesis shows how different types of water soluble gold nanoparticles interact with amyloid 
fibers, with an emphasis on the role of the nanoparticle ligand-shell. Several chemical 
functionalities that make the nanoparticles soluble in buffered conditions are tested: the surface 
chemistry of gold nanoparticles is the main determiner of this bio-nano interface. The size of 
the nanoparticle also affects their interaction with this class of biomolecules. The review 
offered thus far allows for the interpretation of the images presented in the remainder of the 
thesis.  
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The remainder of this chapter introduces the field of monolayer-protected metal nanoparticles, 
and shows how we have been using experiments and simulations to develop nanomaterials 
capable fusing with lipid bilayers. It combines the current state of the literature with my recent 
contributions to the field, both on the understanding of ligand phase-separation, and in the 
development of amphiphilic nanoparticles for the development of cell-penetrating 
nanoparticles.  
1.7? Introduction to metal nanoparticles 
 
Gold nanoparticles have been intensively investigated for past two decades as one of the 
cornerstones of current-day nanoscience. Some of the fascinating properties of these materials 
have intrigued glass blowers of the past, as exemplified by the Lycurgus cup81, a 4th century 
AD dichroic glass cup. The unusual optical properties of this artefact rely on the presence of 
gold and silver particles that produce red color in transmission and green in reflection. Other 
glasses that incorporated metallic salts in their preparation, that form colloidal metal, display 
peculiar optical properties and have been used to manufacture ruby glasses82. The first account 
of “minuscule metallic particles” was given by Faraday in his Bakerian lecture in 1857, when 
he described unusual optical properties of suspended metallic species, especially when made 
of gold83. Evidence that these species were indeed minuscule metallic particles, denominated 
colloids, was given in 186184, and consolidated by Turkevich in 195185. 
 
Colloidal science and interfacial phenomena have become a large field of study that spanned 
different areas of chemistry, physics, materials science and biology. It took the development 
of nanoscience to elucidate several recalcitrant questions in these fields. The transition in 
nomenclature to include the prefix “nano”, meaning a 10-9 scaling factor in the metric system, 
can be traced back to several origins86. The term “nanno” (with two n’s) was first used in the 
scientific literature to describe findings in fossilized plankton87. The seed of nanoscience, 
however, is commonly attributed to Richard Feynman’s talk in December of 1959, at Caltech, 
entitled “There's Plenty of Room at the Bottom”, when he entertained the idea of manipulating 
matter atom by atom. This was achieved in 1989 by Eigler and Schweizer using a scanning 
tunneling microscope (STM) to spell “IBM” using xenon atoms on a nickel surface88.  
 
There are varying degrees of stringency applied to the denomination of a material, device or 
structure as nano: some authors require the satisfaction of the atomic manipulation criterion86, 
while others accept the terminology on the basis of relevant size scales89. Whatever the criteria, 
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this nomenclature has burgeoned since the accomplishments obtained with the STM and has 
shaped research in the past 20 years with new techniques to manipulate and study matter at the 
nano scale. This impact includes a change in the traditional nomenclature of colloidal science 
that culminates in current-day nanoparticle research. Owing to this shift in approach, scope and 
techniques, recent works on nanoparticles differ substantially from the days of colloidal 
science: for example, only recently the importance of nanoscale structure to interfacial energy 
has been elucidated90.  
 
1.8? Overview of self-assembled monolayers and nanoparticles 
 
Despite the interest in directly manipulating matter at the atomic scale88, the study of how 
molecules spontaneously self-organize is a cornerstone of nanoscience89. Thiolate molecules 
form self-assembled monolayers (SAM) on flat gold (Au) surfaces, because of an interplay 
between the robust S-Au bonds91 and van der Waals interactions established between the 
molecules92,93. A rigid interpretation of the S-Au bond is unlikely to capture the dynamic co-
existence of different bonding motifs that establish the gold-thiolate inteface92-94.  Different 
sulfur containing species can form SAMs on gold: thiols (RSH), disulfides (RSSR) and even 
thioethers (RSR), where R stands for an alkyl or aryl group. In fact, the first reported sulfur-
based SAM on gold was obtained using disulfides95, which then led to several studies on a 
variety of SAMs on gold. Figure 1.16(a) shows schematically the basic features that underlie 
a SAM on gold and Figure 1.16(b) depicts recent experimental and theoretical developments 
on the dynamic nature of the Au-S bonding motif on a SAM.  
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Figure 1.16 (a) Schematic view of a thiolate self-assembled monolayer on flat gold. On the right, at a low density, the lying 
down or striped phase, when the alkanethiols establishes a Au-S bond but adopt a configuration parallel to the surface. As the 
density of thiols increases, they adopt the standing up phase which can be ordered or slightly disordered. (b) Recently proposed 
bonding motifs between Au and S atoms. The standard model assumes a single sulfur on top of a hollow site on an 
unreconstructed gold surface. This conventional bonding has been questioned by several calculations and experiments that 
show: possible disulfide bonding; a sulfur on top of a Au adatom; or a sulfur-gold polymeric chain. On the very left, a motif 
backed by recent experimental data in which a RS-Au1+-SR staple is formed. Adapted with permission from references (a) 
(89) Copyright © 2005, American Chemical Society and (b) (91) Copyright © 2007, The American Association for the 
Advancement of Science 
 
The interfacial properties of a SAM, for example wetting, are dictated by the molecular end 
groups of the constituent thiol. The behavior of SAMs made of different thiols in binary (or 
ternary and greater) mixtures on the surface posed a research challenge in the 1990s96,97. 
Stranick et al. showed that binary SAMs, depending on the sample preparation conditions, tend 
to phase-separate into nano-sized domains98. The Gibbs free energy of the system reaches a 
minimum through a trade-off between entropy maximization that drives random mixing, and 
minimization of enthalpy that is satisfied via favorable intermolecular contacts, that drives 
phase separation. The competing driving forces for separation and mixing result in nano-sized 
islands98. This thermodynamic trade-off is common in materials science and its 3D soft 
material archetype rests on the phase-separating mechanisms behind the intricate 
nanostructures adopted by block copolymers99.  
 
When a binary self-assembled monolayer is confined to a small, highly curved 3D object such 
as a nanoparticle, geometric constraints affect how the molecules phase separate. When 
alkanethiols have a size-mismatch, there is an entropic gain for the taller ligands to access 
conformations otherwise unavailable in a side-by-side packing with homologous molecules100. 
This favors tall/short interfaces that, at suitable stoichiometries, manifest as linear alternating 
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domains of each molecule100,101. Figure 1.17 summarizes schematically the driving forces 
behind phase separation in flat and curved binary SAMs, the predicted morphologies and STM 
images for each instance. Figure 1.17(a) shows a cross-sectional schematic representation of 
nanophase separation on a flat surface, followed by the predicted computational model of the 
morphology and the strikingly similar STM image of a surface covered by a mixture of 1-
butanethiol and 1-hexanethiol. The phase separation is evident, however, the domains are 
disordered. Figure 1.17(b) illustrates that when the two ligands are confined to a curved 
surface, the gain in free-volume, in other words, the increase in head-group conformational 
entropy drives ordered phase separation. This driving force favors tall/short molecular 
interfaces, which correspond to the formation of stripe-like domains. The two STM images 
correspond to 4 nm particles protected by 3-mercaptopropionic acid and 1-octanethiol. The 
lines of the taller molecule give the particle its striped morphology, despite some defects in the 
monolayer. Finally, when the particles are below a size threshold, enthalpy becomes the 
dominant parameter and calculations predict complete phase separation100. This Janus 
morphology was identified under STM imaging of a particle protected by 11-mercapto-1-
undecanol and 4-mercapto-1-butanol, seen in Figure 1.17(c)101. The data shown in Figures 
1.17(b) and (c) result from our recent work in the investigation of ligand phase separation on 
gold nanoparticles using STM.  
 
 
Figure 1.17 (a) Overview of binary SAMs on flat surfaces showing the phase-separation pattern predicted by theory and the 
STM image that matches the calculated morphology. (b) Schematic view of the free-volume gain that correlated to a 
conformational entropic gain, leading to the formation of stripe-like domains on a simulated nanoparticle. On the right, two 
images we have recently obtained at high resolution STM (trace and retrace) for 1-octanethiol and 3-mercaptopropionic acid 
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protected particles: the spacing between molecular end-groups across two lines is 1 nm, and within a line 0.5 nm. (c) Schematic 
representation for a monolayer on a particle in which the enthalpic component predominates, and total phase separation is both 
predicted by theory, and observed with STM. Reprinted and adapted from references (100) Copyright © 2007, American 
Physical Society and (101) Copyright © 2013, American Chemical Society.  
 
It is possible that, similar to the amyloid fibers, different morphologies are available to 
monolayer protected gold nanoparticles (AuNPs), and perhaps, careful annealing can favor 
certain monolayer structures. Like in the amyloid case, the issue of property-structure 
relationship can be difficult to verify, but our group has successfully demonstrated the role of 
ligand morphology in several systems90,102,103. A good example that summarizes this section 
and demonstrates a property dictated by nanoscale phase separation is shown in Figure 1.18. 
In this experiment the contact angle and the work of adhesion to displace water molecules from 
the vicinity of the surface are measured by amplitude modulated atomic force microscopy 
(AM-AFM) for mixed-ligand SAMs on flat gold and for films made of binary monolayer-
protected gold nanoparticles. The molecules used are the hydrophobic 1-octanethiol (OT) and 
the hydrophilic 6-mercapto-1-hexanol (MHol). As the amount of MHol on the flat surface 
increases, the work of adhesion increases monotonically with composition (Figure 1.18(a) and 
(d)). When surfaces are made of the same molecules but on nanoparticles, the work of adhesion 
does not scale monotonically with the MHol content. This highlights the importance of 
nanostructure on a fundamental interfacial property. When nano-domains commensurate with 
the solvent correlation length form, the surface structure changes the work of adhesion at the 
molecular scale. Small hydrophobic regions intercalated with hydrophilic ones create pockets 
of solvent cavitation and confinement that increase the work of adhesion at intermediate 
compositions, followed by a collapse of the semi-classical behavior described by the Dupré 
equation: this observation was confirmed by molecular dynamics simulations. Naturally 
occurring complex amphiphilic surfaces such as proteins likely follow this type of wetting 
behavior, rather than a purely composition-dependent approach to interfacial energy90.  
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Figure 1.18 Experimental results for non-classical work of adhesion and contact angle (images obtained using atomic force 
microscopy, AFM). (a) Flat SAM of MHol and OT forms islands and domains larger than 5 nm, and the resulting work of 
adhesion of water is adequately predicted by the classical compositional approach. (b) When the nanodomains become 
commensurate with the water molecules themselves, a structural deviation from the classical approach to the work of adhesion 
if observed, and the results deviate by about 20% due to the nanostructure of the surface (c) Images of nanoparticles covered 
with only one ligand. (d) and (e) experimental results showing the deviation of property from a purely compositional approach. 
Reprinted with permission from reference (90) Copyright © 2009, Rights Managed by Nature Publishing Group.  
 
1.9? Amphiphilic gold nanoparticles: synthesis and characterization 
 
The potential biomedical applications for this class of materials is enormous, because 
nanoparticle structural features can be tuned at the length scale of the building blocks of living 
organisms104. These applications span from drug delivery105, biosensing106, bio-imaging107 all 
the way to direct uses as nanotherapeutics and antiviral agents108. In order to achieve the same 
breadth and utility that conventional molecular biomedical strategies enjoy, the unanticipated 
properties brought by nanomaterials need to be addressed. Furthermore, only by researching 
fundamental aspects of the bionano interface109 can novel solutions be found to address old 
problems. One of the main challenges in working with nanoparticles is the production of 
species that are stable or soluble in physiological buffers and in vivo. Most of the synthetic 
approaches available for gold nanoparticles take place in hydrophobic conditions, and produce 
monolayer-protected AuNPs suitable for non-polar organic solvents110. Although many 
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synthetic routes exist, the standard approach depicted in Figure 1.19 consists of the dissolution 
of a gold salt in water, followed by phase transfer, addition of capping ligands and reduction.  
 
 
Figure 1.19 Simplified synthetic scheme of conventional gold nanoparticles. This synthesis relies on the dissolution of 
tetrachloroaurate (Au3+) in an organic solvent: typically, the gold salt is dissolved in water, and phase-transferred to an organic 
solvent using a surfactant. In this work, HAuCl4?3H2O is dissolved directly in ethanol, to which the thiol compounds are added. 
In the presence of thiols, the Au3+ undergoes a first reduction to form a gold-thiol polymer complex. The addition of a reducing 
agent, typically sodium borohydride (NaBH4) causes the nucleation of the nanoparticles, which then grow to their final sizes. 
A TEM of a typical synthesis performed for this thesis, using a sulfonated thiol is shown to illustrate the size distribution of 
the particles. Adapted with permission from reference (111) Copyright © 2009, American Chemical Society 
 
Polar nanoparticles can be produced using the standard synthetic pathways110, which have 
typically been done with carboxylate and ethylene glycol terminated thiols. Our group has 
discovered that sulfonate terminated thiolates grant the particles remarkable buffer and in vivo 
solubility112. The ligand used to this end was 11-mercapto-1-undecanesulfonate (MUS), which 
when mixed with 1-octanethiol (OT) forms amphiphilic water-soluble nanoparticles, capable 
of diffusing through the lipid membranes of cells in vitro103. The TEM image in Figure 1.19 
shows a typical nanoparticle batch made of particles covered exclusively by MUS, named here 
homo-ligand allMUS nanoparticles (allMUS NPs). Figure 1.20 illustrates the surface 
composition of hetero-ligand MUS:OT particles (MUS:OT NPs), and shows a molecular 
model of the same nanoparticle. Other groups have found different alternatives for buffer-
stable nanoparticles, mainly using zwitterionic terminated thiols or cationic groups113,114. 
Previous work on SAMs had shown that zwitterionic head-groups reduce non-specific protein 
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adsorption115, which has been harnessed to produce in vivo stable nanoparticles, and is used in 
this thesis as a control particle in Chapter 3.  
 
Figure 1.20 Schematic view of the surface of a gold nanoparticle with a mixed SAM of MUS and OT. On the right, a 
simulation snapshot of the mixed SAM. The diameter of the gold core can be tuned both through synthesis and fractionation 
techniques. Image created by Dr. Reid Van Lehn for reference (116).  
 
The synthetic scheme in Figure 1.19 is often referred to as the two phase synthesis. The phase 
transfer step can be skipped, and the gold salt (HAuCl4?3H2O) can be directly dissolved in 
ethanol followed by addition of the thiol mixture. After a short interval, typically 5 to 20 
minutes, depending on the protocol, a saturated, filtered, ethanolic solution of sodium 
borohydride (NaBH4) is added drop-wise, which causes the thiol-gold complex to nucleate and 
grow into nanoparticles. We call this protocol the one-phase synthesis that can be used to 
produce a wide variety of monolayer-protected nanoparticles102,117. For particles covered with 
MUS and OT (the MUS:OT system), this synthesis typically yields a size distribution centered 
around 3 nm but with a high, condition-sensitive polydispersity index. To address this, when 
necessary, size-fractionations are performed using centrifugation in a sucrose gradient.  
 
Furthermore, this synthetic approach can produce populations of ultra-small particles that are 
under-represented in conventional size-distribution analyses. For example, a TEM image of a 
sample is usually analyzed using an image processing software to automatically estimate all 
the sizes and report a size distribution histogram. Any nanoparticle characterization technique 
must be approached with care: small enough particles imaged on a conventional carbon film 
may not be sufficiently electron-dense to produce a contrast that the image processing software 
can detect. To circumvent this problem, other techniques can be used, for example analytical 
ultracentrifugation (AUC)118 can capture detailed information on nanoparticle size distribution, 
but requires laborious data treatment. A simple alternative is the use of Scanning Transmission 
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Electron Microscopy (STEM) that is sensitive to the height of the particles, providing excellent 
contrast for these types of samples (Figure 1.21).  
 
 
Figure 1.21 Comparison between (left) a standard TEM image of a one-phase batch of allMUS nanoparticles, and (right) a 
STEM image of the same sample on the right. If acquired carefully, the standard bright-field TEM image can capture all 
particle sizes. Extremely small particles may appear as densities in a standard carbon grid. This can be addressed by using a 
thinner carbon grid, however, by switching the imaging mode to STEM, when possible, ultra-small particles become evident 
and sample characterization can reflect the presence of these objects that may respond for experimental findings. White arrows 
point to particularly small sub-nanometer particles, that are more evident under STEM mode. Images obtained in an FEI 
TALOSTM Electron Microscope.  
 
Other groups usually synthesize analogous particles using a place exchange approach113. 
Typically, particles are prepared using the traditional two-phase method illustrated in Figure 
1.19 and the desired ligand is place-exchanged onto their surfaces. Ideally, a nanoparticle 
protected by short alkanethiols is prepared (usually 1-pentanethiol), suspended in an 
appropriate solvent, for example, dichloromethane, and placed in contact with an aqueous 
solution of the target thiol under agitation. Longer thiolate molecules readily displace shorter 
ones, cover the particle, which makes this approach successful and creates homogeneous 
samples for a library of ligands114. Given our interest in mixed-ligand nanoparticles to study 
how surface nano-structure affects properties, it is difficult to control and reconcile the 
solubility of two disparate molecules in this kind of preparation, hence the preference for a 
direct synthetic approach that gives an exact ligand stoichiometry and allows us to reproducibly 
study mixed-ligand nanoparticles. 
 
To synthesize larger (4-7 nm) less polydisperse nanoparticles, several conditions using a 
synthetic pathway designed for non-polar ligands were tested119. The synthesis of nanoparticles 
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can be sensitive to several factors: ultimately, an interplay between the chemical potential of 
the different species in the flask and kinetic barriers determine the outcome. When all species 
are soluble during the synthesis, molecules and thiol-gold complexes can exchange across the 
different species to approach thermodynamic equilibrium. Nevertheless, when using two 
ligands with different solubility, exchange of material can be hampered by the high free energy 
cost for an insoluble species to transfer from one assembly to another: in others words, the 
ligand exchange in a bad solvent is not favorable. The particles are, to a first approximation, 
kinetically trapped. We have adapted the method by Zheng et al. that relies on the reduction of 
a gold phosphine precursor (Au1+), to produce MUS-based nanoparticles. Briefly, AuPPh3Cl 
was dissolved in a solvent mixture of 10% water in dimethylformamide (DMF) along with 
MUS and/or OT, and brought to 125°C. The mixture was allowed to equilibrate for 10 to 20 
minutes, followed by the addition of a borane reducing agent (tert-butylammonium bromide, 
etc), in the same solvent mixture. The solution was allowed to stir for one hour, then cooled to 
room temperature and held at 4°C overnight. The nanoparticles precipitated as a black powder 
that was then washed via centrifugation-assisted decantation, followed either by dialysis or 
membrane centrifuge filtration. In this thesis, this method is referred to as the modified Stucky 
synthesis. 
 
The combination of these two synthetic protocols, one-phase and modified Stucky, in addition 
to the sucrose-gradient fractionation120 gave us reasonable control over the particle size 
distribution. Some nanoparticle parameters vary across separate syntheses, for example, the 
ratio between the two different ligands. This issue was addressed by fine-tuning the sample 
preparation for nuclear magnetic resonance (1H-NMR) ligand-ratio determination (Figure 
M.12 in methods). Similar to early works on SAMs97, the ratio of thiols added to the reaction 
does not necessarily correspond to that found on the monolayer. Longer alkanethiols form more 
stable SAMs because their chemical potential in the monolayer phase is lower than that of a 
shorter molecule. This can be explained by the satisfaction of intermolecular van der Waals 
interactions that scale with the length of the molecule, hence, the chemical equilibrium of 
longer alkanethiols favors the monolayer phase compared to its shorter counterparts. From our 
analysis of different syntheses, this rule seems to apply for MUS:OT particles made via the 
one-phase method, in which MUS was over-represented in the final particle ligand ratio. 
However, particles synthesized following the modified Stucky approach had usually a lower 
MUS to OT ratio than that used during the reaction. This indicates that a purely thermodynamic 
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explanation is unlikely to capture all relevant parameters determining this ratio. Figure 2.7 
shows the results of the feed ratio versus calculated post-synthesis stoichiometry for several 
batches synthesized using the two different methods. The approach used to obtain these ratios 
is shown in the methods chapter. This chart is only representative of the nanoparticles we 
prepared in the past few years with these protocols; the system is sensitive to small variations, 
and numbers that do not follow this trend are not necessarily inaccurate. 
 
 
Figure 1.22 The horizontal axis shows the percentage of OT added to the reaction mixture, while the vertical gives the 
calculated ratio on the particles from the etched sample, measured by 1H-NMR (details in Methods chapter). Squares denote 
individual batches of modified Stucky syntheses and diamonds one-phase. Each point is the final ratio, and the instrumental 
error bar can be estimated between 2 to 5% depending on the quality of the NMR spectrum and how it was treated. The black 
line shows a f(x) = x function to help understand where the ratios fall respective to a faithful correlation between feed and 
calculated ratios. There seems to be a trend for one-phase, that lies below the expected ratio: however, more experiments are 
needed to determine how these compositions converge to the central line. The modified Stucky protocol is still under 
development, and recently we’ve succeeded in getting feed and calculated ratios to match. It must be highlighted that different 
people in different times may have obtained results outside the trends above: these reflect observations from syntheses 
conducted exclusively in the past 4 years. 
 
These particles are amphiphilic, and their water solubility decreases as the amount of OT 
increases. For Stucky particles, the water-solubility threshold seems to be around 30-34% OT, 
but this value is slightly higher for one-phase batches. The mechanism behind this difference 
in solubility is still unclear, but can be due to a size-effect: given the same hydrophobic content, 
1 nm NPs may be more soluble than a 5 nm one because of greater ligand end group mobility 
in small particles. These assessments are still qualitative, but carry an important message: 
particles with a high OT content can be solubilized by adding small amounts of an organic co-
solvent (5% ethanol or DMSO) to the water or buffer. This means that biological experiments 
with hydrophobic nanoparticles, possibly carrying unusual nanostructures, are feasible. Figure 
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1.23 shows three different UV-vis spectra for particles synthesized via the modified Stucky 
method with feed ratios of 9:1, 8:2 and 7:3 that by 1H-NMR were determined to be 8:2, 66:33 
and 6:4. The first two batches are soluble in water, buffer and with added organic solvents, 
whereas the third only shows a narrow 520 nm plasmon resonance peak in the presence of 
added ethanol or DMSO. In water or buffer, the UV-vis signal is broad, which indicates 
aggregation and poor solubility.  
 
 
Figure 1.23 UV-vis spectrum of a nanoparticle batch in different solvent conditions (a) 20% OT (b) 30% OT and (c) 40% 
OT. (c) displays a broad peak in water and PBS buffer indicative of poor solubility, which is restored by the addition of ethanol 
or DMSO. In collaboration with Dr. Patrizia Andreozzi.  
 
Finally, the nanoparticles can be fractionated by centrifugation using a sucrose gradient. For 
biological experiments, there is an advantage to initially work with polydisperse samples: if 
EM is involved, it is possible to identify size selectivity and subsequently engineer 
nanoparticles to address specific size-dependent questions. In other words, when the 
experiment is done with similar particles of different sizes, in case smaller or larger particles 
interact preferentially with a given structure, the use of a polydisperse sample can reveal in a 
single experiment size-dependent behaviors. On the contrary, if an experiment is designed to 
use monodisperse 5 nm NPs in a system that would preferentially interact with 2 nm NPs, the 
interactions would not be captured. Given that the two different synthetic methods (modified 
Stucky and one-phase) produce particles with distinct size distributions, the added benefit of 
fractionation provides a level of sample homogeneity otherwise impossible for these polar 
nanoparticles. Figure 1.24 shows TEM images of fractionated one-phase and modified Stucky 
allMUS and MUS:OT syntheses: the sample homogeneity is greater than in the images 
presented in Figures 1.19 and 1.21. The post-fractionation sample homogeneity may be 
important for future spectroscopic experiments involving nanoparticle-protein interactions, 
namely, using multi-dimensional NMR to pinpoint nanoparticle-protein interactions. 
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Figure 1.24 Bright field transmission electron micrographs (TEMs) of (a) One phase fractionated allMUS NPs (b) One phase 
fractionated MUS:OT (30% OT by 1H-NMR) (c) Modified Stucky MUS:OT (30% OT by 1H-NMR) (d) Modified Stucky 
fractionated allMUS NPs. (c) was obtained using a Philips CM12 TEM, and the others using an FEI TALOSTM Electron 
Microscope.  
 
1.10?Amphiphilic gold nanoparticles: interaction with lipid bilayers 
 
Evolution has selected lipids bilayers as the material to encapsulate and delimit the 
compartments of cell-based organisms. Briefly, lipid bilayers are made primarily of 
phospholipids and are permeable to small hydrophobic molecules such as CO2 and O2, semi-
permeable to water and impermeable to most charged species and large molecules121. Lipid 
membranes are controlled by meticulous cellular mechanisms, that inevitably include 
membrane-bound proteins122. The cell membrane, made of a lipid bilayer, topologically 
delimits the inside and outside of a cell. Most small foreign substances never enter the cell, but 
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are rather encapsulated by the membrane inside endosomes, thus remaining, technically, 
extracellular. The cell might then incorporate and process the foreign body, or eliminate it via 
exocytosis depending on the situation. Therefore, traversing the cell membrane is an enormous 
challenge: for example, even sugar molecules depend on specific channels to enter the cell and 
supply it with the energy needed for survival123. There are substances capable of disrupting 
cellular membranes, such as surfactants, viral related cell-penetrating peptides124-126 and small 
oligomers of amyloid precursors127. Mature amyloid fibers are also membrane fusogenic, and 
prostate protein derived amyloid fibers have been reported to interact with cellular membranes 
and enhance HIV infectivity in the process128-130.  
 
The possibility that nanoparticles interact with lipid bilayers became an important field of 
study, whether to assess toxicity, or to design particles that facilitate the delivery of therapeutic 
agents that are otherwise excluded from the intracellular space104. Initial studies showed that 
nanoparticles could not evade endosomal entrapment simply by virtue of size131, and most 
particles designed to improve drug delivery end trapped inside endosomes. In 2008 our group 
reported amphiphilic monolayer-protected nanoparticles capable of passively diffusing 
through cellular lipid membranes without disrupting them103. Nanoparticles covered by 
mixtures of MUS and OT readily entered cells when compared to homo-ligand allMUS 
nanoparticles or hetero-ligand analogues bearing a branched, stiffer alkanethiol (branched OT 
- brOT) instead of OT. Cell-penetration was also detected in samples kept at 4°C, when cells 
cannot use energy to perform endocytosis, which indicates a passive entrance mechanism for 
MUS:OT particles.  
 
This phenomenon has been intensively investigated both through experiments and 
calculations132-135. In order for amphiphilic nanoparticles to enter cells, they must interact with 
lipid bilayers as an obligatory step to passively diffuse through the membrane. The 
thermodynamic framework for a NP to fuse into the bilayer core has been delineated 133,134,136-
138 and reveals that hydrophobicity and size determine the integration of nanoparticles in a 
model lipid bilayer. Figure 1.25 shows a schematic view of the process and the total free energy 
change for moving a nanoparticle from an initial position in the solvent into the bilayer core. 
Thermodynamically, the problem can be stated as the minimization of the total Gibbs free 
energy of the system, as shown in equation (1). 
                        ??????? ? ????????? ?????????? ???????? ????????? ? ????????                 (1) 
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In this equation, ?Gphobic is the system-solvation free energy change, and ?Ginsert the free energy 
cost for charged ligands to interact with the bilayer core. ?Eelec is the free energy change due 
to electrostatic contacts, while ?Ethick accounts for the energy cost of altering bilayer thickness. 
The final entropic term relates to the changes in conformational entropy of the ligands upon 
bilayer integration. The main driving force is the first term that stands for the hydrophobic 
driving force that pushes the system towards the minimization of hydrophobic solvent exposed 
surface area (SASA)139.  
 
 
Figure 1.25 (a) Schematic representation of a typical MUS:OT gold nanoparticle and a lipid bilayer (in a spring model). The 
nanoparticle is shown using a standard Au-S bonding motif, the blue-green parts of the ligands and inside the lipid bilayer 
stand for hydrophobic groups. In blue the solvent-accessible surface area is highlighted: it constitutes hydrophobic surfaces 
exposed to water. Upon integration within the lipid bilayer, the ligands re-arrange in a conformation that maximizes 
hydrophobic contacts and exposes the charged ligands to the aqueous medium. (b) Depicts the free energy calculations for 
three different particle compositions (allMUS and MUS:OT 2:1 and 1:1) in addition to different morphologies that, 
thermodynamically do not differ in this system. Blue and red panels illustrate where the different synthetic protocols discussed 
fall in this formulation. Adapted with permission from reference (135) Copyright © 2013, American Chemical Society.  
 
The thermodynamic approach in addition to careful experimentation demonstrated that 
amphiphilic nanoparticles can integrate into the lipid bilayer core120,135. As the nanoparticle 
partitions to the interior of the bilayer, the ligand shell undergoes a rearrangement that forces 
charged ligand head-groups to face the aqueous exterior, and favors hydrophobic contacts 
between SASA and the aliphatic chains in the lipid bilayer. This phenomenon resembles how 
some proteins integrate the bilayer through a process known as snorkeling140,141 which is more 
accessible for flexible ligands in smaller particles. As the nanoparticle diameter increases, the 
surface curvature decreases and the ligands have less space to rearrange. This decreases the 
ability of larger particles to integrate the core of the lipid bilayer, eventually reaching a size 
cutoff, in which, the change in total free energy is zero (Figure 1.25(b)). These results highlight 
the importance of Figure 1.21, because small nanoparticles in an experiment designed to isolate 
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the effect of surface composition or structure can produce false positives, especially in 
fluorescence-based biological experiments that cannot distinguish signal from particles of 
different sizes.  
 
Recently, as the synthetic protocol to produce sulfonated particles with a size distribution 
between 4-7 nm improved (the modified Stucky synthesis), we’ve observed the right part of 
Figure 1.25(b), highlighted by a red panel, in cell cultures. Particles synthesized using the 
Stucky protocol were tagged with the fluorophore BODIPY and incubated with cells at 37°C 
and 4°C, revealing the importance of hydrophobicity for cellular internalization, in agreement 
with the free energy curves. Figure 1.26 shows Chinese hamster ovary (CHO) cells incubated 
with progressively hydrophobic particles (4-7 nm in core diameter). At 4°C, the fluorescence 
scales with hydrophobic content, which agrees with the theory. These studies are still on-going, 
and will also include the effect of ligand-shell morphology on the cell-penetrating behavior of 
larger, Stucky-prepared gold nanoparticles.  
 
 
Figure 1.26 Chinese hamster ovary (CHO) cells incubated with BODIPY-modified gold nanoparticles. All particles were 
synthesized following the modified Stucky protocol. Clearly, nanoparticles that only contain MUS are not efficiently 
internalized by cells, whereas, as the amount of OT increases, the fluorescence signal increases, especially in the 4°C samples. 
Punctate signal correlates to endosomes, and is visible only at 37°C, when the cell can perform energy-dependent processes. 
This figure showed for the first time that modified Stucky-prepared particles could be effectively used for cellular 
internalization. The ligand ratios correspond to the feed ratio: the 1H-NMR ratios were approximately 20%, 30% and 40% OT. 
In collaboration with Dr. Patrizia Andreozzi, who performed the cell experiments.  
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Despite the invaluable insight offered by the free-energy approach to this problem, the 
mechanisms of nanoparticle-bilayer integration remained largely unknown. Free energy 
minimization cannot explain how the nanoparticles overcome barriers, for example, the 
unlikely first disruption of bilayer integrity for hydrophobic contacts to occur. The mechanism 
behind lipid bilayer integration has been recently elucidated using unbiased atomistic 
simulations and experiments on supported lipid bilayers116. allMUS and MUS:OT 
nanoparticles spontaneously fuse with lipid bilayers through defects and highly curved parts of 
the membranes. This mechanism is likely mediated by stochastic lipid tail protrusions, similar 
to those behind vesicle-vesicle contacts142-144. Figure 1.27 shows the free energy landscape for 
the fusion of nanoparticles into lipid bilayers and AFM images of suspended lipid bilayers 
(SLBs) before and after addition of MUS:OT 2:1 nanoparticles in buffer.  
 
 
Figure 1.27 (a) Proposed pathway for defect-mediated bilayer integration of amphiphilic MUS:OT nanoparticles. Briefly, the 
nanoparticles start in a solvated state A, followed by a gain in free energy due to electrostatic attraction that drives the particle 
to state B. The lipid bilayer imposes an energy barrier related to the rearrangement of lipids to accommodate the incoming 
particle. Once fusion happens via a stochastic lipid tail protrusion, the particle reaches a metastable state C, where it finds 
itself “stuck” on the edge of the bilayer. Here, the transition state (TS2) is associated to the re-creation of the bilayer edge, but 
may also depend on nanoparticle properties. The particle then reaches state D when is can diffuse through the interior of the 
bilayer leaflet. (b) Shows a suspended lipid bilayer made of 1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC) before the 
addition of nanoparticles, and (c) shows not only that particles integrate the membrane through the edges, but are also capable 
of diffusing into the bilayer, corresponding to state D in the energy diagram. The ligands and nanoparticles used in this 
experiment come from my synthetic platform. State D was not observed in the experimental length scale, but was seen in 100s 
of minutes in AFM imaging. Energy diagram courtesy of Dr. Reid Van Lehn, and AFM images from Dr. Ricci, this material 
was published in reference (116). 
 
AFM images of SLBs made of 1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC) showed that 
the nanoparticles did not interact with defect-free bilayers (data not shown). When the bilayers 
were prepared as islands, the edges swelled in the presence of allMUS and MUS:OT 
nanoparticles, which was confirmed by quartz crystal microbalance (QCD) measurements 
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(Figures 1.28 (c) and (d)): the amphiphilic particles inserted into the bilayer islands through 
the edges of the islands. These experimental findings agree with unbiased atomistic simulations 
that revealed the nanoparticles do not interact with the planar aspects of simulated DOPC 
ribbons, but rather insert through the edges. Figure 1.28(a) and (b) show the probable 
mechanism behind edge-on nanoparticle integration: a parameter p (the committor), correlated 
to the probability that a trajectory from state i to f successfully occurs is plotted with the 
hydration (Hc-sol) of the aliphatic tails of the phospholipids. When these two parameters 
intersect in time, it indicates that a successful trajectory is correlated to a spike of aliphatic 
hydration, followed by its decay. In other words, aliphatic lipid tails stochastically protrude 
into the aqueous milieu, which is energetically unfavorable due to the hydrophobic effect139. 
These lipid tail protrusions happen continuously, and normally, the aliphatic chain resumes to 
its original position in the hydrophobic core of the lipid bilayer. However, if an amphiphilic 
nanoparticle such as MUS:OT is in the vicinity of the hydrated aliphatic chain, the unfavorable 
water-contacts can be mitigated by establishing a hydrophobic interaction with the aliphatic 
portions of the nanoparticle ligand shell. This mechanism, already proposed for vesicles142 is 
the likely pathway for nanoparticle-lipid integration. In a more recent calculation, Van Lehn et 
al. predicted that nanoparticles can also insert into defect-free lipid bilayers if the nanoparticle 
brings a longer hydrophobic ligand capable of establishing a protrusion of its own138. 
 
 
 
Figure 1.28 (a) Against time, both the committor p and the number of solvent-lipid anchor contacts Hc-sol are plotted. p 
correlates to the probability that a trajectory starting at an initial energy state i reaches a final state f before returning to i. Hc-
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sol quantifies the number of atoms in water molecules at a distance smaller than 0.5 nm from the aliphatic tail. The red vertical 
dotted line marks the transition states described in Figure 1.27, which corresponds to p values of about 0.5: the tipping point 
to return to the origin or to move onwards to the next state. These plots show that before reaching the interior of the lipid 
bilayer (p = 1), the transition state overlaps with a spike and abrupt drop in the unfavorable water-aliphatic interactions for the 
anchor-lipid (Hc-sol). This means that the unfavorable water-aliphatic interactions are mitigated by a nanoparticle-lipid 
protrusion contact. This is the proposed mechanism of membrane integration for MUS and MUS:OT nanoparticles. (b) 
Simulation snapshots at crucial times for the integration of the nanoparticle into the lipid bilayer. (c) AFM in liquid of DOPC 
islands on silicon. (d) border swellings of the islands when MUS:OT 2:1 NPs are injected in the system. (e) A cryo-EM image 
of lipid vesicles with MUS:OT 2:1 nanoparticles integrated in (or adsorbed on) the bilayers. The ligands and nanoparticles 
were produced in my platform. Images (a) and (b) produced by Dr. Reid van Lehn and (c) and (d) by Dr. Ricci, published in 
reference (116). Image (e) obtained by Dr. Atukorale, published in reference (145), reproduced with permission from the 
Centre National de la Recherche Scientifique (CNRS) and The Royal Society of Chemistry. 
 
Although these results elucidate the original finding of cell-penetrating nanoparticles, they do 
not address the issue of surface morphology like the experiment described in Figure 1.18 does. 
Neither the free-energy calculations, nor the mechanistic approach predicted differences that 
depended on surface structure. As in the case of proteins, subtle local structures146 can manifest 
specific properties that in turn, dictate a structure-property relationship; determination of this, 
however, lies beyond the scope of these works. A detailed understanding of how surface 
structure affects the wetting behavior and how the nanoparticles interact with ions in solution 
can bring this type of research closer to the current view held for proteins. 
 
On the other hand, these contributions help rationalize how MUS:OT nanoparticles, and 
perhaps, similar amphiphilic objects interact with cells. These nanoparticles attack the edges 
of lipid bilayers116 and also insert into lipid vesicles (Figure 2.28(e))145. The latter can be 
attributed to the curvature of the membranes, which increases the probability of hydrophobic 
contacts favorable to nanoparticle-lipid fusion. Furthermore, once nanoparticles fuse with the 
lipid bilayers, they distort its neighboring area137, which creates a local defect that facilitates 
the incorporation of additional nanoparticles. This cooperative membrane fusion can explain 
the effective nanoparticle-vesicle fusion observed experimentally with vesicles135,145. 
Nonetheless, the nanoparticle-membrane fusion does not disrupt bilayer integrity, as calcein, a 
dye used to test membrane leakage does not enter cells or vesicles when exposed to fusogenic 
nanoparticles103,135.  
 
Cells display complex lipid membranes that are, in reality, composites of lipids, proteins and 
sugar molecules under continuous change. Living cells offer a plethora of defects and 
membrane inhomogeneities through which these nanoparticles can fuse and penetrate the cell. 
Contrary to the initial assertion that nano-objects are incapable of traversing lipid 
membranes131, different works showed that carefully designed nanoparticles diffused through 
cell membranes103,147,148, which can be harnessed in several biomedical applications104. The 
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complexities of an organism need to be taken into account when translating in silico and in 
vitro findings to the in vivo environment. The basic knowledge generated by these experiments 
and calculations enable a rationale for applying these materials in vivo145,149. 
1.11?Conclusions 
 
My contribution to the advancement in the understanding of how these particles interact with 
lipid membranes stems from my synthetic work. The details of the syntheses and how they 
were scaled-up to allow multiple experiments can be found in the methods section. To produce 
sufficient amounts of amphiphilic gold nanoparticles based on MUS, and the relevant controls 
(cationic, zwitterionic, etc), gram-scale ligand syntheses had to be implemented (see methods). 
The syntheses outlined in this chapter, and detailed in the methods section, have enabled 
systematic studies to investigate, not only how nanoparticles interact with lipid 
bilayers116,120,145, but also viruses and proteins: my work during the past 4 years provided the 
material base for several different projects. Moreover, we have incrementally improved the 
synthesis and characterization of these particles, providing guiding principles and methods for 
making modified Stucky and one-phase syntheses readily accessible for new group members.  
 
There are still challenges: for instance, syntheses tend to produce polydisperse samples, which 
means that species with completely disparate properties come from the same preparation. 
Below a certain diameter (around 1.7 nm) the electron distribution across gold nanoparticles 
no longer resembles that of bulk gold, but rather behaves as a superatom with defined 
orbitals150,151. This is a simple example of a size-dependent property that can affect experiments 
that rely on the traditional surface plasmon resonance at 520 nm of colloidal gold: below a 
certain size, this optical behavior collapses into a molecular orbital behavior. The approaches 
described above, following proper characterization and the possibility of size fractionation 
increase the degree of certainty and control over the sample.  
 
The amphiphilic gold nanoparticles described in this section have shown unique properties that 
can be harnessed in biological research113,152. Interestingly, these particles behave not only like 
cell penetrating peptides125 but also like the oligomeric species of the amyloid precursors 
described in the first part of this chapter, that also interact avidly with lipid membranes127. 
Furthermore, mature amyloid fibers have been shown to interact with cell membranes128 and 
viruses129, which are two areas of on-going investigation in our group. Chapter 4 will show 
how the class of sulfonated amphiphilic nanoparticles interacts uniquely with the extended 
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surfaces of amyloid fibers. Moreover, we will show that these nanoparticles behave as colloidal 
surfactants, and bind preferentially to small oligomers of amyloid precursors before covering 
the mature fibers. Because small oligomers are likely to have higher surface tension than full 
fibers, analogous to classical nucleation and growth theory, the nanoparticle avidly “attack” 
the small oligomers before covering the grown fibers. The underlying mechanisms of 
nanoparticle amyloid-nuclei and fiber interaction is likely similar to that found with lipid 
bilayers, as demonstrated using molecular dynamics simulations: hydrophobic forces dominate 
unanticipated adsorption motifs. The degree of order adopted by the nanoparticles on the 
surfaces of the mature amyloid fibers have never been reported for a bio-nano interface that 
relies solely on secondary forces.  
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2? Using nanoparticles for amyloid research: statement of the 
problem 
Chapter 1 reviewed how the building blocks of amyloid fibers self-organize, highlighting the 
current state of the literature for the peptides and proteins studied in this work. It emphasized 
the wealth of 3D polymorphisms that a single protein or peptide can adopt in the amyloid state. 
It also introduced a class of amphiphilic gold nanoparticles and summarized our main results 
regarding their lipid-bilayer fusogenic properties. The general outline on how the nanoparticles 
are prepared was given in the second part of the first chapter, and the detailed syntheses can be 
found in the Methods chapter. This chapter briefly discusses the current approaches that enable 
the understanding of the amyloid state described in the first part of chapter 1. It then reviews 
how nanoparticles have been used in biology, especially in the context of immunogold labelling 
and the current ambitious developments that aim to use gold nanoparticles as aides in the 
molecular structure determination of proteins through cryo-EM imaging. Finally, it states the 
hypothesis of this thesis: is it possible to design the ligand shell of gold nanoparticles such that 
it interacts with specific features on the surface of amyloid fibers without the intermediation of 
an antibody? Such development can provide the biological community a novel tool in the study 
of the amyloid state and proteins in general, and improve our understanding of how 
nanoparticles interact with proteins.   
2.1? Current approaches in the study of the amyloid fold 
Chapter 1 focused on the definition of the amyloid fold and the different proposed structures 
obtained from NMR studies and X-ray diffraction of amyloid-like microcrystals23,24,27. Other 
techniques are routinely used to study amyloids, such as Atomic Force Microscopy77,153, 
fluorescence microscopy154, fiber X-Ray diffraction155, Fourier transform infrared resonance 
(FTIR)156,157, circular dichroism158 among many other biochemical manipulations and tools. 
Particularly important are amyloidophilic dyes such as Thioflavin T (ThT) and Congo Red, 
that undergo an enhancement in emission in the presence of amyloids159. Most kinetic studies 
of how amyloid precursors assemble into amyloid fibers use ThT as the reporter molecule159 
and several important parameters about amyloid formation can be derived from kinetic 
studies160, for example the role of secondary nucleation in the formation of A?1-42 fibers161.  
Electron microscopy is commonly used to assess fiber morphology and dimensions using 
negatively stained techniques to observe dry samples. Scanning transmission electron 
microscopy (STEM) and dark-field EM are routinely used to determine the mass-per-length of 
amyloid fibers162: these values are used as constraints in the simulations performed to propose 
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the structures of mature amyloid fibers using the molecular contacts determined with NMR. 
Cryo-EM provides a good method to observe amyloid fibers (as well as viruses, proteins and 
other biostructures) in their native solvated state. Excluding potential (but limited) artefacts 
that can occur during sample preparation163, such as the formation of crystalline ice that can 
damage the sample, a well-acquired cryo-EM image can be used to propose structural models 
of complex biological assemblies such as the F-actin-tropomyosin complex164, and amyloid 
fibers as discussed in chapter 180. Figure 2.1 summarizes some of the most commonly used 
biophysical tools in the study of the amyloid fold, including two different uses of ThT to 
interrogate amyloid-related phenomena.  
 
Figure 2 From left to right, the most widely used (but not all) tools to study the amyloid fold. On the left, atomic force 
microscopy images (AFM) showing the typical 3D topographic images in dry state165 and property-related imaging modes that 
can probe physical properties of the fibers77. As reviewed in chapter 1, NMR and dark field EM (most commonly STEM) to 
determine the mass-per-length of fibers are used to propose 3D structures of amyloid fibers39. Cryo-EM is successfully used 
to generate density maps that can be used to propose approximate structures of the fibers. The most commonly used probe for 
amyloid research is the dye thioflavin T (ThT), that can be used to track the kinetics of amyloid formation166 or even to directly 
image the fibers and propose different polymorphs based on polarization-resolved fluorescence microscopy154.  
 
2.2? Use of gold nanoparticles in bio-electron microscopy.  
 
The use of colloidal gold predates current-day nanoscience. The earliest documented use of 
gold nanoparticles for diagnostic dates back to 1912, when Dr. Lange reported that colloidal 
gold precipitated readily in the serum and cerebrospinal fluid of neuro-syphilitic patients167, an 
observation possibly related to the findings reported in this thesis. Rational approaches to 
control the assembly of gold nanoparticles using DNA were first reported in 1996168,169, 
shifting the paradigm in nanoscience towards controlled assembly of these nano building 
blocks. Meanwhile, gold colloids were routinely used as electron microscopy markers for 
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biological tissues from the 1970s onwards170. This technique relies on coupling suitable 
antibodies to colloidal gold, which is then added to microtomed tissue samples for electron 
microscopy, as schematized in Figure 2.2(a). Immunogold has been invaluable for 
immunocytochemistry, allowing biologists to identify spatiotemporal distribution of proteins 
in cells and tissues171.  
 
Recently, the group of Roger Kornberg has recognized the enormous potential of using small 
gold nanoparticles as contrast agents in cryo-EM for protein whose structures cannot be 
determined with other techniques172. This approach relies on the conjugation of atomically 
precise ‘ultrasmall’ nanoparticles with the Fab fragment of an antibody, to establish 4 points in 
space that can be used to increase the resolution of the image reconstruction in cryo-EM173. 
This elegant approach to protein structural biology has one important caveat: the way 
nanoparticles interact with proteins, depending on the ligand shell that coats them, can 
influence the outcome. Can these non-specific interactions interfere with the way these 
molecular immunogold labels attach to the proteins and hence interfere with the interpretation 
of the image? Briefly, what properties on the nanoparticle ligand-shell determine its interaction 
with proteinaceous materials, and are there energetically favorable interactions for a given type 
of nanoparticle with certain structures on the surfaces of proteins? Figure 2.2 summarizes the 
immunogold approach, and shows a recent cryo-EM of neuraminidase ‘decorated’ with 
nanoparticles conjugated to the Fab segment of an antibody (Figure 2.2(b)).  
 
Figure 2 (a) Classical immunogold labeling approach. A gold colloid is conjugated to an antibody, which is then added to a 
microtomed sample, for EM imaging. On the right, a TEM of a heart cell with immunogold labels for connexin 43171. (b) 
Arguably the state of the art in the use of gold nanoparticles in biology: the conjugation of atomically precise gold nanoparticles 
to the Fab fragments of antibodies, to label single proteins in 3D. The nanoparticles serve as a cryo-EM staining agent, 
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facilitating high resolution imaging to determine the structure of proteins that cannot be crystallized. The larger particles in 
the image correspond to 10 nm NPs added as markers in a sample of N9 neuraminidase. So far, no high resolution structure 
has been proposed with this approach, but it is the direction the field has taken in the past 10 years172,173.  
 
2.3? Statement of the problem 
Amyloid fibers have been extensively studied using the probes described so far. Following the 
rationale proposed by the Kornberg group, this thesis aims to establish the properties of a gold 
nanoparticle that allow it to interact discriminatively with mature amyloid fibers. In others 
words, given a twisted ribbon fiber, what are characteristics that lead the nanoparticles to 
adsorb preferentially to one facet of the cross-section of the fiber, and not the other? Amyloid 
fibers are arguably the most generic protein fold, accessible to several polypeptides as reviewed 
in chapter 1174: thus, to test the discriminative behavior of nanoparticles towards fibrous protein 
aggregates, amyloids provide a good common denominator. On the other hand, this limits our 
ability to interpret what structures the nanoparticles spontaneously adsorb onto, given the 
current uncertainties regarding the molecular structure of mature amyloid fibers. Nonetheless, 
it raises several opportunities to elucidate the contacts established between the ligands on the 
gold nanoparticles and the amyloid fibers, which can help the understanding of amyloid fiber 
structure.  
 
It is impossible to predict how different parameters influence the way gold nanoparticles 
interact with amyloid fibers or proteins in general. To this end, different types of particles, that 
are colloidally stable in buffered conditions, have been tested with four types of amyloid fibers: 
A?1-40 and A?1-42, ?-synuclein and Tau-441. These polypeptides were chosen because of their 
relevance in neurodegenerative diseases (Alzheimer’s, Parkinson’s among others) and the 
different types of fibers they form. For example, ?-synuclein contains several acidic residues 
in the C-terminal, which renders it more electronegative than the other two types. Tau-441 has 
long disordered segments while A? has much shorter ones: these key differences enable us to 
study the interaction between different types of gold nanoparticles prepared via ligand 
synthesis, with fundamentally distinct, medically relevant, amyloid fibers. Several types of 
particles are tested, emphasizing first the role of charged end groups on the thiolate ligands that 
protect the gold core, followed by an in-depth analysis of the discriminative adsorption of small 
amphiphilic sulfonated NPs, that hold the potential to become a useful tool in the study of 
amyloids and proteins in general.  
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3? Interaction of charged gold nanoparticles and amyloid fibers 
 
3.1? Overview 
Different types of water soluble monolayer-protected gold nanoparticles were prepared and 
tested with amyloid fibers made of A?1-40, ?-synuclein and Tau-441. Nanoparticles protected 
by phosphate-terminated thiols did not interact significantly with the fibers but aggregated with 
other nanoparticles. Cationic nanoparticles adsorbed to the particles cooperatively and 
indiscriminately, while zwitterionic nanoparticles did not interact, in agreement with the 
previous reports on the protein adsorption resistance of mixed charge surfaces114,115. On the 
other hand, MUS and MUS:OT particles, adsorb onto the fibers, and depending on their 
diameter, do so discriminatively. The latter will be critically analyzed in the next chapter. This 
chapter shows how mature amyloid fibers interact with these different nanoparticles. Most 
findings here can be roughly explained by coulombic interactions, but other parameters are 
discussed such as hydrophobicity and the strength of the solvation shell that surrounds 
zwitterionic nanoparticles.  
 
3.2? Prior nanoparticle-amyloid fiber interactions 
There are several reports of amyloid fibers decorated with gold nanoparticles. To our 
knowledge, apart from three exceptions175-178, all other gold nanoparticle decorated amyloid 
fibers result from immunogold staining. Researchers used immunogold to ascertain the nature 
of their fibrils or identify their association with other proteins, producing TEM images that 
resemble the data shown in this project179-181. Other groups, especially Prof. Linse’s, has laid 
the foundations for amyloid-nanoparticle research, but did not focus on adsorption.  
 
Previous nanoparticle-decorated amyloid fibers can be categorized as: (1) immunogold 
labelled samples, illustrated by Figures 3.1(d) and (e) (2) non-specific nanoparticle amyloid 
adsorption, seen in Figure 3.1(a)-(c), and (3) amyloid directed synthesis of metallic 
nanostructures178,182. The last item is less relevant for our results, and the reader can consult 
references (182) and (178). A non-specific interaction means that no bio-recognition or 
covalent bonding scheme was used. Instead, the interactions result from secondary forces such 
as electrostatic contacts, van der Waals forces and hydrogen bonds that determine how 
nanoparticles interact with amyloid fibers.  
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Figure 3.1 (a) Anionic colloidal gold used on A?1-40 fibers to demonstrate that, despite an overall negative charge, the fibers 
possess dense regions of positive charges on their surfaces. (b) Use of citrate stabilized gold nanoparticles to slow the formation 
of A?1-40 fibers showed, in the end, particles that associated randomly with the fibers. (c) The authors show that the particles 
interact with the fibers but not the amorphous non-fibrillar material seen in the sample. (d) Tau filaments from mouse model 
AD brain, immunostained with gold nanoparticles coated with antibodies BR134 and Tau-C3 (e) Use of nanoparticles coated 
with PER4 antibody to demonstrate that fibers extracted from Lewy Bodies of a patient with dementia were made of ?-
synuclein. Figure (a) reproduced with permission from reference (176) Copyright © 2007, American Chemical Society. (b) 
and (c) reproduced with permission from reference (175) Copyright © 2012 WILEY-VCH Verlag GmbH & Co. KGaA, 
Weinheim. (d) Reproduced with permission from reference (179) Copyright © 2008 American Society for Investigative 
Pathology. Published by Elsevier Inc. All rights reserved and (e) reproduced with permission from reference (180) copyright 
© by the National Academy of Sciences.  
 
3.3? Cationic nanoparticles adsorb indiscriminately and cooperatively onto 
amyloid fibers 
Figure 3.1(a) shows the published image that most resembles our own176. Yoshiike et al. argues 
that, despite being net-negatively charged (-3 at neutral pH), A?1-40 fibers have cationic regions 
along its surface, that respond for their interaction with anionic lipid bilayers183 and 
cytotoxicity176. The study uses negatively charged colloidal gold to demonstrate the existence 
of discrete cationic features along the surface of the fibers. The image shown in Figure 3.1(a) 
is a dry TEM and reveals an ordered nanoparticle assembly on the edges of the fibers. They 
chemically modify basic amino acid side groups via glycation and acetylation (likely K16 and 
K28) to demonstrate that the particle-fiber binding is due to coulombic interactions, thus 
proving the existence of lines of positively charges on the surface of the fiber.  
 
These lines are predicted by the detailed structural models reviewed in chapter 1, because the 
in register parallel packing of beta sheets can align lysine side groups (K16) along the surface 
of the fiber. The authors of Figure 3.1(a) may have adsorbed their negatively charged colloidal 
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gold onto these lines due to electrostatic attraction. We have observed a similar phenomenon 
with positively charged particles. Our results suggest that coulombic forces alone cannot 
explain how monolayer-protected gold nanoparticles interact with amyloid fibers: we have 
observed an aggregation behavior of cationic particles that contradicts Figure 3.1(a), in addition 
to other fiber-binding nanoparticles with disparate charges and ligand-shell compositions. 
From our results, in addition to coulombic interactions, the hydrophobic effect plays a 
definitive role in mediating how gold nanoparticles interact with amyloid fibers  
 
Figure 3.2 (a) Schematic representation of cationic nanoparticles, and the corresponding ligand, N,N,N-Trimethyl(11-
mercaptoundecyl)ammonium Chloride (TMA) used in their synthesis. On the right, a bright-field TEM image of the particle 
batch used in these experiments. The size distribution is 3.9 ± 1.6nm: there are enough different NP diameters in this batch to 
capture eventual size-selectivity. (b) TEM of negatively stained (2% Uranyl acetate) A?1-40 mature fibers, with allTMA NPs. 
Aggregation and sedimentation was obvious in the sample: under EM, the particles bind cooperatively on the mature fibers, 
and seem to induce fiber-bundle formation. (c) Higher magnification of the same sample (bar 20 nm) (d) Crop from (e), a 
cryo-EM of the same sample, showing that the cooperative indiscriminate coverage of fibers and bundle formation are not 
drying artefacts. Images in (a), (b) and (c) were obtained in an FEI TALOSTM Electron Microscope and the cryo-EM image 
(e) and its crop (d) in an FEI TecnaiTM Spirit BioTWIN. 
 
Cationic nanoparticles coated only with the positively charged thiolate molecule TMA, 
(N,N,N-Trimethyl(11-mercaptoundecyl)ammonium Chloride) were prepared following 
modifications on the Stucky protocol described in chapter 2, and detailed in the methods 
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section. A batch with size distribution of 3.9 ± 1.6nm was purified and characterized (see 
methods), dispersed in Milli-Q water and filtered through a 0.2 μm PTFE syringe filter to an 
approximate particle concentration of 2 mg/mL. Due to polydispersity, we report nanoparticle 
concentrations in mass per volume: it is difficult to determine molar amounts, but in the size 
range between 2 to 4 nm, a 1 mg/mL solution falls in the micromolar regime. A?1-40 fibers 
were prepared following the protocol described in the methods section: briefly, after 
ultracentrifuging the monomeric solution, the concentration was adjusted to about 10 μM by 
absorbance using pH = 7.2, 13 mM sodium phosphate buffer (50 mM NaCl). The solution was 
agitated at 37°C (300rpm for the fibers in Figure 3.2) and fiber growth was monitored by 
thioflavin T (ThT) fluorescence and electron microscopy. Once mature A?1-40 fibers were 
formed, 10 μL of the nanoparticle stock solution was added to 90 μL of the fiber suspension. 
This step changes the ionic strength of the buffer, because the nanoparticle Milli-Q water 
vehicle dilutes the buffer. Although proteins can be sensitive to changes in salt concentration, 
this buffer-dilution is unlikely to affect our results. If it does, it has been a consistent parameter 
throughout the different experiments, which does not change comparisons between different 
particles. The mixture was then allowed to incubate at 37°C and 300 rpm agitation for periods 
from 2 to 12 hours. Figure 3.2 shows a 12 h incubation. The samples were analyzed and stored 
at 4°C.  
 
Whenever TMA protected cationic gold nanoparticles were added to the fiber suspension, the 
solution turned slightly red, and macroscopic aggregation ensued within 5 to 10 minutes. The 
phenomenon can be described as flocculation, because discrete red aggregates formed and 
precipitated, clearing the supernatant. Vigorous agitation suspended these aggregates, but once 
the mechanical stimulus ceased, they sedimented to the bottom of the vial. Electron microscopy 
reveals that TMA-protected gold nanoparticles adsorbed cooperatively onto the fibers. Several 
undecorated fibers can be seen on the TEM grid, as depicted in Figure 3.2(b) and also under 
cryo-EM in Figure 3.2(e). Titration with higher nanoparticle concentrations, to test whether all 
fibers can be covered has not been done yet. Nonetheless, the observations made so far suffice 
to discuss the cooperative adsorptions of allTMA nanoparticles onto amyloid fibers.  
 
Following Yoshiike’s reasoning, cationic particles bind to the fibers because of an electrostatic 
attraction: the fibers are net-negative and the particles positive, therefore coulombic 
interactions dictate their association. This is probably the dominant driving force, but in 
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addition to the hydrophilicity conferred to TMA by the quaternary amine, the three methyl 
groups render it amphiphilic: for example, these particles are soluble in absolute ethanol. This 
observation suggests that hydrophobic interactions can be an additional driving force.  
 
If the adsorption of negatively charged particles reveals the presence of discrete cationic 
regions, our observation indicates similar anionic regions or the absence of strong enough 
cationic features to repel allTMA nanoparticles. From the models described in chapter 1, the 
in register cross beta sheet arrangement can force charged side groups to concentrate along the 
body of the fiber, thus both cationic and anionic features can exist in this configuration. The 
amyloid fiber surface, depending on the constituent polypeptide and the polymorphism, can be 
a complex nanostructured zwitterionic surface. For A?1-40, cationic rows of lysine 16 are as 
probable as anionic lines of glutamic acid 22, depending on the polymorph. In reality, high-
density regions of both negative and positive charges can co-exist on the surface of amyloid 
fibers and can be responsible for many of their physicochemical and biological properties.  
 
Our observation does not demonstrate the existence of specific anionic surface features on the 
A?1-40 fibril. Instead, it points to an electrostatic potential minimization via charge pairing and 
a cooperative adsorptive behavior. Once a nanoparticle lands on the fiber, it may lower the 
energy barrier for vicinal adsorption (likely by electrostatic shielding), which successively 
leads to total coverage. The nanoparticles do not seem to prefer edges or faces, but form 
multiple rows along the length of the fiber. Therefore, a combination of electrostatic attraction, 
hydrophobic interactions and charge screening allows cationic TMA-protected gold 
nanoparticles to cooperatively and indiscriminately coat A?1-40 fibers. This effect seems to be 
accompanied by a fiber-bundling behavior that may result from the elimination of repulsive 
interactions between different fibers. This is flagrant when the same experiment is performed 
with ?-synuclein, as shown in Figure 3.3. In this case, the transition from randomly oriented 
fibers on the TEM grid, to bundles, correlates with the presence of allTMA particles. Figures 
3.3(a) and (b) show two images of the same grid, in which undecorated fibers are randomly 
oriented, whereas the covered ones adopt collective bundled orientations. Depending on the 
preparation, amyloid fibers have a tendency to agglomerate and form bundles. But the 
intertwined rope-like aggregates observed in these experiments were mediated by the presence 
of allTMA nanoparticles. On the top part of Figure 3.3(b), the fibers are not densely covered 
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by particles and lie separated on the grid, in different orientations. In the region where fibers 
are densely coated by allTMA nanoparticles, the fibers become interlaced.  
 
 
Figure 3.3 Interaction of ?-synuclein with allTMA nanoparticles. (a) Portion of the grid without allTMA particles. A few 
nanoparticles are visible in the center, but overall the fibers are clear and randomly distributed. (b) When ?-synuclein fibers 
interact with allTMA particles, they self-associate on the grid and form bundles of particle-decorated fibers. The dark loop in 
the image contains densely packed nanoparticle-fiber associations. Images obtained in an FEI TALOSTM Electron Microscope. 
 
Figure 3.4(a) reveals that allTMA nanoparticles may first adsorb onto the edges of ?-synuclein 
fibers. This challenges the indiscriminate mode of adsorption attributed to these particles for 
A?1-40 fibers. Perhaps, nanoparticle chains nucleate and grow on the surface of the fibers, 
because of the lower free energy barrier for vicinal adsorption. The inherent propensity of 
allTMA nanoparticles to aggregate in the presence of biomolecules may be related to this 
phenomenon. The interparticle distance along the edge of the fiber in Figure 3.4(a) is around 
3.5 nm. The same approximate distance is measured for lines of particles in the cryo-EM image 
in Figure 3.4(c).  
 
On the other hand, cryo-EM does not show evident edge-binding: the fibers may act as a 
scaffold that, upon drying, organizes the particles into the arrangement seen in the dry sample 
(Figure 3.4(a)). In liquid, (cryo-EM) the particles are less ordered, and once a chain of particles 
form, instead of following the contour of the fibers, they terminate abruptly (Figure 3.4(c)). 
This creates several short strings of particles that seem to follow an orientation, as highlighted 
by thin dotted white lines in Figure 3.4(c). Their similar orientations can stem from the helical 
nature of the fiber: once a line of particles begins to follow the edge, because of its stiffness, it 
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cannot continue along the fiber contour, so it truncates. Figure 3.4(d) shows fibers covered 
with nanoparticles, in which the particle superlattices appear less rigid and follow the curvature 
of the fiber. In these cases, the fibers are densely coated by the nanoparticles, without any 
preference to an obvious underlying fibril-morphology feature, hence the categorization of 
non-discriminative adsorption, despite the organization seen in Figure 3.4(a). The cryo-EM 
image captures the solvated state, so it is given more weight to develop the final interpretation.  
 
The ?-synuclein fibers intertwine, either due to loss of inter-fiber screening, or gain of an 
adhesive property mediated by allTMA nanoparticles. This effect was also observed for A?1-
40 fibers, but is more pronounced with ?-synuclein. The zeta potential of allTMA particles is 
about +40 mV (in water), and that of ?-synuclein fibers has been reported to be approximately 
-23 mV at neutral pH184. Therefore, fiber bundling may reflect a point of zero charge co-
precipitation, whereby the allTMA nanoparticles screen the electrostatic repulsions between 
the fibers, causing the coated fibers to interlace; or the nanoparticles screen the repulsive 
interactions between different fibers, which leads to fiber-weaving. The bundles have not been 
as evident under cryo-EM: the ice was too thick around regions that potentially contained these 
structures.  
 
 
Figure 3.4 (a) Higher resolution of a single fiber covered by particles, showing a degree of ordered edge binding decoration. 
(b) Same image of a bundle of nanoparticle-covered fibers, in which the ordered adsorption is less clear. (c) Cryo-EM of a 
single ?-synuclein fiber with allTMA nanoparticles: no specific morphology is discernible. (d) Cryo-EM of the same sample, 
showing full “disordered” coverage of the fibers. Images in (a) and (b) were obtained in an FEI TALOSTM Electron Microscope 
and (c) and (d) in an FEI TecnaiTM Spirit BioTWIN.  
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When Tau-441 fibers were mixed with allTMA nanoparticles, the macroscopic precipitation, 
described above as flocculation was not observed. The Tau-441 fiber preparation produced a 
high density of fibers, as seen in Figure 1.5(c). To accommodate for the higher number of 
fibers, the concentration of the allTMA nanoparticle stock solution was increased by a factor 
of 4. Despite this precaution, most fibers were free of nanoparticles. Both negatively stained 
dry TEM and cryo-EM images were taken for this sample, and looked similar. Figure 3.5 shows 
representative electron micrographs of Tau-441 fibers and non-fibrillar species in the presence 
of allTMA nanoparticles.  
 
 
Figure 3.5 (a) Typical allTMA aggregate found in Tau-441 samples along the fibers. (b) Some fibers can be found with 
particles on their surfaces. (c) Another example of how allTMA particles distribute across a Tau-441 fiber sample. (d) Cryo-
EM of the same sample, show several non-decorated fibers. (e) Higher resolution of the same sample. (f) Crop from (d) 
showing particles that line a fiber. Dry images obtained in an FEI TALOSTM Electron Microscope and Cryo-EM images FEI 
TecnaiTM Spirit BioTWIN. 
 
Fibers of Tau-441 can be approximated to a rigid amyloid core, surrounded by a charged 
polymer brush. The protein is 441 residues long, but residues from 1 through 243 and from 370 
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to 441 tend to not participate in the cross beta sheet formation. Instead, they form a layer of 
disordered peptide chains called the fuzzy coat. It acts as a polymer brush with a positive 
interior and negative exterior at neutral pH, that determines the adhesive properties of the 
fiber77. The allTMA nanoparticles have a tendency to aggregate in the presence of proteins, 
and this can partly explain the agglomerates seen in the images. The properties of the surface 
of Tau-441 fibers dictate how allTMA particles interact with them, because the results differ 
considerably from the observations made with A?1-40 and ?-synuclein. allTMA nanoparticles 
probably interact with these fibers via electrostatic forces: ?-synuclein fibers have more 
electronegative surfaces, onto which cationic particles bind, which screens the inter-fiber 
repulsions and interlace them. Instead, the zwitterionic fuzzy coat that surrounds Tau-441 
fibers favors peptide-water interaction146 which generates a small driving force of adsorption.  
 
3.4? Zwitterionic nanoparticles do not bind to amyloid fibers 
The importance electrostatic interactions can be demonstrated by modifying the thiol end-
group, with the introduction of a sulfonate moiety following the quaternary amine. This 
produces a sulfobetaine terminated thiol 3-[(11-Mercapto-undecyl)-N,N-dimethyl-amino]-
propane-1-sulfonate115 abbreviated here as ZW ligand (Figure 3.5(a)). Zwitterionic surfaces 
have been reported to resist non-specific protein adsorption115, and nanoparticles protected by 
these types of ligands do not form protein corona in vitro114. This class of ligands serves as an 
adequate control to assess the importance of electrostatic interactions between nanoparticles 
and macromolecules.  
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Figure 3.6 (a) Molecular structure of 3-[(11-Mercapto-undecyl)-N,N-dimethyl-amino]-propane-1-sulfonate, and a schematic 
depiction of the nanoparticle produced with it. (b) Dry TEM image of the nanoparticle batch, 2.9 ± 0.9 nm. The particles cover 
the grid densely. (c) A cryo-EM image of the nanoparticles in the preparation with A?1-40 fibers. This image illustrates the 
colloidal stability of these particles, that distribute evenly through the buffer. (d) Crop of a Cryo-EM image of A?1-40 fibers to 
which ZW NPs were added. No binding is observed. (e) Crop of a cryo-EM of Tau-441 fibers, to which ZW NPs were added, 
no binding was observed on the fibers. Image (b) was obtained in an FEI TALOSTM Electron Microscope and (c)-(d) in an 
FEI TecnaiTM Spirit BioTWIN. 
 
Zwitterionic nanoparticles (ZW NPs) were synthesized following a modification to the Stucky 
approach (see methods) which yielded nanoparticles of 2.9 ± 0.9 nm. In experiments with 
amyloid fibers, no aggregation or precipitation was observed. Instead, the samples maintained 
the red color of the nanoparticle dispersion, which indicates the particles are colloidally stable 
in the presence of amyloid fibers. Even centrifugation at 13000 g for 10 minutes did not create 
a red pellet: instead, a pale aggregate accumulated at the bottom of the tube, and the solution 
remained red. The fibers sedimented while the nanoparticles remained in solution. These 
nanoparticles have a zeta potential of -9.2 ± 0.2 mV, which, at a first glance, might explain 
their inertness towards amyloid fibers. Both fibers and particles are net-negative, thus mutually 
repellant. This explanation does not agree with (1) Yoshiike’s results185 and (2) the fact that 
MUS nanoparticles bind, and have a zeta potential ranging from -35 to -60 mV depending on 
NP size. These results show that negatively charged particles do adsorb onto the fibers, 
therefore, it is unlikely that the slight electronegativity of ZW NPs is responsible for its 
inertness.  
 
These results must be interpreted in the context of protein-fouling resistant surfaces. Ethylene 
glycols (EGs) are the materials of choice for manufacturing protein-resistant surfaces186,187. 
 75 
Zwitterionic surfaces resist non-specific protein adsorption more efficiently than EGs in vitro 
and in vivo114,187. Both moieties form hydration shells that need to be disrupted for a protein to 
adsorb, and the unfavorable rearrangement of water molecules exert a repelling force against 
protein adsorption188. Zwitterionic monolayers form dense electrostatically based water shells 
that must pay a high free energy penalty to accommodate a protein188. This culminates in a 
repellant force against protein-zwitterionic contacts, whereas the EG hydrogen bond based 
water network is suppler, hence exerts a smaller repellant force188. 
 
To date, zwitterionic molecules ending in sulfobetaine or phosphorylcholine head-groups form 
the most efficient surfaces against non-specific protein adsorption. Mixing individually 
charged ligands on a surface can outperform the single-molecule zwitterions as indicated by 
Holmlin et al.115. The zwitterionic nanoparticles used in these experiments with A?1-40 fibers 
(Figure 3.6(d)) and Tau-441 fibers (Figure 3.6(c)) do not interact with the fibers because the 
energy cost to rearrange the water shell around the zwitterionic groups generates a repulsive 
force that prevents them from adsorbing onto the fibers187. Figure 3.7(a) shows how A?1-40 
fibers form aggregates, without affecting the colloidal distribution of ZW NPs. These fiber 
aggregates differ from the allTMA NPs-induced ?-synuclein fiber interlacing. In this case, 
A?1-40 fibers have a tendency to aggregate which does not affect the stability of the ZW NPs. 
Figure 3.7(b) compares this aggregation to the evenly distributed Tau-441 fibers in solution. 
The zwitterionic nanoparticles are also well-distributed throughout the buffer, but show signs 
of local aggregation. The clear disconnect between particles and fibers in these images reveal 
why under centrifugation, a pale pellet is observed while the supernatant remains red, proving 
that nanoparticles remain in solution. To test if hydrophobic interactions can overcome the 
repulsive forces that prevent zwitterionic nanoparticles from interacting with amyloid fibers, 
we will introduce hydrophobic moieties to the nanoparticle monolayer.  
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Figure 3.7 (a) Cryo-EM of A?1-40 fiber aggregate in the presence of ZW NPs. The nanoparticles are stable even in the presence 
of strongly aggregative species. Inset shows a crop from the same set of images to help visualize the nanoparticles (b) Tau-
441 fibers with ZW NPs. In this case, the fibers do not aggregate as much among themselves, and the particles also remain 
well dispersed in solution. The inset is a crop from the same set of images, to help visualize the nanoparticles. Imaging Tau-
441 fibers under cryo-EM posed a challenge: the focus plane of nanoparticles differed from the fibers. The inset if a 
compromise between both, to show the fibers and particles. Cryo-EM images obtained in an FEI TecnaiTM Spirit BioTWIN.  
 
3.5? Negatively charged nanoparticles 
We have shown that an adsorptive and aggregating phenomenon can be eliminated by 
chemically converting the positively charged quaternary amine into a zwitterionic sulfobetaine 
group. This chemical modification changed the aggregation behavior of the nanoparticles, and 
their interaction with amyloid fibers. Now, we show that anionic nanoparticles can effectively 
adsorb onto amyloid fibers, depending on their ligand shell composition: anionic particles with 
a higher hydrophobic content adsorb more effectively onto A?1-40 fibers, but this parameter did 
not alter the interaction with ?-synuclein fibers. These results suggest that hydrophobic 
interactions are important to generate nanoparticles capable of interacting preferentially with 
specific surface features of the amyloid fibers. Negatively charged nanoparticles can be 
synthesized using different types of ligands, terminated in head-groups such as carboxylic 
acids, phosphates and sulfonates. Nanoparticles protected by carboxylic acids are water 
soluble, but tend to precipitate in standard biological buffer conditions: this makes them ill-
suited for these experiments. Phosphate and sulfonate headgroups confer buffer solubility to 
gold nanoparticles, rendering them good candidates for this work.  
 
Figure 3.8 shows that nanoparticles protected by 11-Mercaptoundecylphosphoric acid (MUP) 
synthesized via the one phase method (bimodal distribution, 2.74 ± 1.32 nm), despite good 
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buffer solubility, did not interact with the A?1-40 fibers, but rather, tended to aggregate. Figure 
3.8(a) shows the chemical structure of the ligand and a schematic depiction of the nanoparticle. 
Figures 3.8(c)-(e) are cryo-EM images of allMUP NPs with A?1-40 fibers. Nanoparticle 
aggregation dominated the samples, and no obvious fiber-particle interactions could be 
observed. During sample preparation, the macroscopic behavior is reminiscent to that of 
allTMA nanoparticles. After addition of the red nanoparticle stock solution, the amyloid fiber 
suspension becomes red, followed, after 5 to 10 minutes, by the formation of a purple 
precipitate and a clear supernatant. Unlike the allTMA experiments, when the pellets were red, 
these form large purple flecks. In principle, these particles should interact with the proposed 
positive charges on the surface of the A?1-40 fibers176, but instead, the ionic content of the buffer 
probably screens inter-particle repulsions which in the presence of small amounts of A?1-40 
monomers and oligomers, drives aggregation. These particles have not been thoroughly 
studied, but these images serve as an example that gold nanoparticles do not interact with 
amyloid fibers simply by virtue of size, charge and buffer solubility. The properties of the 
ligand shell determine the bionano interface, as exemplified in the two previous cases. It is, 
however, possible that allMUP can adsorb onto other types of fibers. 
 
 
Figure 3.8 (a) MUP ligand and a schematic depiction of a gold nanoparticle protected by it. (b) TEM image of the 
nanoparticles after the synthesis. This batch had a bimodal size distribution, but overall, the sizes were 2.74 ± 1.32 nm. This 
undesirable polydispersity is an advantage for this experiment, because it would allow us to observe size-dependent 
phenomena (c) Cryo-EM image of A?1-40 in the presence of allMUP NPs. The nanoparticle aggregate is the main feature in 
these samples. (d) and (e) Additional cryo-EM images of A?1-40 fibers and allMUP nanoparticles showing no organized 
interaction. Both fibers and nanoparticle aggregates are visible. (b) was acquired in an FEI TALOSTM Electron Microscope 
and the Cryo-EM images in an FEI TecnaiTM Spirit BioTWIN.  
 
When the sulfonate-based nanoparticles described in chapter 2 were added to amyloid fiber 
preparations, we observed different modes of adsorption. The nanoparticle-fiber interaction 
depended on the size of the nanoparticles and ligand-shell composition. The negatively charged 
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allMUS and MUS:OT particles bind to all three fibers tested in this thesis, but the presence of 
OT in the ligand-shell improves the adsorption of small nanoparticles onto A?1-40 and Tau-441 
fibers. When ?-synuclein fibers were used, we saw no significant differences between allMUS 
and MUS:OT under cryo-EM, but a size-selection phenomenon was detected: the smaller 
nanoparticles adsorbed onto the edges, while the larger ones aggregated in the surroundings.  
 
When a batch of allMUS nanoparticles synthesized via the one phase method (2.42 ± 1.77 nm), 
was added to A?1-40 fibers no discernible fiber adsorption was observed under negatively 
stained dry TEM imaging (Figures 3.9(c) and (d)). The particles were added to the fiber mixture 
and kept under 300-1000 rpm agitation at 37°C for 2 to 12h depending on the experiment: no 
precipitation was observed under these conditions. Only after overnight storage at 4°C, a red 
band or pellet developed, clearing the supernatant: this behavior varied across experiments. 
The sample was re-suspended (using vortex or pipetting), and grids prepared for negatively 
stained TEM imaging: Figures 3.9(c) and (d) show the typical image of allMUS NPs with A?1-
40 fibers. These particles did not seem to adsorb with any degree of order onto the fibers, and 
scattered particles could be seen over the grid, usually aggregated close to the fibers. However, 
when this sample was size-fractionated in a sucrose gradient (Figure 3.9(f)), which removes 
larger particles and decreases the polydispersity (2.65 ± 0.92 nm) and potentially ‘worse’ 
particles, the same experiment revealed avid A?1-40 decoration, as seen in Figure 3.9(f).  
 
 
Figure 3.9 (a) Molecular structure of MUS ligand and schematic depiction of the allMUS nanoparticle. (b) TEM of a one-
phase synthesized allMUS nanoparticle batch. The size distribution is wide (see methods). (c) and (d) Typical images of A?1-
40  with the nanoparticles depicted in (b). In dry microscopy, some binding is detectable, but a lot of particles distribute 
randomly across the grid. (e) The same batch after fractionation, that eliminates most of the particles above 4 nm (2.65 ± 0.92 
nm). (f) Using the fractionated nanoparticles, the A?1-40 fibers were decorated. Image (c) was acquired in a Philips CM12 TEM 
all others in an FEI TALOSTM Electron Microscope.  
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The addition of 1-octanethiol (OT) to the nanoparticle ligand shell changed their adsorptive 
behavior onto A?1-40 fibers. Different ratios of MUS to OT were used, as shown in Figure 2.7. 
In this work, to address the effect of nanoparticles on the aggregation kinetics of amyloid 
precursors, each MUS to OT stoichiometry was synthesized in triplicates. This means that 
separate nanoparticle batches prepared with MUS:OT ratios of 9:1, 8:2, 7:3 all the way to 1:9 
and all OT were prepared, three times each, using the one phase method. A similar approach 
is on-going for Stucky particles, albeit more laborious. Unfortunately, experiments that rely on 
EM cannot afford the verification of each type of nanoparticle: electron microscopy is not a 
high throughput technique. Whenever we added MUS:OT nanoparticles with 10% and 30% 
OT by 1H-NMR (feed ratio 7:3 and 1:1 respectively, see Figure 2.7 and Methods) to A?1-40 
fiber suspensions, they adhered onto the fibers as observed under dry negatively stained TEM. 
Given the observation made with allMUS nanoparticles, that size-fractionation changed 
adsorptive behavior, the same experiment was performed for an MUS:OT NP batch with 30% 
OT. No change in adsorption was observed between fractionated and unfractionated MUS:OT 
nanoparticles, i.e. small changes in polydispersity did not affect how these amphiphilic 
nanoparticles adsorb on the fibers. When the image in Figure 3.9(f) is compared to those in 
Figures 3.10(c), (e) and (f), the association between the MUS:OT nanoparticles and the fibers 
seems qualitatively tighter than fractionated allMUS. These observations indicate the 
importance of hydrophobicity in promoting the adsorption of 1-3 nm anionic particles onto 
amyloid fibers. Furthermore, the fractionation might be excluding low-quality nanoparticles 
with poor surface coverage, and large particles that induce particle-particle aggregation before 
they can reach the surfaces of the fibers. This may explain Figure 3.9(f): under cryo-EM, 
nanoparticles containing OT pack more densely on the A?1-40 fibers, which confirms the 
observations made with dry TEM.  
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Figure 3.10 (a) Molecular structure of the ligands used: MUS and 1-octanethiol in addition to a schematic rendition of the 
nanoparticle ligand shell. (b) A TEM of an unfractionated batch synthesized via the one phase method (2.62 ± 1.4 nm). The 
OT content by 1H-NMR was 30% (the MUS:OT feed ratio in the reaction was 1:1) (c) Representative image of A?1-40 fibers 
in the presence of MUS:OT nanoparticles. The fibers were covered by nanoparticles that seemed to be embedded with the 
cores of the fibers. (d) The same nanoparticle batch after fractionation, which produced sizes of 2.40 ± 0.98 nm. (e) and (f) 
show that fractionation did not change the adsorptive behavior. Image (c) was acquired in a Philips CM12 TEM, and the others 
in an FEI TALOSTM Electron Microscope.  
 
In a prelude to chapter 4, to ensure the observations in Figure 3.10(a) is not a drying artefact, 
a series of cryo-EM images were obtained. These images confirmed that MUS:OT NPs cover 
fibers more densely than allMUS, and that small particles adsorb onto the edges of twisted 
ribbon fibers. Both types of particles adsorb preferentially on the edges of the fibers, but 
MUS:OT nanoparticles decorate these features at longer length scales, more reproducibly 
across different experiments and seem to establish a tighter association to the edge. We have 
tested both fractionated and unfractionated particles, in addition to several different batches to 
assess the differences between the two types of ligand shell. Qualitatively, MUS:OT 
nanoparticles have covered the fiber edges and highlighted the underlying fibril geometry more 
effectively than their allMUS counterpart. This phenomenon is discussed in detail in Chapter 
4, under the light shed by Chapter 1 and molecular dynamics (MD) simulations. Electrostatic 
interactions may be the main driving force, establishing contacts between tightly packed rows 
of lysine 16 on the edges of the fibers and the negatively charged nanoparticles (zeta potential 
between -35 and -45 mV). However, the role of the hydrophobic ligands and the adsorption 
onto the edges of ?-synuclein fibers suggest a different mechanism, as do the MD simulations. 
 
 81 
 
Figure 3.11 (a) Cryo-EM of A?1-40 fibers with fractionated allMUS NPs (Figure 3.9(e)). Generally, allMUS nanoparticles did 
not cover the fibers as densely as MUS:OT for these fibers. The distances from two pairs of particles sitting seemingly on the 
edges of the fibers are indicated on the figure. Red dots were drawn recapture the mode of binding seen in the next image, for 
MUS:OT particles. (b) Same fiber sample with MUS:OT NPs (30% OT), fractionated nanoparticles (Figure 3.10(d)) added to 
the sample. The fiber coverage is denser, and edge-binding is noticeable for certain fibers. The same concentrations were used 
in both experiments. Cryo-EM images an FEI TecnaiTM Spirit BioTWIN. 
Figure 3.11 reveals that sulfonated nanoparticles adsorb onto the fibers. Unlike the cooperative 
and indiscriminate adsorption of cationic NPs, the allMUS NPs in Figure 3.11(a) are evenly 
distributed across different fibers, which agrees with an electrostatically driven interaction: 
nanoparticles find equally suitable counter-charges in different fibers. Close inspection of 
Figure 3.11(b) indicates that hydrophobicity, conferred to the nanoparticles by the OT ligands, 
induces a mode of nanoparticle-fiber adsorption never reported before. Yoshiike et al. reported 
dry images that resemble how cationic nanoparticles adsorb onto ?-synuclein fibers in Figure 
3.4(a); but cryo-EM (Figure 3.4(c) and (d)) reveals a completely different morphology. 
Therefore, the way his nanoparticles bind to the fibers in solution is not known: the drying 
process can template the nanoparticles on the edges of the fibers, as discussed for allTMA 
particles on ?-synuclein fibers. Despite the utility of negatively stained dry TEM, the 
comparison between Figures 3.4(a) and (d) demonstrates that the dry state does not necessarily 
reflect how the species exist in the solvated state. For these reasons, the edge-binding on the 
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twisted ribbon morphology shown in Figure 3.11(b) is a novel supra-molecular assembly 
between two unrelated, yet similar materials. The cross-edge MUS:OT interparticle distances 
shown in Figure 3.11(b) fall in the 9 nm range. In the allMUS sample, it is difficult to find 
conspicuous cross-edge particle pairs to measure such distances (Figure 3.11(a)). So far, these 
values are not statistically rigorous, but to a first approximation, when similar fibers are 
compared, the interparticle distances for MUS:OT nanoparticles are about 1 nm lower than 
allMUS. Red dots were added to Figure 3.11(a) to illustrate how MUS:OT nanoparticles would 
adsorb onto the fibers, and the reported values correspond to the width of the fibers measured 
in ImageJ. The red dots were placed tangent to the limit of the electron-density that can be 
attributed to the fiber. However, the MUS:OT nanoparticles do not simply rest tangent to the 
edge, but appear convoluted with it: these particles form a tight interface with the edges of the 
fibers.  
 
We added these two batches of particles, unfractionated (Figures 3.9(b) and 3.10(b)), to a 
preparation of ?-synuclein fibers: they both adsorbed onto the edges of twisted ribbons 
identically. Moreover, Figure 3.12 shows that ?-synuclein fibers exclude larger particles from 
a row of nanoparticles that delineates the edges of the fibers. The typical interparticle distance 
between a pair that sits on opposite edges is about 15 nm, which reflects the width of the fiber 
core.  
 
Figure 3.12 (a) Cryo-EM of ?-synuclein fibers in the presence of allMUS unfractionated nanoparticles. Unlike A?1-40 fibers, 
allMUS adsorb efficiently onto the edges of these twisted ribbons, highlighting the helical pitch. There is a cutoff size of 
nanoparticles that cannot join the row of particles that follow the edge of the fibers (~4.5 nm). (b) Unfractionated MUS:OT 
(30% OT) nanoparticles behave no differently from allMUS when the fibers are made of ?-synuclein, at least from the cryo-
EM perspective. The same edge-on adsorption is observable, and the interparticle distances across the edges is similar between 
the two samples. Perhaps the two nanoparticles behave differently with ?-synuclein fibers under other measurements. Cryo-
EM images an FEI TecnaiTM Spirit BioTWIN. This imaged will be revisited in chapter 4. 
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Out of the 140 amino acids in ?-synuclein, the core of the fiber is commonly attributed to a 
central stretch of about 35 residues called the NAC region (non-amyloid ? component)30. 
Different reports have shown the involvement of segments that span from position 35 to 98 in 
the formation of the fiber59,71, as described in chapter 1. A conservative estimate predicts two 
disordered tails: (i) an amphipathic 34 residue N-terminal that includes both negatively and 
positively charged moieties; and (ii) a C-terminal made of about 40 residues with a balance of 
15 anionic groups, i.e., the number of basic residues subtracted from the acidic ones. The 
overall zwitterionic N-terminal and negatively charged C-terminal form disordered tails that 
surround the spine of the fiber. Figure 3.1(e) shows how immunogold, designed to recognize 
epitopes on these segments, produces a cloud of randomly distributed nanoparticles around, 
but not on the fiber. In Figure 3.12, the nanoparticles adsorbed onto the rigid core of the 
amyloid fiber, as highlighted by the interparticle distances across the edges. Because ?-
synuclein has a longer fiber-forming domain than A?1-40, the measured interparticle distances 
are correspondingly larger: about 10 nm in Figure 3.11 and ~14 nm in Figure 3.12 (crude 
averages from manual measurements in ImageJ). The disordered side-segments may sieve the 
nanoparticles by size, which excludes larger ones (more detail in chapter 4) and may also help 
the allMUS NPs adsorb onto the edges. Nevertheless, these segments should repel negatively 
charged nanoparticles; instead, anionic particles adsorb more efficiently onto the edges of ?-
synuclein, which weakens a purely electrostatic interpretation of the phenomenon. The role of 
the C-terminal disordered segments can be tested in the future by cleaving it using enzymes.  
 
MUS and MUS:OT nanoparticles also adsorbed onto Tau-441 fibers. The particles sat on the 
body of the fiber instead of interacting with the disordered side chains seen in Figure 3.1(d): in 
fact, immunogold labelling was used to demonstrate the existence of the fuzzy coat76. This 
adds to the observation made with ?-synuclein: these nanoparticles interact, most likely, with 
the cross beta sheet backbone, rather than the disordered segments that surround Tau-441 
fibers77. Both allMUS and MUS:OT nanoparticles adsorbed, and depending on the fiber, the 
center-to-center distance between two particles on different sides of the amyloid varied from 
7.4 to 16 nm (Figures 3.13 and 3.14). Again, allMUS nanoparticles did not decorate the fibers 
as effectively as its MUS:OT counterpart. Figure 3.13(c) shows a representative cryo-EM of 
the Tau-441 fiber preparation with 0.2 mg/mL fractionated allMUS nanoparticles (Figure 
3.9(e)). Most particles formed aggregates of two to five particles, which likely underlines a 
connection with oligomeric forms of Tau protein.  
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Figure 3.13 (a) Negatively stained TEM image of Tau-441 fiber with allMUS nanoparticles. Tau fibers have long disordered 
segments that surround the fiber and are called fuzzy coats, to which the immunogold probes attach in Figure 3.1(d). The 
particles attach to the core of the fiber, as shown by the distances between nanoparticle-pairs in opposite sides of the fiber. 
Most are distanced by 10 nm. (b) A broader view of the same sample (image (a) is a crop of this one). Most fibers are not 
coated by the allMUS particles, instead, they seem to associate with oligomers. (c) Cryo-EM image of the same sample: most 
fibers are not covered by nanoparticles, which is to be compared to Figure 3.13(c). Image (b) ((a) is a crop of it) was acquired 
in an FEI TALOSTM Electron Microscope, and (c) in an FEI TecnaiTM Spirit BioTWIN. 
 
Figure 3.14 shows that the same concentration of fractionated MUS:OT nanoparticles (0.2 
mg/mL) decorated the bodies of the Tau fibers more effectively. Although other types of 
aggregates could be seen in the sample, this experiment reveals that MUS:OT nanoparticles 
have a higher affinity to the underlying interface of the amyloid fiber than its allMUS 
counterpart. Negatively stained dry TEM showed fibers with two rows of particles on each 
side: the distance between pairs of particles separated by the fiber varied between 7.4 to 12 nm. 
Figure 3.14(a) depicts some of these pairs and their distances measured in ImageJ. We 
compared the value found in dry images with the equivalent particle-particle distances found 
under cryo-EM, and in this case, the results were similar. In cryo-EM images (Figures 3.14(b)-
(d)), the cross-edge interparticle distances varied from 9 to 17.6 nm. The small differences 
between dry samples and solvated ones may stem from a drying effect, or different types of 
fibers measured. The latter is true, because various types of fibers with different widths were 
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observed in the cryo-EM images. Unlike the well-defined edge-binding revealed by Figure 
3.11(c) for A?1-40 and in Figure 3.12 with ?-synuclein, MUS:OT nanoparticles cover the body 
of Tau-441 fibers without following a conspicuous geometric feature. Tau protein is 10 times 
larger than A?1-40, and contains cysteines that could bind nanoparticles via Au-S bonds even if 
they are committed to disulfide bridges. The fiber core is probably formed by a complex 
association of the amyloid-forming rigid core segment of the protein that adopts a superpleated 
serpentine-like monomeric form. Chapter 1 briefly described the structure of Tau-441 fibers, 
but reliable 3D models are not available. Nonetheless, when compared to the distribution of 
immunogold labels that target the fuzzy coat (Figure 3.1(d)), the results shown in Figures 3.13 
and 3.14, demonstrate that MUS:OT, and to a lesser extent, allMUS nanoparticles interact with 
the core of the amyloid fibers. The disordered side chains may play a role, which can be verified 
by further experimentation, such as digesting away the fuzzy coat77. Nonetheless, this class of 
particles forms a favorable interface with the basic units of the amyloid fiber, possibly the 
solvent exposed cross-beta sheets.  
 
 
Figure 3.14 (a) Negatively stained TEM of a Tau-441 fiber covered by the same particles from Figure 3.10(d). When different 
particles form pairs separated by the body of the fiber, we’ve highlighted their distances, measuring the center-to-center 
interparticle separation. In this fiber, most values are around 10 nm, however a lot of “defects” prevents a long-range order 
claim (b) A crop from a cryo-EM image of a long Tau-441 fiber covered by unfractionated MUS:OT nanoparticles (~30% 
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OT), showing similar cross-edge distances between pairs of particles. (c) Cryo-EM of MUS:OT NPs shown in Figure 3.10(d). 
These particles decorate the fibers more effectively than allMUS. (d) A 1 mg/mL solution of MUS:OT nanoparticles that 
showed complete fiber coverage and numerous non-fibrillar aggregates. The particle used in this image is an unfractionated 
batch of MUS:OT (~30% OT). Image (a) was acquired in an FEI TALOSTM Electron Microscope, and the others an FEI 
TecnaiTM Spirit BioTWIN. 
 
3.6? Conclusions 
This chapter has shown how different types of water-soluble nanoparticles interact with 
amyloid fibers. It starts from a dialogue with the preceding literature that relied on electrostatic 
interactions to demonstrate the existence of dense regions of positive charges on the surface of 
A?1-40 fibers. Such surface features agree with 3D detailed structural models of A?1-40 fiber, 
because the in register cross beta sheet motif can create a line of lysine 16 that points to the 
outside of the U-shaped monomer. Whether these facets are solvent exposed depends on the 
configurational polymorphism adopted by the protofibrils. It is unlikely that lysine 28 is 
exposed to the solvent and can form these cationic surface structures, because in all models 
reviewed, this residue is committed to salt bridges that stabilize the structure of the monomer. 
Of course, future work plans on using mutated sequences to test the role of these charged 
residues.  
 
Our results show that positively charged nanoparticles, coated with quaternary amine head-
groups can also adsorb onto A?1-40 fibers. We can interpret this result following Yoshiike’s 
rationale185, to conclude that cationic particle adsorption demonstrates the existence of dense 
anionic features on the surface of the fiber. This interpretation does not contradict the structural 
models described in chapter 1, because the cross beta motif can group acidic residues into rows 
of solvent exposed anionic surface features on A?1-40 fibers. For example, the glutamic acid at 
position 22 can form a row of negative charges, which has been described to sit on the edges 
of a twisted ribbon morphology for A?1-42 fibers32. Nonetheless, under cryo-EM the cationic 
allTMA nanoparticles do not conspicuously adsorb on the edges of the fibers. The dry samples 
show a degree of edge-binding, which can be a consequence of the drying process: as the 
sample sets on the surface of the grid, the fibers template the deposition of the nanoparticles 
that are attracted by the edges of the fibers. In the negatively stained samples, the electron 
density comes from the uranium atoms of the dye (uranyl acetate) and the core of the 
nanoparticles: the fiber no longer exists in its solvated form. This urges the interpretation of 
cryo-EM images, that capture the solvated state via vitrification of the sample. Under this 
imaging mode, certain fibers have a high density of allTMA nanoparticle coverage, without 
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any signs of preferential docking. Figure 3.2(d) and (e) show that multiple parallel rows of 
particles completely cover the fiber. Moreover, they accumulate in certain fibers, which leaves 
several others free of particles. We call this behavior a cooperative adsorption, which can be 
influenced by the aggregation propensity of these particles in the presence of biomolecules189. 
The role of monomers and oligomers cannot be discarded: once in the solution, the particles 
can interact with the non-fibrillar species, and co-aggregate with them. The fibers offer a linear 
template, onto which the nanoparticles (or nanoparticle-oligomer complexes) can collectively 
adsorb, minimizing the excess surface energy of the system.  
 
The cationic particles do not follow any fundamental geometric constraint of the fibers, other 
than its linear nature. For these reasons, we refer to allTMA nanoparticle-fiber adsorption as 
indiscriminate and cooperative. In other words, they do not conspicuously adsorb onto any 
feature of the fibers, but collectively cover individual fibers, leaving others free of any 
particles. A simple electrostatic explanation is unlikely to capture this phenomenon because 
simple charge pairing would distribute the nanoparticles across different fibers evenly. Instead, 
lines of particles nucleate and grow on the surface of the fibers: growth is likely mediated by 
the same driving forces that drive aggregation in the presence of globular proteins189. The 
circular dichroism (see methods) of mature fibers did not change in the presence of cationic 
nanoparticles, which indicates no detectable alterations in the secondary structure of the 
peptides. However, it is possible that the nanoparticles change the local environment, which 
favors the adsorption of the neighboring site, in what has been termed vicinal adsorption. 
Whatever the case, when sufficiently screened, these nanoparticles form aggregates and the 
net-negative fibers may simply provide a template onto which they can accumulate.  
 
The same rationale can be used to explain how allTMA nanoparticles interact with ?-synuclein 
fibers. In this case, the fibers are more electronegative than A?1-40184, which leads to faster 
aggregation. Once covered by cationic nanoparticles, the individual ?-synuclein fibers 
interlace with one another, forming bundles (similar to ropes) of multiple fibers. This 
phenomenon can be the consequence of a co-precipitation phenomenon, in which, the allTMA 
nanoparticles screen the electrostatic forces that prevent fibers from aggregating. The 
mechanisms that lead the fibers to interlace escape the current discussion: simple charge 
screening cannot explain the level of fiber weaving observed in Figures 3.3(b) and 3.4(c). 
When allTMA nanoparticles were added to Tau-441 fibers, the linear aggregation was a rare 
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finding. Figure 3.5 shows that random aggregates predominate in the presence of Tau. The 
non-fibrillar proteins and oligomers probably induced the nanoparticle aggregation before they 
could interact with the fibers.  
 
To test the importance of coulombic forces in the adsorption of gold nanoparticles onto amyloid 
fibers, a sulfobetaine terminated thiolate was synthesized. These ligands offer a zwitterionic 
end-group that render the nanoparticle, to a first approximation, neutrally charged. However, 
zeta potential measurements show a slight negative charge: two different batches of 
zwitterionic particles had zeta potentials of -2.4 ± 0.5 mV and -9.2 ± 0.2 mV. The latter was 
used in these experiments, and showed remarkable colloidal stability in the presence of all 
amyloid fiber preparations. A flocculation-like phenomenon was observed when all other 
nanoparticles were added to the fiber suspensions. In this case, even centrifugation (13,000 g 
for 10 min) only created a pale pellet, while the supernatant remained red. All images collected 
with these particles showed evenly distributed nanoparticles that did not interact with the 
amyloid fibers. The charge-neutrality is probably not responsible for this behavior: an 
additional experiment using PEGylated neutral nanoparticle needs to be done to confirm this 
claim. Previous studies indicate that zwitterionic surfaces form strong hydration shells that 
prevent non-specific protein adsorption115,190,188,187,114. These types of head-groups form an 
electrostatically mediated water shell that is more cohesive than its hydrogen-bonded 
counterpart found in ethylene glycol coatings187. The disruption of this water shell is 
energetically unfavorable, which manifests as a force opposing the contact with a protein. We 
hypothesize that the same phenomenon causes the colloidal stability of our zwitterionic 
nanoparticles in the presence of amyloid fibers and their non-fibrillar species. This hypothesis 
is difficult to challenge experimentally, because we lack the means to demonstrate this 
proposed water shell and then verifiably disrupt it.  
 
When we studied how negatively charged nanoparticles interact with the fibers, the reductionist 
coulombic approach did not provide a straightforward interpretation of our observations. We 
prepared two types of negatively charged gold nanoparticles. The first, protected by a 
phosphate group, precipitated in the presence of A?1-40 fibers, and has not been tested yet with 
other proteins. The second was the sulfonate-based particles discussed in chapter 2: these 
particles revealed that electrostatics alone cannot explain all binding phenomena. Using the 
same concentration, particles protected only by the MUS ligand did not adsorb onto A?1-40 and 
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Tau-441 fibers as efficiently as its MUS:OT counterpart. The two particles only showed the 
same behavior when added to the anionic ?-synuclein fibers, which, again, goes against a 
purely electrostatic explanation. Amyloid fibers of full-length peptides often have disordered 
side chains, which in the case of Tau protein form large fuzzy coats76 that have been described 
as charged polymer brushes (Figure 1.13) 77. Our results indicate that MUS-based nanoparticles 
adsorb onto the spine of the amyloid fiber, and not diffusely around the disordered segments, 
as in Figure 3.1(d). The brushes might contribute to nanoparticle adsorption, but do not 
constitute the final interface between nanoparticles and amyloid fibers. Instead, allMUS and 
MUS:OT nanoparticles adsorb onto the rigid fiber core, that is made of a cross beta sheet motif. 
Cryo-EM reveals that small MUS:OT nanoparticles discriminate the edges of fibers that adopt 
a twisted ribbon morphology in 3D. The edges of twisted-ribbon fibers made of A?1-40 or ?-
synuclein were effectively decorated by these particles. Only electrostatics cannot explain these 
observations, because of the importance of ligand-shell hydrophobicity brought about by 1-
octanethiol ligands in the adsorption onto A?1-40 fibers. Our results neither confirm nor 
contradict the image shown in Figure 3.1(a). Instead, it reveals that the interaction between 
nanoparticles and amyloid fibers depends on the properties of the nanoparticle ligand shell and 
on the amyloid fiber.  
 
Chapter 4 shows that a phenomenon similar to the lipid bilayer fusogenic behavior described 
in chapter 2 may drive this discriminative adsorption. Experiments show that the amphiphilic 
nanoparticles described in the previous chapter bind to the edges of the twisted ribbon amyloid 
fibers and follow their underlying geometric constraints. Molecular dynamics calculations 
predict favorable contacts between the ligand-shell of these nanoparticles and parts of the beta-
sheet of the protofibrils or the elbow of the U-shaped monomer.  
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4? Discriminative adsorption of amphiphilic gold nanoparticles 
onto amyloid fibers 
4.1? Introduction 
Chapter 3 covered how water soluble gold nanoparticles interact with amyloid fibers. It 
systematically provided experimental evidence that electrostatics alone cannot explain how 
nanoparticles behave with these protein assemblies. Instead, several parameters, including 
coulombic interactions, hydrophobic forces and the organization of water molecules in the 
ligand shell dictate how this nano-bio interface109 occurs. This offered insight for the design of 
immunogold labels to prevent non-specific interactions; apart from zwitterionic nanoparticles, 
all other ligand shells investigated showed some degree of interaction or aggregation in the 
presence of amyloid fibers and the corresponding non-fibrillar species. It also introduced an 
unanticipated phenomenon: sulfonated nanoparticles adsorbed preferentially onto the edges of 
amyloid fibers with a twisted ribbon morphology. The helicity of these ribbons was highlighted 
by the presence of the sulfonated particles in the case of A?1-40 and ?-synuclein fibers imaged 
under cryo-EM. Moreover, it showed that the presence of 1-octanethiol in the ligand shell 
improves the decoration of amyloid fibers made of A?1-40 and Tau-441.  
 
This chapter tackles the discriminative adsorption of MUS:OT and allMUS nanoparticles onto 
amyloid fibers. This class of nanoparticles does not adsorb onto all the interfaces generated by 
the amyloid fold. Instead, they dock on the edges of fibers that adopt a twisted ribbon 
morphology, in a process we call discriminative adsorption. The total free energy of the system 
is minimized when the nanoparticles attach to a particular structure on the surface of the fibers. 
For example, small MUS:OT nanoparticles arranged into either two or three intertwining lines 
of particles, that agree with two basic polymorphs described in chapter 128,31. Unlike cationic 
nanoparticles, that completely cover the fibers, sulfonated particles follow the geometry of 
these supra-molecular assemblies: this is only possible if the nanoparticles interact with an 
underlying ordered surface feature. This chapter shows a set of different experimental 
conditions that either favors or eliminates this behavior.  
 
Both size and ligand-shell composition affect the ability of these nanoparticles to adsorb onto 
the edges of the fibers. The larger (4-6 nm) allMUS and MUS:OT nanoparticles, synthesized 
using the modified Stucky method, did not adsorb onto the edges of the fibers as conspicuously 
as one phase prepared NPs. Furthermore, in polydisperse samples, the smaller nanoparticles 
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adsorbed more efficiently onto these features; this agrees with atomistic molecular dynamics 
(MD) simulation that showed favorable binding for smaller particles.  Following the model 
used by van Lehn et al.135 a set of three nanoparticles was built: 2 nm allMUS, 2 nm MUS:OT 
(30% OT) and 5 nm MUS:OT (30% OT). These particles were in placed in the vicinity of 
model protofilaments of A?1-40 and A?1-42: the 2 nm particles spontaneously adsorbed onto the 
protofilaments in the simulation timescale, whereas 5 nm particles had to overcome a 3.5 
kcal/mol energy barrier to bind to the A?1-42 model. 
 
The insights gained from these calculations and experiments enable the proposal of verisimilar 
binding geometries. It is impossible to unambiguously establish the binding sites at a molecular 
scale relying solely on microscopy and calculations; nonetheless, this system satisfies the 
requirements to determine ligand-peptide contacts using nuclear magnetic resonance38, which 
opens opportunities for future experiments. The impact of this discovery is two-fold: first it 
sheds light on the rapidly growing interest to use gold nanoparticles for protein structure 
determination94,173. Here we describe an antibody-free method to mark discrete structures on a 
protein assembly. Second, given the current search for substances that recognize and bind to 
amyloid fibers177, in addition to the drugs already in phase 3 clinical trials that target  the mature 
amyloid191,192 the description of a class of materials that recognizes discrete surface features 
can become a useful tool in amyloid research.  
 
Figure 4.1 Schematic of the problem: why do MUS and MUS:OT nanoparticles bind to the edges of amyloid fibers and not 
on the longer facets? Here the fiber is oversimplified as a flat twisted ribbon, with a rectangular cross section. How the 
constituent monomers assemble to form the core depicted by the rectangle can be proposed using the detailed molecular 
structures described in chapter 1. Such models differ from the results proposed by high-resolution cryo-EM reconstructions80, 
which render this assignment challenging. Regardless of what the particles adsorb to, the results match the current 
disagreements in the literature.  Disordered segments are omitted, but likely play role, especially in the case of ?-synuclein 
and Tau protein. Experiments show that the particles probably sit on the rigid backbone of the fibers. Not drawn to scale.  
4.2? Cryo-EM  results with A?1-40 : binding and non-binding conditions 
The results are shown sequentially, to illustrate the experimental conditions that produced 
images with edge-binding and what parameters erased the phenomenon. All experiments with 
 93 
A?1-40 were done by preparing a monomeric solution of the peptide at ~10 μM, unless otherwise 
noted. The fibers were allowed to grow in 96-well plates, or inside Eppendorf tubes in a 
thermomixer at agitations that ranged from 300 to 1000rpm at 37°C for 12 h: the condition is 
specified in the caption of each figure. Growth was monitored by ThT fluorescence and 
negatively stained dry TEM imaging. We have also performed fiber growth in the presence of 
the different types of nanoparticles in a plate reader to assess their effect on fiber formation 
kinetics. Examples of the kinetic curves are shown in the Methods section (Figures M.16 and 
M.18). Under regular TEM and cryo-EM, the fiber-NPs species from co-growth or post-
addition showed little differences: the NP ligand shell and diameter has determined the 
decoration of fibers by the nanoparticles. Preliminary data indicates that the type of 
nanoparticle can change the length of the fibers, and under AFM imaging, their thickness. Here 
we focus on the cryo-EM results that allow us to visualize the metallic core of the nanoparticles, 
and the silhouette of the fibers. Figure 4.1 shows an experiment in which 10 μL of 1 mg/mL 
unfractionated allMUS nanoparticles was added to 90 μL of the mature amyloid fiber solution: 
the mixture was agitated for 12 h under 1000 rpm at 37°C.  
 
Figure 4.2 Unfractionated allMUS nanoparticles added to mature A?1-40 fibers. (a) This image is somewhat an exception: it 
shows the allMUS particles (2.42 ± 1.77 nm) binding to the edges of this type of fiber. With A?1-40 this has not been the rule. 
This image also shows that larger particles are excluded from the row of NPs that cover the edges of the fibers. Striated 
structures have been observed in allMUS unfractionated samples, and we do not know their nature. (b) and (c) Typical finding 
on A?1-40  fibers with unfractionated allMUS nanoparticles. Images acquired in an FEI TecnaiTM Spirit BioTWIN. 
 
When fractionated allMUS (2.65 ± 0.92 nm) nanoparticles were used, the overall observations 
did not change. The fiber preparation followed the same protocol, and the only significant 
difference may stem from a higher effective concentration of nanoparticles in the fractionated 
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experiment. In other words, unfractionated particles contain a higher amount of larger NPs, 
that are heavier. The particle stock solution is prepared gravimetrically, that is, a 1 mg/mL 
solution is prepared based on the mass of the nanoparticle powder, which can cause a higher 
effective nanoparticle concentration for fractionated samples. Figure 4.3 shows typical images 
of sparsely covered fibers. The TEM characterization of the NPs used in these two experiments 
can be found in Figures M.13 and M.14.  
 
Figure 4.3 Fractionated allMUS nanoparticles, added to A?1-40 fibers. (a) Some edge-coverage was observed in this sample 
and seen in fibers in the center of the image or lower left. (b) The typical aspect shows fiber binding, but no decoration that 
highlights underlying geometric fiber properties. Images acquired in an FEI TecnaiTM Spirit BioTWIN. 
 
MUS:OT (30% OT) unfractionated nanoparticles (~1-4 nm) were added to the same type of 
A?1-40 fiber preparation. Overall, the macroscopic behavior of the sample was similar to 
allMUS: the solution was homogeneous during agitation, and upon storage at 4°C, or even 
room temperature, a red solid precipitated to the bottom of the vial. This effect was absent only 
in two types of nanoparticles: ZW NPs and MUS:OT NPs with 10% OT composition. Figure 
4.4 shows clear edge-adsorption of these MUS:OT NPs that displayed a typical center-to-center 
interparticle distance across the fiber of 11 nm, at the widest part of the ribbon. The distance 
between neighboring NPs on the same chain oscillate between ~5-6 nm, to 12 nm, as illustrated 
in Figure 4.4(b).  
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Figure 4.4 Different views of A?1-40 fibers with MUS:OT (30% OT) nanoparticles adsorbed on their edges. (a) This image 
shows two measurements of the center-to-center distances between nanoparticles that sit on different sides of the twisted 
ribbon. The fibers can be wider than the values reported here, but these sizes were the most commonly observed. (b) Different 
helical pitches are often reported for amyloid fibers, and used to categorize them. This image shows a fiber that does not 
“twist” and two distances between neighboring nanoparticles on the edges. (c) A common finding in regions with a high 
density of fibers: when they aggregate, it can be difficult to distinguish single fibers, but the particle binding is still observable. 
Red dots were placed on top of nanoparticles that sit on candidate single fibers that are difficult to distinguish. (d) On the 
bottom of this image, three lines of particles can be seen around one fiber, which may be indicative of a 3-fold symmetric A?1-
40 polymorphism. Image acquired in a JEOL 2200FS by Dr. Davide Demurtas.  
 
The images shown in Figure 4.4 have been reproduced in several different experiments, as will 
be shown in the next section. We have searched for experimental conditions to prevent this 
type of edge-adsorption onto A?1-40 fibers from happening. The experimental parameters that 
prevented the particles from adsorbing effectively were: (i) decreased time of incubation, (ii) 
presence of 1% fetal bovine serum and (iii) nanoparticles synthesized using the Stucky method. 
This last item is still under investigation: from the definition given here to discriminative 
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adsorption, the MUS:OT (33% OT) Stucky nanoparticles may be adsorb onto the same sites as 
their smaller counterparts. The “discriminative” qualifier used to describe the mode of 
adsorption is morphological and qualitative: when nanoparticles clearly delineate the twisted 
ribbon morphology, it receives this qualifier. Nonetheless, the nanoparticles shown in Figure 
4.5(d) may have adsorbed onto the same sites as their smaller counterparts, but in these 
conditions do not form long chains of on the edges of the fibers. Figure 4.5 summarizes the 
findings under these conditions.  
 
Figure 4.5 Experimental conditions that have prevented discriminative adsorption of MUS:OT NPs onto A?1-40 fibers. (a)
Presence of 1% FBS: caused nanoparticle aggregation. (b) Shorter incubation time: sample shaken for 2h at 37°C. All other 
experiments had 5 to 12 h incubation periods. Some binding is seen, but not comparable to Figure 4.4. (c) allMUS Stucky 
nanoparticles (4.82 ± 1.83 nm). Particle aggregation was observed and only a few nanoparticles landed on the fibers. (d) 
Stucky MUS:OT (33% OT) nanoparticles (5.0 ± 1.0 nm). The addition of OT to the nanoparticles increased their adsorption 
onto the fibers. All images acquired in an FEI TecnaiTM Spirit BioTWIN.
 
Figure 4.5(c) and (d) reveal that nanoparticle diameter and more importantly, the ligand shell 
composition determine the adsorptive behavior of MUS-based nanoparticles on A?1-40 fibers. 
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This finding remounts to Figure 1.25(b), that showed the importance of nanoparticle diameter 
in their propensity to fuse with lipid bilayers. Larger nanoparticles have lower ligand mobility, 
which may prevent them from interacting with the available amyloid surfaces. The MD 
calculations showed this behavior, in addition to the larger electrostatic repulsions between 
allMUS and 5 nm MUS:OT 7:3 NPs, that can disfavor the formation of particle chains on the 
edges of the fibers. The proteins present in FBS can eliminate the adsorption via different 
mechanisms. For example, the nanoparticles can interact with serum proteins, forming a 
protein corona that prevents the ligand shell from contacting other surfaces. Alternatively, 
serum proteins may competitively bind to the fibers, preventing nanoparticles from adsorbing 
onto them: a combination of these two effects is possible. Recently, the dissociation constant 
between albumin and MUS-based nanoparticles has been experimentally calculated, and 
corresponds to a binding energy around -70 kcal/mol (unpublished data). If the MD 
calculations are correct, the binding energies between these nanoparticles and the amyloid 
fibers range from -23.04 to -65.16 kcal/mol: therefore, in the presence of albumin, the 
nanoparticles may favorably bind to the abundant globular proteins. If the particles are not 
covering the fibers because they first interact with serum proteins, an increase in the amount 
of NPs that surpasses the globular protein binding sites, can generate NPs free to interact with 
the fibers. An analogous experiment has been performed with Tau-441, but the competition is 
between non-fibrillar material and fibers of the same protein. It is difficult to envision an 
experiment with these techniques to address the possibility that the fibers are covered by serum 
proteins thus preventing NP adsorption. Figure 4.5(b) points towards an endergonic adsorption: 
the samples need agitation at 37°C to yield covered fibers.  
 
The adsorption of nanoparticles onto the edges of the fibers has been observed across different 
sample preparations: the phenomenon has been reproducible apart from the conditions shown 
in Figure 4.5. How the monomers arrange in space to constitute the amyloid fiber is difficult 
to establish, as reviewed in chapter 1. Nonetheless, during our experiments, we have observed 
two conspicuous morphologies: two and three fold symmetric twisted objects. Figure 4.6(a) 
and (d) show 2-fold symmetric fibers with two intertwining chains of nanoparticles that 
correspond to the helicity of a twisting ribbon. The 3-fold symmetric fibers were less abundant 
in our sample preparations, but Figure 4.6(b) and (c) show three intertwining chains of 
nanoparticles: care must be exercised because the intertwining lines are 2D projections of NPs 
on a 3D twisted triangular prism. For a ribbon it suffices to measure the largest dimension to 
obtain its width. For the three-fold symmetric fiber, the three ‘sinusoidal’ lines (see red dots in 
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Figure 4.6(b)) trace how the nanoparticles arrange in 3D along a twisted pyramidal prism: 
vertices and faces are symetrically equivalent in the 2D projection. In this case, the longest 
center-to-center distance between a pair of particles on opposite sides (~15 nm) can correspond 
to the distance between particles sitting on the faces or the vertices of this twisting prism. The 
three-fold symmetric model for A?1-40 predicts a ~7 nm facet for such prism28; if the center of 
a particle is 3 nm from the surface it interacts with (gold core radius plus ligand shell), simple 
geometric considerations would make the center to center distances fall in the 9 nm rage for 
vertex interactions, and ~7 nm for face-on interactions.   These calculations and approximations 
need to be made with great care: Figure 4.15 depicts an approach to this problem, but this 
section simply introduces the finding of two symmetries in the same sample. To our 
knowledge, the 3-fold morphology has only been shown under cryo-EM once, with dimensions 
that did not match the ssNMR models79. Our sample was prepared  at 37°C under 1000 rpm, 
which according to the literature28,47, favors the two-fold symmetric species. Three fold 
symmetric fibers were usually described in quiescent preparations31 and also in brain-derived 
A?1-4033.  
 
Figure 4.6 In the same sample, with A?1-40 fibers and MUS:OT (10% OT) nanoparticles, the two polymorphs commonly 
described in the literature were easily detectable. (a) A bundle of twisted ribbon fibers and a single one on the bottom. Careful 
inspection can help distinguish between three-fold symmetric fibers from overlapping two-fold fibers. (b) Two examples of 
three-fold symmetric fibers that co-exist in this sample with the other polymorph. The triangle indicates the symmetry in the 
the axis of the fiber. Red dots were placed on top of NPs to illustrate the ‘sinusoidal’ pattern adopted by single chains of 
particles in the 2D projection plane of the image. (c) Longest width found for a center-to-center NP distances in a 3-fold 
symmetric fiber. (d) The same type of distance on the same image on (a). Images acquired in an FEI TecnaiTM Spirit BioTWIN.  
 
The observation that nanoparticles can highlight the underlying geometry of two different 
polymorphs led us to attempt a sample preparation that results in three-fold symmetric fibers. 
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Following Paravastu et. al.28, 50μM of A?1-40 monomeric solution was prepared, and allowed 
to fibrillate under quiescent conditions at room temperature. Fiber growth was monitored by 
negatively stained TEM. After one month under these conditions, the sample had abundant 
fibrillar material, and we faced a conundrum: agitation at 37°C is necessary to decorate the 
fibers, but it has been reported to cause a morphology shift from 3-fold to 2-fold symmetric 
fibers47. Also, the results from Figure 4.6 showed that it was possible to find 3-fold symmetric 
fibers in the conditions necessary for nanoparticle adsorption. Thus we added 10 μL of 1 
mg/mL MUS:OT (30% OT) one phase nanoparticles to 90 μL of the fiber solution, and kept it 
under 300 rpm at 37°C overnight. The sample showed nanoparticle adsorption, as depicted in 
Figure 4.7(a), but did not resemble Figure 4.6(b): no fibers with three chains of particles could 
be detected, but most fibers had a single line of particles running through one side. The sample 
was then returned to the thermomixer and agitated at 1000 rpm and 37°C for 48h: many mono-
decorated fibers (i.e. only one side) remained, but wide, conspicuous twisted-ribbon two-fold 
symmetric fibers had nanoparticles on both edges (Figure 4.7(b)) in additions to a few 3-fold 
symmetric fibers (bottom panel of Figure 4.7(b)). Although these are microscopy findings, that 
risk being statistically unrepresentative, thorough imaging revealed a clear difference between 
the samples before and after the 48h agitation.   
 
Figure 4.7 (a) Quiescently prepared A?1-40 fibers with MUS:OT (30% OT) added, after 12h at 300 rpm and 37°C. Most fibers 
had particles only on one side, and several short strings of particles protruded from the main fiber. This can be indicative of 
secondary nucleation. (b) Same sample after 48h under 1000 rpm at 37°C eliminated, for the most part, the string-like 
protrusions and generated edge-decorated twisted ribbon fibers. The fibers were considerably wider than the ones reported in 
previous figures and seen in other experiments starting with 10 μM monomer concentration. The bottom panel shows a possible 
three-fold symmetric fiber. The experiment aimed favoring three-fold symmetric fibers, but instead showed a complex fiber-
nanoparticle interaction, and possible secondary nuclei in the quiescent preparation. Images acquired in an FEI TecnaiTM Spirit 
BioTWIN. 
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4.3? Nanoparticle adsorption onto ?-synuclein is size dependent 
One phase synthesized allMUS and MUS:OT NPs adsorbed equally onto ?-synuclein fibers. 
This experiment revealed another phenomenon: an apparent size selectivity of the adsorption 
on the edges of these fibers. A more comprehensive analysis of this data is on-going, but initial 
results suggest that the polydispersity index PDI  (or simply dispersity, ?) of nanoparticles 
adsorbed onto A?1-40 fibers is higher than of those adsorbed on ?-synuclein fibers. PDI can be 
defined in different ways, for example as the ratio between weight and number average 
molecular weights for polymers; but in colloidal science, the ratio between standard deviation 
and mean size is a common assessment of size distribution110. From analyzing two sets of 
images, one for A?1-40, shown in Figure 4.6, and the set of images that contains Figure 4.7(b), 
the PDI of the NPs on the edges of A?1-40 fibers is approximately 0.53 and for ?-synuclein 
0.44. A more comprehensive image analysis will refine these preliminary values, but inspection 
of an image such as Figure 4.6(a) shows that A?1-40 fibers accommodate different sizes of 
particles. On the hand, larger (~5 nm) nanoparticles are excluded from the edges of ?-synuclein 
fibers (Figure 4.9), and size mismatches seem to cause defects on the linear NP superlattices 
that form on the edges  (see arrows in bottom part of Figure 4.9(b)).  
 
Figure 4.8 Size distribution of nanoparticles on the edges of the fibers and distributed across the sample. ?-synuclein fibers 
seem to “select” small nanoparticles that can dock on its edges. As seen in Figure 4.6, there is no significant difference between 
the diameters of the nanoparticles adsorbed onto A?1-40 fibers and those in the rest of the image. These measurements require 
more data points to quantitatively reveal a size-dependent phenomenon. So far, the comparison between Stucky and one phase 
NPs suffices to demonstrate the role of nanoparticle diameter on fiber adsorption.  
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Figure 4.9  ?-synuclein fibers with a twisted ribbon morphology were equally decorated both by (a) unfractionated allMUS 
nanoparticles and (b) unfractionated MUS:OT (30% OT) nanoparticles. The size distribution on the surface of these fibers is 
slightly lower than those on A?1-40 fibers. Larger particles seem to disrupt the chain of particles on the edge of the fibers as 
indicated by arrows with asterisks. Excluded larger NPs are shown with white circles. The typical center-to-center distances 
between NPs on different sides, on the widest portion of the ribbon, are indicated in the images. The white rectangle shows 
the nanoparticle distance and the inner red rectangle the approximated distance between the nanoparticles surfaces, as 
estimated in these images: the defocus does not allow for a precise assignment, and an error between 0.5 to 1 nm must be 
considered. On the other hand, the center-to-center distances are reliable: the nanoparticles serve as a cryo-EM contrast 
imaging agent. The inset in figure 1 comes from reference (69) and was explained in Figure 1.12 in chapter 1. Their model 
places the solvent-exposed beta sheets on the edges of the twisted ribbons, and our nanoparticles are spaced by about 11 nm 
(surface-to-surface): if our sample corresponds to their model, the NPs are probably interacting with the cross-beta motif and 
not with disordered tails or surface loops. Images acquired in an FEI TecnaiTM Spirit BioTWIN. 
 
The size distributions of particles on the edge of each type of fiber, and on the overall sample 
is shown in Figure 4.9. More image analysis is needed to ensure the reliability of this analysis, 
but the plots agree with image inspection. Figure 4.8 shows the particle size distribution in the 
?-synuclein image in which a size cutoff occurs between 3 and 4 nm, while A?1-40 fibers 
accommodate a greater variety of sizes. These results agree with the molecular dynamics 
simulations that predicted a greater binding energy for 2 nm allMUS and MUS:OT (7:3) NPs 
in comparison to 5 nm MUS:OT (7:3) NPs: thus, it is expected to find a bigger amount of 
smaller nanoparticles on the edges of the fibers.  
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4.4? Insights from molecular dynamics simulations 
In collaboration with Dr. Francesco Tavanti and Prof. Alfredo Alexander Katz, the interaction 
between monolayer-protected AuNPs with A?1-40 and A?1-42 proto-filaments was simulated. 
AuNPs with  core diameters of 2 nm and 5 nm were built according to the previous work of 
Van Lehn et al.135. The monolayer composition and the core diameter were designed to create 
three types of NPs: 2 nm allMUS, 2 nm MUS:OT 7:3 and 5 nm MUS:OT 7:3. The A?1-40 proto-
filament comes from the ssNMR work of Petkova et al.78 and the A?1-42 from the H/D exchange 
experiments by Lührs et al.32. The system is placed in a cubic box with the height of the proto-
fibril, which is equivalent to constructing a continuous proto-filament.  
 
AuNPs bound spontaneously to A?1-40 and to A?1-42 during the simulations. The 2nm and the 
5nm AuNPs interact with the beta-1 region of A?1-40 making stable contacts with the amino 
acids from histidine 12 to phenylalanine 20. In simulations with 2 nm NP with a ligand-shell 
composition of MUS:OT 7:3, the amino-acids in the A?1-40 tail interact with the AuNP after 
binding. Up to 4 disordered tails grab the AuNP especially through alanine 2 and phenylalanine 
4 due to hydrophobic interactions: in the same region, two positively charged amino acids, 
asparagine 1 and 7, could make electrostatic interactions with the negatively charged MUS 
ligands, but they remain far form the sulfonate groups. When 2 nm allMUS NPs are used, an 
A?1-40 disordered tail seems to mediate the interaction with the NP driving the binding to the 
beta-1 region. The first interaction happens through a contact between an MUS ligand with 
arginine 5 and histidine 6 as shown in Figure 4.10(b). Then the NP is close enough to the proto-
filament to interact with the beta-1 region and form a stable contact with that facet. The binding 
site found here, spanning from histidine 14 to phenylalanine 20 (14HQKLVFFA21) is 
compatible with the predicted binding site (16KLVFFA21) of drugs and peptides described in 
the literature193,194. 
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Figure 4.10 On top, the representation of the AuNP and of its ligands. (a) a snapshot of the simulation of the 2 nm MUS:OT 
7:3 NP, bound to the beta-1 region of the A?1-40 proto-filament, interacting with 5 disordered tails. (b) Arginine 5 and histidine 
6 grab a sulfonate group in the early steps of binding with allMUS NPs. Amino acids are colored according to the legend at 
the bottom of the figure. 
 
To better understand how these nanoparticles interact in the vicinity of a similar cross beta 
sheet structure, a simulation using the A?1-42 proto-filament was also performed. All 2 nm NPs 
interacted directly with the elbow of the folded monomers (27NKGAI31), that links the two beta 
strands. First the NP interacts with hydrophilic residues near the C-terminal of the beta-1 
strand. After 20ns, the NP moves toward the region with hydrophobic amino acids closer to 
the N-terminal region of the beta-2 strand. Figure 4.11 shows this mode of approach, observed 
in both types of 2 nm NPs that we denominated 'side binding', which is equivalent to contacting 
the loops described in chapter 1. This configuration is characterized by ligand shell interaction 
with glycine, alanine and isoleucine, illustrated in Figure 4.11: the nanoparticle remains stable 
for more than 100ns suggesting that this is a possible stable binding site for small MUS-based 
gold nanoparticles.  
 104
 
Figure 4.11 (a) and (b) show different views on the side-binding motif, in which the nanoparticle finds an energy minimum 
via interaction with the elbow of the monomers. (c) and (d) show different views of the stable interaction the NPs establish 
with the beta-2 segment. 
 
The other binding site is located on the beta-2 segment (31IIGLMVGGVVI41), shown in Figure 
4.11(c) and (d), a region characterized by a sequence of hydrophobic amino acids. The 
nanoparticle interacts with the N-terminal portion of the beta-2 strand, and after 10 ns moves 
along the beta sheet region. By establishing contacts with the hydrophobic side groups of 
isoleucine 31, glycine 33, methionine 35, glycine 37, valine 39 and isoleucine 41 the NPs 
remained bound on this beta sheet for more than 100 ns. On the other hand, the 5 nm diameter 
NP is never bound to the proto-filament over the 100 ns simulations suggesting the existence 
of an energy barrier.  
 
a) 
b) 
c) 
d) 
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Figure 4.12 (a), (b) and (c) show the free energy of binding for the three types of nanoparticles approaching the beta-1 strand 
of an A?1-40 proto-filament. The energy gain is highest for 2 nm allMUS and 5 nm MUS:OT 7:3 NPs, which contradicts our 
comparative nanoparticles studies. (d), (e) and (f) show the different binding energy profiles for the nanoparticles to interact 
with the elbow (dashed curves) and the beta-2 segment (solid line). These results agree with our experimental findings, because 
they show a higher gain in free energy of binding for 2 nm MUS:OT 7:3 NPs.  
 
4.5? Possible binding motifs 
Analysis of the images obtained for the three types of amyloid fibers studied in this thesis 
shows remarkable similarities in the center-to-center nanoparticle distances between two 
different edges on the amyloid fibers. The ‘extreme’ type of disordered segment-containing 
fiber is made of Tau-441, followed by ?-synuclein and then A?1-40. The case of Tau presented 
in Figure 1.14(d) shows that, if the nanoparticles adsorbed on the disordered segments, their 
center-to-center distances would oscillate in a cloud of particles distanced from ~23 nm to 50 
nm on the opposite sides of the fiber. Instead, Figures 3.13 and 3.14 show that the center-to-
center nanoparticle distances coincide with the dimensions measured for the Pronase-digested 
Tau-441 fiber (~11 to 16 nm). This means that our amphiphilic nanoparticles traversed the 
fuzzy coat to adsorb onto the rigid core of the PHFs. The same is true for ?-synuclein, and the 
center-to-center nanoparticle distances match the length scale of the amyloid fibril core (Figure 
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4.9). Figure 4.13 shows schematic differences between the disordered ‘tails’ that protrude from 
these different types of amyloid fibers, and the consistent center-to-center distances between 
NPs on opposite sides of the fibers. The disordered segments may play a role, for example, in 
the size-selection of NPs adsorbed onto ?-synuclein. Experiments that use smaller peptides are 
on-going, but we chose to show the effect on relevant full-length polypeptides to demonstrate 
that the adsorptive phenomenon occurs at the rigid backbone of the fiber. The MD dynamics 
simulation revealed a degree of interaction between the ligand shell and the N-terminal of A?1-
40, so the disordered tails may contribute to the adsorptive behavior, but the nanoparticle’s final 
interaction is determined by the rigid backbone.  
 
Figure 4.13 Comparison of the center-to-center distances between MUS:OT NPs on opposite sides of three different amyloid 
fibers. Green asterisks indicate proposed site of adsorption. (a) A schematic rendition, reminiscent of Figure 1.13, showing 
that fibers made of Tau-441 protein have long disordered tails that protrude radially outwards. As reviewed in chapter 1, the 
‘tails’ form the fuzzy coat that surrounds the fiber core, analogous to a polyelectrolyte brush. Nonetheless, the distances 
measured fall in the ~12 nm regime: comparison to immunogold labelled fuzzy coats in Figure 1.13(d) shows MUS:OT NPs 
interact with the core of the fiber.  (b) A depiction of ?-synuclein with ‘intermediate’ disordered segment length: in this case, 
as reviewed in chapter 1, the long C-terminal is negatively charged, which should repel the MUS:OT NPs. Again, the particles 
seem to establish an interface with the core of the fiber. (c) In the case of A?1-40, most models (except those derived by cryo-
EM 195) predict a disordered N-terminal between 9 to 17 residues long: we assume in this image that such segments are 
sufficiently shorter than their equivalents in ?-synuclein and Tau-441. Left-hand panel in (c) was acquired by Dr. Davide 
Demurtas in a JEOL 2200FS, the others in an FEI TecnaiTM Spirit BioTWIN. The lower panel in (a) is a negatively stained 
TEM acquired in an FEI TALOSTM Electron Microscope.  
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The molecular dynamics simulations show that the nanoparticles bind favorably to the beta-1 
strand of an A?1-40  monomer. However, the energy minima found in the simulations do not 
correlate with the comparisons found between the different nanoparticles experimentally. We 
have shown that one phase MUS:OT NPs (30 or 10% OT) adsorb discriminatively onto the 
edges of amyloid fibers with a twisted ribbon morphology. Moreover, we have observed 
binding to three-fold symmetric fibers, that, according to the detailed molecular structural 
models, expose the beta-1 strands to the solvent, while the beta-2 segments face inwards, 
establishing hydrophobic contacts via methionine 35. The model proposed by Lührs et. al. for 
A?1-42 predicts beta-1 or beta-2 segments as the interfaces of the edges in a twisted ribbon 
morphology model. If this is accurate for the fibers studied in this project, a nanoparticle-beta-
2 contact on the edges of the twisted ribbon morphology could reconcile both the simulations 
and the experimental observations.  
 
During this thesis work, there was no technique to unambiguously characterize the arrangement 
of the proto-filaments that compose the fibers, and except for NMR the options seem limited. 
Given the observations made in the images and the insight from the MD calculations, the 
nanoparticles bind preferentially either to the beta-1 stretch or the elbow of the U-shaped 
monomers. Both structures are necessarily tied to the geometry of the fiber, and self-correlate 
in space via a screw symmetry, although flat fibers are often observed. What sits on the edges, 
that interacts with allMUS and MUS:OT nanoparticles cannot be unambiguously determined 
with the current approaches. A hypothesis was already given for ?-synuclein fibers, in Figure 
4.9, based on the geometric constraints of the model by Vilar et. al.69. The same can be done 
for A?1-40, but as reviewed in the first chapter, there are too many possibilities: whichever way 
our nanoparticles adsorb onto the fibers, they do so in absolute agreement with the current 
disagreements in this field.  
 
Figure 4.14(a) shows a fiber splitting longitudinally into two thinner fibers, half the width of 
the original one (or equivalently, two thin fibers that coalesce into a wider one). The 
nanoparticles occupy all available edges, that can be formed either by the elbows of the 
monomers or by solvent-exposed beta sheet segments. The inset in Figure 4.14(a) shows a 
cross section of a fiber, proposed by ssNMR, in which four U-shaped monomers stack to create 
a cross-section of 6 by 8 nm: the smallest 6 nm dimension corresponds to solvent exposed beta-
sheets (beta-1) 28. Figures 4.14(b) and (c) show two different possible arrangements that could 
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explain the longitudinal fissure in the fiber, that in turn generates fresh interfaces onto which 
the NPs adsorbed. The interpretation offered in Figure 4.14(b) matches both the MD 
calculations and the dimensions measured in the cryo-EM image. Such measurements need to 
be done carefully because slight beam misalignments or depending on the relative position of 
the focal plane and the sample, distortions can occur. However, the nanoparticles offer 
conspicuous guiding points for cryo-EM images, and center-to-center measurements can be 
done at the resolution of the technique. The main question becomes the distance between the 
center of the NPs and the underlying surface. In Figure 4.14(a), the distance between the 
surfaces of two NPs was measured in ImageJ (red), and gave a value ~8 nm, whereas the center-
to-center distance was 12.6 nm. If the rationale in Figure 4.14(b) is correct, the distance 
between the center of a NP and the underlying fiber surface is approximately 2.3 nm: this value 
varies with nanoparticle diameter and possible heterogeneities in the tightness of the adsorption 
across different NPs.  
 
Figure 4.14 (a) A?1-40 fiber that from left to right, split into two fibers, or, from right to left, coalesce into one. Although we’ve 
shown that the adsorption process takes time (agitation at 37°C), this fiber, that “splits into” two smaller twisted ribbons, has 
its edges immediately covered by the nanoparticles. The nanoparticles act as surfactants that minimize the excess surface free 
energy of the unfavorable interfaces created by the rigid edges. Another possibility is that the disordered tails disfavor 
adsorption in the regions they occupy, because the nanoparticle would reduce the conformational entropy accessible to the 
disordered tails, by reducing the free volume. Images acquired in an FEI TecnaiTM Spirit BioTWIN. 
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Following the approximations offered in Figure 4.14, we turn to the the 3-fold symmetric 
fibers. As discussed in the presentation of such polymorphs in Figure 4.6, this type of 
morphology can be approximated to a twisted triangular prism; the 2D projection of the 
nanoparticles that sit on the surfaces of such prism produce three intertwining chains of NPs, 
as illustrated in Figure 4.15(a).  
 
Figure 4.15 The 3-fold symmetric polymorph. (a) A simplistic representation of a triangular prism in 3D and the 2D projection 
of beads that sit on its surface, to clarify the observation in the cryo-EM images. (b) Two proposed binding motifs: on the 
vertices (elbows and beta sheet-disordered segment interfaces) or on the faces of the triangular cross-section. The expressions 
given of Lv correspond to the center-to-center NP distances on a triangular cross section of side length l. The detailed structural 
model proposed from reference (28). (c) Shows two crops of cryo-EM images of candidate 3-fold symmetric fibers. The 
longest measured center-to-center NP distances was ~16.8 nm, whereas the face-to-face inner NP distance was ~10 nm. (d) 
Images of fibers with ultra-small NPs in focus. The set of images that contains the 3-fold symmetric fibers is not in focus with 
the plane of the NPs. The electron-density observed in the edges, where no nanoparticles seem evident, may be caused by 
nanoparticles with ~1nm diameters. The image on the left shows a high resolution of the same batch of NPs on a different 
fiber preparation, whereas the image on the right shows a synthesis designed to produce a population of sub-nanometer NPs, 
and the red arrows point to their presence on the edges of the fibers. The electron densities on the edges in (c) are likely caused 
by these small NPs. Images acquired in an FEI TecnaiTM Spirit BioTWIN.
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Currently, how the nanoparticles sit on the triangular prism established by the core of the fiber 
is largely inconclusive. In the 2D plane of the cryo-EM images, the maximum center-to-center 
NP distances is equal to Lv, the distance between two nanoparticles on the cross-section of the 
triangular prism. This value depends on the values of dcs, the distance between the center of 
the NPs and the subjacent surface, and on the size l of the triangular cross-section, which is 
determined by the A?1-40 monomer. From inspection, it is clear that vertex-binding generates 
larger interparticle distances in the 2D projection than the face-on motif. Furthermore, there 
are no tools to verify that the 7 nm value proposed for this polymorph corresponds to our 
sample or is even a realistic value in the solvated state; also the monomers can arrange in this 
symmetry, but with segmental or even configuration polymorphisms that expand the triangular 
cross section. If we assume l = 7 nm and dcs = 3 nm, the vertex and face-on configurations 
would give values of 12.2 and 8.7 nm respectively: neither match our measurements, but the 
former is closer. If we assume an l of 10 nm, these values rise to 15.2 and 10.2 nm. This 
suggests that our measurements agree better with an expanded version of the fiber-NP object 
in a vertex-on association. More detailed analysis of this data may clarify this issue, but it must 
be stressed that a rigid commitment to the 7 nm dimension may be unrealistic in the solvated 
state: an estimation of the effective size will be performed to clarify this issue. 
 
For ?-synuclein fibers, we have concluded that the NPs sit on the solvent exposed beta sheets 
on the edges. The same was proposed for twisted-ribbon A?1-40 fibers; however, (for now) the 
3-fold symmetric species suggests a nanoparticle adsorption that does not involve docking onto 
the solvent exposed beta-sheets. In this case, the interaction with loops and the interface 
between beta-sheets and disordered segments would be the site of adsorption, which agrees 
with the MD simulations that found favorable interaction between the NPs and the loops of the 
A?1-42 monomers (Figure 4.11(a) and (b)). The models available in the literature range from 
slightly different, as shown for the detailed structural models in chapter 1, to simply 
incompatible, as depicted in Figure 1.14(a) and (b) from the work of the group of Prof. 
Grigorieff79,195. If our samples corresponded to his models, the nanoparticles would interact 
with edges made of partially disordered N-terminals. However, how can this be reconciled with 
the systematic observation of edge-binding on fibers made of ?-synuclein? These 
contradictions are currently beyond the possibilities of our experiments, but these nanoparticles 
can become a great aid in the structural determination of amyloid fibers. Moreover, the 
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determination of a realistic cross-sectional size for the 3-fold symmetric fiber can strengthen 
the beta-sheet adsorption motif.   
 
Perhaps the nanoparticles do not bind to a particular solvent-exposed conformation of beta-
sheets or elbows, but rather to a combination of both features at their interface, which could 
explain the observation made with the 3-fold symmetric fibers. Although an unambiguous 
conclusion cannot be reached, the evidence for beta-sheet binding compels the assertion that 
this is the driving force behind the discriminative adsorption of MUS-based NPs onto these 
fibers. The agreement between our cryo-EM images and the model for ?-synuclein proposed 
by Vilar et. al.69, in addition to the results from the MD simulations that predicted favorable 
NP interaction with the beta-1 faces of A?1-40 protofilaments support the possibility that these 
NPs adsorb preferentially onto solvent exposed beta sheets. The only evidence from our own 
experimental work against this hypothesis came from the 3-fold symmetric fibers, but the 
calculations may be incorrect, or the solvated size may be greater than 7 nm. Nonetheless, as 
reviewed exhaustively in Chapter 1, there are enough disagreements in the literature of 
structural models for amyloid fibers, in addition to the possibility that the monomers adopted 
different conformations throughout our experiments, the calculations made in Figure 4.15 
alone do not disqualify the hypothesis, but rather make us reluctant to reach an overarching 
definitive conclusion. Whatever the case, our NPs have consistently agreed with the current 
disagreements in the field.  
4.6? Competitive binding and A?1-42 secondary nuclei 
Figure 4.5(a) showed that the presence of FBS prevented the discriminative adsorption of 
MUS-based gold nanoparticles on the edges of amyloid fibers. The phenomenon could be due 
to a competitive adsorption, in which the nanoparticles are first consumed by globular proteins: 
in case the number of particles increases, they would be free to adsorb onto the fibers. A similar 
experiment has been performed, by adding different types and amounts of MUS and MUS:OT 
nanoparticles onto a Tau-441 preparation. Figure 4.16(a) and (b) show different regions of a 
sample that contained 0.1 mg/mL of fractionated allMUS NPs. The fibers were rarely decorated 
by nanoparticles, but non-fibrillar species were covered by three or more particles throughout 
the sample. Tau contains cysteines which man mediate the interaction with gold particles via 
Au-S bonds. When MUS:OT (30% OT) particles were used, also at 1 mg/mL the oligomers 
and some fibers were covered (Figure 4.16(c)). If the nanoparticle concentration is increased 
ten-fold the fibers are completely covered along with several other aggregates. The non-
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fibrillar species are more favorable adsorption sites for the nanoparticles: as these sites are 
filled, the supernumerary particles can then occupy other sites, namely those exposed by the 
surface of the fiber.  
 
 
Figure 4.16 Cryo-EM of samples that with changes in the amount and type of nanoparticles in the same Tau-441 preparation. 
(a) and (b) show images of the same sample, with 0.1 mg/mL allMUS NPs. Decorated fibers were rare, the silhouettes of thick 
fibers can be see, free of particles. Trimers and tetramers of NPs were abundant in the sample and highlighted in red. (c) When 
MUS:OT (30% OT) NPs were used, the fibers started being covered, but small aggregates were visible throughout the sample. 
(d) When the final NP solution (MUS:OT 30%OT) was 1 mg/mL, the fibers were completely covered, along with several 
types of smaller aggregates. Images acquired in an FEI TecnaiTM Spirit BioTWIN. 
 
A similar phenomenon has been consistently observed whenever the experiments presented in 
this thesis were attempted with A?1-42. Small nanoparticle chains that protrude from the body 
of the fibers were observed in all occasions when we worked with A?1-42 and in one occasion 
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with A?1-40: when the fibers were allowed to grow quiescently, at room temperature from a 
50?M monomeric solution. Instead of covering the fibers as was observed for all three peptides 
studied, the nanoparticles covered structures reminiscent of the recently described secondary 
nuclei on the surface of A?1-42153,161. 
 
Figure 4.17 (a) Reproduced from reference (184) an AFM image showing secondary nuclei protruding from the surfaces of 
A?1-42 fibers. (b) and (c) show similar protruding strings of nanoparticles, that can correspond to secondary nuclei. The black 
arrow indicated a twisted ribbon fiber that otherwise is coated by MUS:OT nanoparticles on the edges. (d) and (e) show similar 
such strings on an A?1-40 preparation that used 50 ?M monomeric solution under quiescent conditions. Several small such 
protrusions were identifiable throughout the sample, but not as conspicuously as in the A?1-42 experiments. (f) Shows that after 
agitating the same sample over a 48 h period at 1000 rpm at 37 °C, the aspect of the fibers changed, and discriminative 
adsorption could be observed, without as many protruding strings.  
 
These two experiments may correlate to the findings with FBS: MUS-based nanoparticles 
adsorb first to oligomeric species to which it has higher affinity. This is not a mere tautological 
claim: MUS-based nanoparticles may be acting as colloidal surfactants, and first adsorb onto 
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objects with high surface tension. The secondary nucleation that protrude from the A?1-42 fibers 
have been correlated with toxicity, and so are oligomeric species of proteins such as Tau15,166. 
Furthermore, it has been hypothesized that early nuclei have structures that deviate form the 
cross-beta sheet motif, which makes their surface more unstable24,53: this correlates to the 
traditional description of nucleation and growth. Nuclei have to pay high surface tension 
penalty, and only growth can placate the Gibbs free energy of the material, with the favorable 
bulk free energy thus overcoming the unfavorable surface tension. One way to stabilize small 
nuclei, such as the nanoparticles used in this thesis, is with surfactants, capable of decreasing 
the excess surface tension to stabilize these objects. Figure 4.16 and 4.17 reveal that the MUS-
based NPs act, to a first approximation, as surfactants that first bind to high surface energy 
nuclei, oligomers and secondary nuclei, to then occupy the sites to which they have remarkable 
affinity on the surface of the amyloid fibers. This finding may be helpful to study and visualize 
secondary nucleation in experiments that search for substances that aim to eliminate this 
process. Evidently such scenario urges careful controls: for example, the nanoparticles could 
interact with the candidate substance that can block secondary nucleation, which could hamper 
the utility of the NPs in this context. Finally, to our knowledge, secondary nucleation of A?1-
40 has not been reported: the images in Figure 4.17(d) and (e) may reveal that A?1-40 fibers are 
also capable of nucleating secondary nuclei on their surfaces, but significantly less than A?1-
42. 
 
4.7? Conclusion 
Although the behavior of the nanoparticle that gave this thesis its name has been studied in 
greater depth, it might be the last finding that holds potential applications for these new 
materials. The discriminative adsorption itself might be able to reconcile two fields that have 
been producing disparate structural molecular models for amyloid fibers: the spectroscopic 
community23,24 and the cryo-EM structures proposed for A? fibers80. The nanoparticles 
presented in this thesis, that in Chapter 2 were shown to fuse with lipid bilayers, may serve as 
a cross-instrumental probe, whereby they facilitate cryo-EM structural assignments and also 
reveal ligand-shell peptide interactions in dully isotopically labelled samples for NMR studies: 
the nanoparticles can add a constraint to the system to disambiguate, for example, the nature 
of the edges of the fibers. We have briefly shown the presence of ultra-small nanoparticles in 
Figure 4.15(d): this corresponds recent progresses in the attempt to produce atomically precise 
MUS-based nanoparticles, that would greatly increase the quality of a structural determination 
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effort that joins spectroscopy and electron microscopy. Finally, these nanoparticles seem to act 
as spherical surfactants that cover early unstable nuclei and oligomers (Figures 4.16 and 4.17). 
This can become a tool for amyloid researchers to study, not only mature amyloid fibers, but 
also oligomers under controlled conditions. More importantly, this thesis shows a novel 
phenomenon: regardless the utility, it presents a new scientific fact at the interface of two 
complex nascent fields. This work has systematically approached how the chemical properties 
of the ligand-shell dictates the amyloid-nanoparticle interface, and showed a remarkable level 
of supramomecular structure through the self-assembly of ordered proteins-nanoparticle 
objects without the use of peptides or other linkers to create such structures: this alone is a 
novel accomplishment in the field of supramolecular chemistry that merits profound 
investigation and the determination of the nature of the discriminative adsorptive behavior.  
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5? Outlook and future work 
The results presented in this thesis belong to a larger project that can provide a novel tool in 
the study of amyloids and proteins in general. This work was exploratory and 
phenomenological in nature, and it offers a good starting point for other researchers to design 
experiments to probe the interaction between amyloids, proteins and metallic nanoparticles. It 
has also systematically shown the role of charged end groups at the bionano interface with 
amyloids: for example, to avoid non-specific adsorption (thus false positives), this thesis 
provides enough evidence that zwitterionic surfaces are ideal coverage for the colloidal gold 
used in immunogold labelling. We have also seen that small MUS:OT nanoparticles allowed 
us to easily distinguish two and three-fold symmetric A?1-40 fibers. This has introduced a 
potential tool to study dynamic amyloid phenomena, for example, to verify the presence of 
secondary nuclei, onto which the nanoparticles adsorbed preferentially when A?1-42 fibers were 
used. Furthermore, the advances in electron microscopy, for example, the possibility of 
imaging in liquid196, open the possibility of studying how amyloid fibers behave in real time 
in 3D. In this case, the nanoparticles described in this thesis would act simultaneously as 
immunogold staining and an analogue of dyes such as thioflavin T. The use of the gold-thiol 
bond to perform further modifications on the nanoparticles, such as the introduction of antibody 
fragments or any other chemical modification can be easily exploited to take advantage of the 
non-specific phenomena described in this work.  
5.1? Determination of MUS:OT adsorption site onto the amyloid fibers 
This thesis has raised, through experiments, a fundamental question that was tackled in chapter 
4: what is the feature on the edges of the amyloid fibers onto which small sulfonated 
amphiphilic gold nanoparticles adsorb? How come these nanoparticles do not also sit on the 
other facet of the twisted ribbon amyloid fibers? Unfortunately, a detailed review of the 
literature did not allow us to conclude, unambiguously, what type of supramolecular structure 
the nanoparticles bind to. As outlined in chapter 1, different motifs have been ascribed to the 
edges of the ribbons, such as solvent exposed beta sheets, or the loops that connect different 
beta sheet segments in the polypeptide sequence. The amyloid samples used in this work were 
not prepared and characterized completely, to allow for an unambiguous 3D model on which 
one could ascribe a specific sequence or structure to the edge of facet of the ribbons. 
Nonetheless, these types of particles may help determine the nature of the edges, and add an 
additional constraint on the experimental sets ups used to simulate the 3D structure of amyloid 
fibers using data from NMR and electron microscopy. One ‘brute force’ approach to solve this 
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question is to synthesize isotopically labelled (13C) MUS or OT ligands and amyloid fibers (13C 
and 15N) and perform the NMR and cryo-EM experiments. According to our simulations, the 
fiber-nanoparticle interaction satisfied the requirements for this experiment to succeed: the 
ligand-peptide contacts are below 8 Å and there are about 1.5 ligand per peptide chain, as 
depicted in Figure 5.1. This means that this laborious and potentially costly experiment is, so 
far, justifiable both from the experimental results and the insights from the molecular dynamics 
simulations.  
 
 
Figure 5.1 Snapshots from the simulation between MUS:OT nanoparticles and A?1-40 protofilaments. According to the 
simulations, the ligand shell that establishes contact with the solvent exposed beta sheets (beta-1 segment) compresses the 
ligand to maximize ligand-peptide contacts. This means that there are several ligand-peptide contacts that fall below the 8 Å 
threshold for good NMR signal. The side view on the right shows in purple, the stretches of the peptide that, in the MD 
calculations, established this type of contact with the ligands on the nanoparticles. Given appropriately isotopically labelled 
samples, one can envision an experiment that visualizes the nanoparticles on the edges of the twisted ribbons, and establishes, 
via NMR, the ligand-peptide contacts, thus determining which residues are exposed on the edges and what conformation the 
nanoparticles seem to discriminatively adsorb to: solvent exposed beta sheets or other less rigid structures? This concept can 
be extended to the other fibers, such as ?-synuclein that so far, lacks reliable 3D models.  
 
Other approaches can be adopted to tackle the site of adsorption, or the type of protein structure 
the nanoparticles preferably bind to spontaneously. Ingenuous use of less expensive NMR 
techniques, that escape the expertise of the author might clarify these questions. For example, 
instead of the non-trivial isotopic labelling of the ligand shell, one could simply include in a 
typical NMR-based amyloid structural determination study, a cryo-EM session in the presence 
of our nanoparticles. In this context, more could be said about the nature of the edges on such 
samples, which would strengthen the argument for a mode of adsorption. This type of 
experiment would not be a direct measurement of intermolecular contact, but could provide 
reliable and accessible information regarding this unanticipated discriminative behavior. 
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Indirect evidence can also be obtained by forming microcrystals as described by the Eisenberg 
group. In this case, the anisotropic microcrystals display beta sheet facets parallel to the long 
axis, and their cross section (a fractured crystal) is made of packed layers of the constituent 
monomers. The crystals can be prepared, and their structure verified to match those published 
by Eisenberg’s group. The nanoparticles can be incubated in the presence of these crystals, 
followed by imaging such as cryo-EM, AFM, among other possibilities. If the nanoparticles 
form organized lattices on the lateral facets of the microcrystals, it strengthens, but does not 
prove, the hypothesis that in the absence of oligomers and other lower-order amyloid 
aggregates, the nanoparticles form ordered arrays upon adsorption onto solvent exposed beta 
sheets.  
 
Ultimately, we have experimentally discovered that sub-4 nm MUS:OT nanoparticles, and 
allMUS as well in the case of ?-synuclein, adsorb discriminatively onto the edges, and only 
the edges of twisted ribbon amyloid fibers. The main question now is: what are the 
supramolecular protein structures that these nanoparticles prefer to adsorb to, in the absence of 
factors such as serum proteins, lower order oligomers and secondary nuclei? Whatever the 
mechanism, this is in itself a reproducible and falsifiable scientific fact that merits further 
investigation.  
5.2? Immediate utility of MUS:OT NPs for amyloid research: dynamics 
and secondary nucleation 
Several studies can be performed using these nanoparticles as EM markers or tags to 
demonstrate amyloid-related phenomena. Of immediate interest, and currently under 
investigation, is the use of liquid state TEM to visualize how the fibers behave in their native 
solvated state. The nanoparticles provide the electron density necessary to visualize the fibers, 
and such experimentation would be virtually impossible without these NPs. In this context, 
these nanoparticles act as an EM analogue to ThT. Another experiment on the line if the 
verification of the utility of MUS:OT nanoparticles as markers for secondary nucleation in A?1-
42 fibers. As shown in figure 4.17, we currently believe that the nanoparticle protrusions from 
fibers made of A?1-42 correspond to secondary nucleation recently described in the 
literature153,161. It has been hypothesized that the surface of the fiber acts as a catalyst to the 
formation of new, secondary fibers. In addition to the observation that the nanoparticles tend 
to bind first to small oligomers and these secondary nuclei, we plan to take advantage of this 
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behavior to use the nanoparticles to verify the absence of secondary nucleation. One strategy, 
currently underway, is the use of the protein chaperone BRICHOS that has been reported to 
block the secondary nucleation process166.  
 
 
Figure 5.2 Schematic representation of an experiment that uses the MUS:OT nanoparticles tendency to adsorb onto oligomers 
and secondary nuclei to test for the absence of such protrusions in the presence of a secondary nucleation blocker. Depending 
on the nature of the blocker, it is difficult to predict the outcome. The more favorable binding sites offered by the secondary 
nuclei may vanish, and the nanoparticles will assume their location on the edges of the mature fibers. Or, if the fiber is then 
covered by a protein chaperone, or another complex biomolecule, we expect at least to no longer observe the discrete 
nanoparticle protrusions from the surfaces of the fibers. Nonetheless, it is possible that in the presence of a protein-based 
secondary nucleation blocker such as the BRICHOS protein, that nanoparticles aggregate onto this third protein in the system 
and yield inconclusive results.  
 
5.3? Different physical properties across distinct polymorphs  
So far, attempts to establish different physical properties between polymorphs of A?1-40 has 
shown little difference between the two and three-fold symmetric variants47. It is possible that 
the choice of monomer for such experiments was such that, the difference between the 
polymorphs studied was not significant. Whenever working with Tau-441, and more recently 
Huntintin, we have noticed that some types of fibers are readily covered by the nanoparticles, 
whereas others are not. This effect is flagrant in image 3.13, in which certain Tau fibers are 
completely covered by the MUS particles, whereas other fibers that appear morphologically 
different, are free of particles. This can be an indication that, for larger amyloid precursors 
capable of forming diverse polymorphs, the surface properties of the amyloids can be probed 
using, for example, AFM to determine properties such as adhesion77 that may depend on the 
polymorph. This type of experimentation should become routine in collaboration with an AFM 
 121 
group capable of carrying out such measurements, because it can produce data immediately 
relevant to the debate of amyloid polymorphisms. The nanoparticles can act as a guide to 
identify one polymorph from another, in a morphologically-based classification. We anticipate 
this will become a persistent observation whenever large proteins are used as amyloid 
precursors. On a final note, we did observe coated and uncoated fibers in the quiescently 
prepared A?1-40 samples, shown in Figure 4.17(d)-(f), but this may be a consequence of a lower 
particle count relative to the available amyloid surface. Nonetheless, the potential for 
polymorph-dependent surface property determination (adhesion, deformability, etc) cannot be 
ruled out for fibers made of A?. Such studies can be relevant to understand the pathologic role 
of amyloids as different surface properties, correlated to different polymorphs (or strains) can 
yield different interactions with cellular membranes and other biomolecules, correlating to the 
severity of the disease. There is already evidence that different clinical presentations in two 
patients correlated to different structures of the A?1-40 fibers33. This is likely a common 
phenomenon throughout amyloid pathogenicity and its biophysical underpinnings are 
amenable to good use of AFM experimentation and the use of our nanoparticles to identify 
different polymorphs.  
5.4? Additional experiments: fiber modifications and mutations 
 
Some of the observations in this thesis were not fully addressed experimentally. For example, 
in chapter 3, in the discussion of Figures 3.3 and 3.4 it is stated that ?-synuclein fibers carry 
many negative charges, which could explain its prompt interaction with cationic particles and 
the formation of nanoparticle bundles. Further experimentation is needed to use electrostatics 
as the sole reason behind this observation. The disordered C-terminal that carries most of the 
acidic residues that under neutral pH confer the fiber a negative charge can be cleaved 
enzymatically, and the experiment can be re-performed with the allTMA nanoparticles. If the 
bundling phenomenon vanishes, it is a strong indication that indeed electrostatics play the 
major role in forming these ‘almost ropes’ of ?-synuclein mediated by the allTMA NPs. 
Furthermore, a careful zeta-potential measurement can be performed to verify whether the 
bundling and subsequent flocculation coincides with a point-of-zero charge precipitation.  
 
Although the adsorptive behavior has been repeated across considerably dissimilar fibers, with 
discriminative adsorption of small MUS:OT nanoparticles on the edges of twisted ribbon 
amyloid fibers, the effects of mutations on the sequence of the polypeptides on this phenomena 
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have not been challenged. For example, the substitution of positively charged residues such as 
lysine at position 16 or 28 can challenge the idea that the nanoparticles are simply attaching to 
favorable lines of counter-charges on the surface of the fibers. Such manipulations must be 
done with care, because the substitution of lysine 28 for example, can change completely the 
structure of the fiber, and render the wild-type and the mutant incomparable. Again, it would 
be best to perform this type of experiment in collaboration with an NMR group to have the full 
characterization of the fibers, and more confidence in the interpretation of the cryo-EM images 
and results. The use of mutants and truncated versions of amyloid precursors such as Tau and 
Huntintin are already underway, and so far, the main observation falls in the discussion 
proposed in section 5.3. It is difficult to anticipate how subtle mutations can influence the 
nanoparticle-amyloid interactions, especially after observing strikingly similar phenomena 
using completely different amyloid precursors such as A?1-40 and ?-synuclein. So far, an 
explanation revolving a stable adsorption onto a general feature such as solvent-exposed beta 
sheets is favored over specific amino acid sequence recognition.  
5.5? Other experiments and biologically relevant studies 
During this thesis, several techniques were employed to study the interaction between the 
different nanoparticles and the amyloid precursors and fibers. Due to the different properties 
of the two classes of materials studied, several difficulties arose. For example, depending on 
the type of nanoparticle used (MUS or MUS:OT), they had different affinities for the chips of 
Biacore surface plasmon resonance machines. This made experimentation challenging and 
results inconclusive. The attempt to separate nanoparticle-amyloid aggregates using size 
exclusion chromatography was unsuccessful: apparently the nanoparticles have a high affinity 
for the stationary media (Superdex 200) and do not move through the column. Nonetheless, 
progress has been made in forming NP monolayers on gold chips for Quartz Crystal 
Microbalance (QCM), which means we can finally study the role of the ligand shell on the 
affinity between amyloid precursors and the nanoparticles.  
 
Furthermore, there has been a lack of biologically relevant studies. Initially, there was no room 
for such experiments because the interactions between all the nanoparticles described in this 
study and the amyloid fibers and their precursors are completely unknown. Now that these 
interactions are understood, in vitro studies can be performed to assess, for example, we it is 
possible to decorate fibers intracellularly. Furthermore, we can study whether nanoparticles 
that have stabilized amyloid formation (MUS:OT 9:1) can have a chaperoning effect and 
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minimize the cytotoxicity of the amyloidosis process. Or the contrary, whether such type of 
particles stabilize toxic oligomers and lower order aggregates that are more deleterious to the 
cells. Given the intense research on biopharmaceuticals that target the mature amyloid 
fold191,192, we can take advantage of a class of nanoparticles we know already has an affinity 
for amyloid fibers, and use the gold-thiol chemistry to conjugate drugs or antibodies that target 
different types of amyloid fibers and oligomers for therapeutic purposes.  
5.6? Final remarks 
The vast majority of potential applications for the discoveries described in this thesis will be 
judged and evaluated by the scientific community at large, through reproducibility of the 
experiments and progressive experimentation towards both scientific insight and practical 
applications. It is impossible to envisage the ramifications of a project of this nature in the long 
term. Furthermore, this has been only a first step in the systematic understanding of how 
nanoparticles interact with fibrous protein materials. This work will continue being carried out 
with other bio-fibrillar materials such as collagen and actin fibers, to better understand what 
nanoparticle properties dictate such interactions. Only the results will tell how these 
interactions take place, but so far, the discriminative adsorption described in chapter 4 is unique 
to small MUS:OT gold nanoparticles and amyloid fibers. It is possible that other small 
nanoparticles behave identically, say, pegylated or sufficiently soluble carboxylated AuNPs. It 
is also possible that small MUS:OT AuNPs also adsorb discriminatively onto other fibers, such 
as actin, or even on viruses and smaller proteins. Such results would only confirm an 
underlying hypothesis approached by this thesis: small amphiphilic nanoparticles adsorb 
preferentially to specific proteinaceous interfaces. Finally, we believe it rests on the amyloid 
community to use our nanoparticles in their research. Figure 5.3 shows a simple Venn diagram 
of how we see the potential utility of these nanoparticles in the study of amyloid fibers, as a 
potential cross-technique probe, that can reconcile observations made in cryo-EM with 
spectroscopic measurements obtained by NMR specialists. The engineering of the 
nanoparticles will be improved to fine tune their size distributions and improve our knowledge 
on the nature of their ligand shell, which will only improve the quality of this novel potential 
tool in biology.  
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Figure 5.3 A Venn diagram of how we see the possible role that nanoparticles of the type described in this thesis can play in 
the study of amyloids and other proteins. Such AuNPs are amenable to several chemical modifications that render them flexible 
tools to study different aspects of challenging topics such as amyloidosis. For example, in this thesis, we’ve shown how by 
simply adding MUS:OT AuNPs we could readily identify two and three-fold symmetric A?1-40 polymorphs. More in-depth 
and careful experimentation hold enormous potential for the use of these novel materials in the efforts to understand biological 
macrostructures and other complex systems through a multi-instrumental approach.  
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M.  Methods 
Unless otherwise indicated, all chemicals were purchased from Sigma Aldrich. Only the 1H-
NMR spectra of final products, key to this project, are shown. All 1H-NMR were acquired in a 
Bruker Avance 400 MHz or in an Avance III 400MHz. Yields and mass spectra are not reported 
in this version. This section intends to enable anyone to reproduce the results showed in this 
thesis, and explain how experiments were made. It is not an orthodox organic synthetic 
chemistry report, nor an exhaustive description of each sample. Instead, it explains in sufficient 
detail how to prepare and characterize the nanoparticles. It also shows the difficulty in finding 
experimental techniques amenable to both amyloid fibers and nanoparticles, and examples of 
the results obtained routinely in kinetic assays of amyloid growth.  
M.1 Ligand synthesis  
M.1.1 Synthesis of sulfonated ligands 
Figure M.1 shows the synthetic route used to produce gram-scale sulfonated thiols, modified 
from reference103.  
 
 
Figure M.1 Synthetic route amenable for gram-scale sulfonated thiolate molecules. During my thesis work, I have produced 
molecules with x = 4, 5, 6, 7, 8, 10 and 11. For large scale syntheses, the UV irradiation step may need longer illumination.  
 
The modifications to the original synthesis103 of MUS is described below. A gram-scale 
synthesis is outlined, adaptable to scales from 1 to 40 g of precursor. A synthesis using 25 mL 
of the precursor is described.  
 
Sodium undec-10-enefulfonate: 11-bromo-1-undecene (25 mL, 111.975 mmol), Sodium 
Sulfite Na2SO3 (28.75 g, 227.92 mmol) benzyltriethyl-ammonium bromide (10 mg) were 
added to a mixture of 200 mL methanol and 450 mL DI-water (4:9 MeOH:H2O ratio) in a 1 L 
round bottom flask. The mixture was refluxed at 102°C for 48h. The mixture was extracted 
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with diethyl ether 5 times, (5 x 400 ml), and the aqueous phase was evaporated in a rotary 
evaporator. The white powder was dried under high vacuum, suspended in pure ethanol and 
filtered. The methanolic solution was evaporated, and the process was repeated twice, to 
decrease the amount of inorganic salts. Usually, about 33 g of white, methanol soluble power 
was collected at this scale. 1H-NMR (D2O): 5.76 (m, 1H), 4.78 (m, 2H), 2.69 (t, 2H), 1.53 (m, 
2H), 1.11 (br s, 12H). 
 
Sodium 11-acetylthio-undecanefulfonate: Sodium undec-10-enefulfonate (33 g, 147.807 
mmol) was dissolved in 500 ml of methanol. A 2.6 times excess of thioacetic acid (27.324 mL, 
384.3 mmol) was added to the solution and stirred in front of a UV lamp overnight (12h). The 
solution was evaporated in a rotary evaporator until the solid residue turned orange-red. The 
solid was washed with diethyl ether, until no colored material could be removed. The solid was 
dried under high vacuum, and then dissolved in methanol producing a yellow solution. About 
3 g of carbon black was added to the solution, vigorously mixed, and the mixture was filtered 
through celite in a fluted filter paper. The filtered solution was clear, the solvent completely 
evaporated and about 35 g of white solid was collected. 1H-NMR (D2O): 2.69 (t, 4H), 2.17 (s, 
3H), 1.53 (m, 2H), 1.39 (m, 2H), 1.11 (br s, 14H). 
 
11-mercapto-1-undecanesulfonate (MUS): Sodium 11-acetylthio-undecanefulfonate was 
refluxed at 102°C in 400 mL of 1M HCl for 12 h. 200mL of 1M NaOH was added to the final 
solution, additional 400 mL of DI-water was added to create a 1 L volume. The clear solution 
was kept at 4°C and crystallized overnight. The viscous white product was centrifuged down 
in 50 mL falcon tubes, and dried under high vacuum. 12 g (about 30% yield) of methanol 
soluble MUS is collected from this purification step. More material can be extracted from the 
supernatant of the centrifugation step, by reducing volume and keeping it at 4°C. 1H-NMR 
(D2O): 2.69 (t, 4H), 2.34 (t, 3H), 1.53 (m, 2H), 1.39 (m, 2H), 1.11 (br s, 14H). Calculated mass 
290.42 g/mol.  
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Figure M.2 1H-NMR (D2O) of 10-mercapto-1-decanesulfonate (MDS) and 8-mercapto-1-octanesulfonate. Both syntheses 
were done at the 4-5 g scale, following the same steps in Figure M.1.  
 
 
Figure M.3 1H-NMR (D2O) of 6-mercapto-1-haxanesulfonate (M6S) and 5-mercapto-1-pentanesulfonate (M5S). Smaller 
chains tend to form disulfides in the de-protecting step under HCl. This issue has been recently circumvented by de-protecting 
under inert conditions. Both syntheses were done at the 4-5 g scale, following the same steps in Figure M.1. 
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Figure M.4 1H-NMR (D2O) of 11-mercapto-1-undecanesulfonate (MUS) synthesized at a 15 g scale, following the steps in 
Figure M.1. This synthesis was performed several times, and crystallization yields a clear NMR baseline.  
 
The synthesis of sulfonated ligands is straightforward and reproducible following this 
approach. Crystallization from water yields pure, methanol-soluble products that can be used 
directly to synthesize nanoparticles. For methanol solubility, crystallization from acidic water 
is recommended: to a volume V of 1M HCl, add V/3 of 1M NaOH. The material did not 
crystallize from 1M HCl, and the powder collected is not methanol-soluble when crystallized 
from a pH 7 solution. Ligands shorter than 7 carbons do not crystallize in the conditions 
described. Crystallization from water probably excludes disulfide bi-products, which renders 
the aqueous approach applicable to molecules longer than 7 carbons. To avoid disulfide 
formation, performing the de-protection step in dry inert conditions (dry, degassed methanolic 
HCl) solves the problem. Dry methanolic HCl under inert conditions, (using acetyl chloride in 
methanol) is a better de-protection scheme in this case: the volatiles can then be evaporated, 
and serial evaporations with solvents like toluene or hexanes yield a pale yellow powder. 
Water-soluble nanoparticles could be synthesized in the one phase protocol using all sulfonated 
ligands prepared with this method. The 2 and 3 carbon long mercaptosulfonates are 
commercially available; the former is MESNA, a pharmaceutical anti-cancer adjuvant used to 
mitigate urotoxicity197.  
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M.1.2 Synthesis of quaternary amine terminated thiols (TMA) 
 
Figure M.5 Synthetic route amenable for gram-scale of cationic trimethylamine terminated thiolate molecules. During my 
thesis work, I have produced molecules with x = 4, 5, 6, 7, 8, 10 and 11. For large scale syntheses, (30 g above) UV irradiation 
may require longer than 12 h to complete the reaction. This synthesis was adapted from reference 198 
 
N,N,N-Trimethyl-10-undecenylammonium chloride: 11-bromo-1-undecene (25 mL, 
111.975 mmol) was added to 300 mL of an ethanolic Trimethylamine solution (31-35 wt. % in 
ethanol, 4.2 M) and stirred for 2 days at room temperature. The solvent was evaporated, the 
yellow powder was dissolved in ~50mL DCM, and precipitated into hexane (500 mL) in a 1L 
beaker, yielding 30 g of white solid. 
 
N,N,N-Trimethyl(11-mercaptoundecyl)ammonium Chloride: N,N,N-trimethyl(10-
undecenyl)ammonium bromide (30 g, 102.6 mmol) and thioacetic acid (21 mL mL, 308 mmol, 
ACROS) in 500 mL of methanol was and stirred in front of a UV lamp overnight (12h). The 
volatiles were removed in a rotary evaporator until the product became orange-red. The residue 
was washed several times with diethyl ether until not more orange bi-product could be 
removed. The product was dried under high vacuum, then dissolved in 300 mL of methanol, to 
which ~3 g of carbon black was added, vigorously mixed, followed by filtration through celite 
in a fluted filter paper. The clear solution was evaporated, yielding 32 g of white powder. This 
product was then dissolved in 400 mL of 1M HCl, and refluxed at 102°C overnight (~12 h). 
The pH was raised by the addition of 100 mL 1M NaOH, followed by the addition of 400 mL 
of MilliQ water, placed inside a 4°C. Thin elongated crystals grew, and were collected via 
centrifugation-assisted decantation. Vacuum filtration is not advised. After drying, ~10 g of a 
“shiny” crystalline powder was collected. 1H-NMR(D2O): 1.24-1.49 (m, 14H), 1.53- 1.66 (m, 
2H), 1.67-1.84 (m, 2H), 2.52 (t, 8 Hz, 2H), 3.12 (s, 9H), 3.30-3.41 (m, 2H). 
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Figure M.6 1H-NMR (D2O) N,N,N-Trimethyl-10-undecenylammonium chloride (TMA). ~10 g synthesis scale, produced as 
described above.  
 
This synthesis is a modification to reference 198; the shorter ligands have not been reported, but 
The shorter versions of this molecules, from 10 to 4 (except 6) carbons long have also been 
synthesized, following the same protocol. Below 7 carbons, crystallization was not observed; 
sequential evaporations with addition of toluene or hexanes to the final product yielded the 
product. These molecules have not been exploited much in this work, thus, for brevity, we omit 
their spectra.  
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M.1.3 Synthesis of zwitterionic ligand 
 
Figure M.7 Synthesis of sulfobetaine terminated thiol. 3-[(11-Mercapto-undecyl)-N,N-dimethyl-amino]-propane-1-sulfonate, 
modified from reference 115 
 
This synthesis was performed only once, with this length.  
11-bromo-1-undecene (15 mL, 68.4 mmol) was added to a solution of 2 M dimethylamine in 
THF (AcroSeal™, ACROS Organics™) and the reaction mixture was stirred 48 h at room 
temperature. The volatiles were evaporated in a rotary evaporator. A yellow oil remained, to 
which 200 mL of 1 M was NaOH was added, followed by an extraction with DCM. The DCM 
phase was separated, dried with anhydrous sodium sulfate, filtered, and concentrated in vacuo 
as a yellow oil. 6.02 g of this oil was added to 100 mL of dry acetone (AcroSeal™, ACROS 
Organics™), followed by addition of 1,3-propanesultone (1.6 mL, 38.25 mmol): the reaction 
mixture was stirred at room temperature for two days. The white precipitate was filtered, and 
the resulting solid was washed with excess acetone, then dried under high vacuum. 4 g (~11.68 
mmol) of the power was dissolved in methanol with thioacetic acid (1.426 mL, 20 mmol) and 
stirred at room temperature in front of a UV lamp. Volatiles were removed in a rotary 
evaporator, yielding a yellow oil. 20 mL of methanol was added to this oil, and this solution 
was added drop-wise into 400 mL of dry acetone (AcroSeal™, ACROS Organics™). The 
white precipitate was filtered using vacuum filtration and dried under vacuum. A solution of 
methanolic HCl was prepared by adding 3.56 mL (50 mmol) of acetyl chloride to 50 mL of 
methanol. The powder was added to this mixture and refluxed overnight. The volatiles were 
evaporated in a rotary evaporator, which produced a yellow oil. Toluene was added and 
evaporated from this oil until a pale yellow powder formed (~3 g). 1H NMR (D2O) is shown 
in Figure M.8. This synthesis is a modification from reference 115, and several steps were 
modified. Of notice, the intermediate in the third step can be recrystallized for higher purity. 
The de-protection reported by the authors in basic conditions created disulfides in our 
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synthesis; methanolic HCl is a robust alternative. The only sensitive step of the reaction is the 
de-protection that we recommend be done under inert conditions.  
 
 
Figure M.8 1H-NMR (D2O) of sulfobetaine terminated thiol. 3-[(11-Mercapto-undecyl)-N,N-dimethyl-amino]-propane-1-
sulfonate.  
 
M.2 Nanoparticle synthesis and characterization 
To address the issue of nanoparticle batch-to-batch reproducibility, several syntheses under the 
same conditions were performed. The project began with a comprehensive assessment of how 
different compositions of MUS:OT nanoparticles and MUS:brOT affected the growth kinetics 
of amyloid fibers. To address the issue of batch-to-batch reproducibility, each composition was 
prepared three times (triplicates), in increments of 10% 1-octanetiol (and brOT, which is on-
going work). This means that three batches of allMUS, MUS:OT 9:1, 8:2, 7:3 all the way to 
1:9 and allOT were produced. The result of the ligand composition measured by NMR versus 
the feed ratio is shown in Figure 2.7. Here I describe the methods to produce the nanoparticles 
used in this work, and the characterization of representative samples. An exhaustive 
characterization of all batches produced is prohibitively lengthy and is still on-going. High-
throughput assays can be performed faster than our ability to fully characterize each batch: 
thus, a general scheme of relevant characterization is presented, and particles that were used in 
the body of the thesis are highlighted. 
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The general synthesis for one phase nanoparticles in this thesis followed, with some 
modifications, the report in 112. The main difference lies on the purification of the particles. 
From a strict point of view, the nanoparticles were not purified: they were washed and cleaned 
of impurities. They are not amenable to column chromatography, crystallization or other 
conventional purification techniques; the closest we get to a purification step is the sucrose-
gradient size fractionation. Increasingly, nanoparticles are being crystalized and completely 
characterized as atomically defined gold clusters94,199. In theory, the manipulation of these 
nanoparticles can evolve in this direction, providing unambiguous characterization of the 
species, that can be of great value to domains such as molecular structural biology, drug 
discovery, medicine and others104,151,173. 
 
M.2.1 One phase allMUS and MUS:OT synthesis 
All glassware was cleaned with fresh aqua regia (HCl:HNO3 3:1) before synthesis. 
 
Generally, in a 500 mL round bottom flask, 0.9 mmol of gold salt (HAuCl4?3H2O) in 200 mL 
ethanol and 0.9 mmol of the desired thiol ligand mixture was added while stirring the reaction 
solution. This might be a crucial step in determining ligand ratio, because a gold-thiol complex 
forms, which is evidenced by the increasing turbidity of the mixture. A filtered, saturated 
ethanol solution of sodium borohydride (NaBH4) was added drop-wise. The solution was 
stirred for 2 h and the reaction vessel was kept at 4?C overnight; a black precipitate was 
collected via decantation. This residue was washed several times (5X each step) with ethanol, 
methanol and acetone, then dried under vacuum. To completely remove unbound species, 
particles were either dialyzed using cellulose membranes (MWCO 3500) or centrifuged several 
times with MilliQ water using Amicon® Ultra-15 Centrifugal Filter Devices (10k or 30k 
NMWL). The particles were then suspended in a small amount of water (~2 mL) and freeze 
dried. The powder could then be weighed and manipulated accordingly. 
 
In a typical modification to this synthesis, to produce the triplicate series, to a 250 mL round-
bottom flask we added 70 mL of absolute ethanol. We added 118.15 mg (0.3 mmol) of 
tetrachloroaurate HAuCl4?3H2O to the flask, which gave a yellow solution. In a separate glass 
vial, 87.13 mg of MUS (~0.3 mmol) was dissolved in 15 mL of methanol, aided by sonication. 
The methanolic MUS solution was filtered through a PTFE syringe filter into another vial. 
Concomitantly, a saturated NaBH4 ethanolic solution was prepared, filtered, and added to a 
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dropping funnel. The ligand solution was added to the ethanolic gold mixture, allowed 10 
minutes to stir, which turned the mixture opaque, followed by the drop-wise addition of the 
reducing agent. This synthesis was repeated several times, using different 0.3 mmol sums of 
MUS and OT. 
 
This synthetic approach was not amenable to TMA ligands: the ethanolic gold solution 
becomes intensely orange upon TMA addition, and precipitation is visible. The addition of the 
reducing agent yields nanoparticles up to 40 nm in diameter. This approach was also not 
adequate for the zwitterionic ligand: the nanoparticles did not form. Both these particles were 
synthesized through modifications to the Stucky synthesis 119. 
 
M.2.2 Stucky allMUS and MUS:OT synthesis  
A 9:1 mixture of DMF and MilliQ water was prepared in a 250 mL round-bottom flask. Three 
different 20 mL aliquots of this mixture were used to completely dissolve the reagents in 
separate vials: (i) 277.7 mg (0.56 mmol) of chloro(triphenylphosphine)gold(I); (ii) 346 mg (1.2 
mmol) of MUS with 56 μL (0.3 mmol) of OT and (iii) 142.3 mg (1.5 mmol) of borane tert-
butylamine complex. Dissolution was completed by sonication for 15 minutes at room 
temperature. The gold-salt solution was added to the round-bottom flask, followed by addition 
of the MUS:OT (4:1) mixture. The solution was stirred under 800 rpm for 10 minutes at room 
temperature and became turbid. We added the reducing agent solution, connected the flask to 
a condenser, in an oil bath at 125°C (800 rpm) for 1.5 h. After this, the reaction flask was taken 
out of the heating bath and cooled while stirring (800 rpm). The flask was then kept at 4°C 
overnight to precipitate: the black solid (nanoparticles) was collected by decantation.  
The nanoparticles were washed by centrifugation using different solvents to remove unbound 
molecules. The washing steps were identical to those described in the one-phase synthesis. 
 
M.2.3 Stucky synthesis of allTMA and ZW nanoparticles 
A 1:1 mixture of ethanol and toluene was prepared in a 250 mL round-bottom flask. Three 
different 20 mL aliquots of this mixture were used to completely dissolve the reagents in 
separate vials: (i) 277.7 mg (0.56 mmol) of chloro(triphenylphosphine)gold(I); (ii) 1.2 mmol 
of TMA or ZW ligand and (iii) 142.3 mg (1.5 mmol) of borane tert-butylamine complex. 
Dissolution was completed by sonication for 15 minutes at room temperature. The gold-salt 
solution was added to the round-bottom flask, followed by addition of the ligand solution. The 
mixture was stirred under 800 rpm for 10 minutes at room temperature. We added the reducing 
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agent solution, connected the flask to a condenser, in an oil bath at 125°C (800 rpm) for 1.5 h. 
After this, the reaction flask was taken out of the heating bath and cooled while stirring (800 
rpm). Here, the methodology for ZW and allTMA nanoparticle synthesis departed: (i) ZW 
nanoparticles precipitated like the MUS and MUS:OT particles, and its cleaning procedure 
followed exactly that described above. (ii) allTMA nanoparticles did not precipitate; they 
remained stably soluble in the mixture. Thus, the volume was decreased in a rotary evaporator, 
which decreased the ethanol content of the mixture; once toluene was in a large enough excess, 
the nanoparticles precipitated. The washing protocol for allTMA nanoparticles was different 
because they are soluble in ethanol. All TMA NPs were washed by centrifugation using diethyl 
ether and toluene. The pellet was dried, dissolved in MilliQ water, followed by the usual 
Amicon® Ultra-15 centrifuge-assisted dialysis (10k or 30k NMWL). The particles were then 
suspended in a small amount of water (~2 mL) and freeze dried. 
 
This synthesis scale usually gave ~80 mg of MUS-based particles and allTMA, but ~30 to 40 
mg of ZW NPs: the cause of lower yield in the latter case is unknown.  
 
M.2.4 Nanoparticle characterization 
Several techniques can be used to characterize the nanoparticles. Size distribution was 
routinely assessed under transmission electron microscopy (TEM). Nuclear magnetic 
resonance was used both to assess the presence of unbound ligands (which will shortly de 
demonstrated to be disulfides) and determine the ligand-shell composition. Thermogravimetric 
analysis (TGA), zeta-potential measurements, dynamic light scattering, UV-vis among other 
techniques have been used in different instances. Here we describe some of the batches relevant 
to this thesis and recent publications. 
 
M.2.4.1 Ligand-shell composition determination 
1H-NMR is used to determine if the particles are free of unbound ligand. During my work, I 
have noticed that the chemical shift of the unbound species does not correspond to CH2-SH, 
but rather to the disulfide species. Figure M.9 shows the differences between the two disulfide 
species, prepared using iodine (I2), Figure M.10 shows the difference between washing a 
nanoparticle batch 5 times and 10 times using dialysis filtration (MUS:OT via the Stucky 
method). 
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Figure M.9 1H-NMR (MeOD-d4) of MUS, OT, the disulfides produced by addition of I2 in the case of MUS:OT and only 
MUS. This figure depicts the shift in the CH2-SH  
  
 
Figure M.10 Blue represents MUS and orange OT. The “free ligands” have the chemical shift of disulfides. 1H-NMR in 
MeOD-d4 and 5% D2O ensures both MUS and OT solubility. These are the spectra for MUS:OT nanoparticles prepared via 
Stucky method, comparing 5 water washes to 10. Instead of disulfides, the “free ligands” could be thiol-gold complexes that 
adsorb and desorb from the nanoparticles dynamically: however, the chemical shift of a -CH2-S-(Au)x-S-CH2 would not 
necessarily coincide with that of disulfides. Further experimentation is needed to verify this hypothesis in case it is of interest. 
For now, I prefer reporting the excess ligands as disulfides based on the current evidence.  
 
In washing the nanoparticles, the goal is to achieve a smooth spectrum, free of sharp peaks. 
Figure M.11 illustrates the probable contaminants, and a spectrum of a nanoparticle sample 
that can be deemed clean by 1H-NMR. For mixed-ligand nanoparticles, the solvent used must 
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contemplate both molecules. If a bad solvent is used, the signal can be broadened independently 
of the absence of free species. The right-hand panel in Figure M.11 shows the difference 
between using D2O and a mixture of D2O and MeOD-d4: the terminal methyl group of OT is 
revealed with the deuterated methanol. Due to the low amount of sample, the spectrum must 
be zoomed in, and the sharp peaks in the green line come from the MeOD-d4.  
 
 
Figure M.11 1H-NMR of the supernatant extracted from the nanoparticles during the washing procedure. The aqueous phase 
carries possibly two types of disulfides that agree with the spectrum. The spectrum was acquired in D2O, thus is it unlikely the 
disulfide formed only by the hydrophobic ligand is present. On the right, a comparison between the nanoparticle NMR in D2O 
and a mixture with MeOD-d4: the –CH3 group is “revealed” with the methanol. The inset shows the typical clean spectrum of 
a one phase batch, used in chapters 3 and 4.  
 
Figure M.12 summarizes the technique used to determine the stoichiometry of the ligand shell 
for the particles used in this thesis. An etching solution of 15 mg of Iodine (Acros) in 100 mL 
of MeOD-d4 (Sigma) is prepared. Between 1 to 5 mg of nanoparticles is suspended in 0.6 mL 
of the etchant mixture for 30 min under sonication. A precipitate forms, which, in this work, 
has not changed the quality or quantification under 1H-NMR: in other words, performing the 
ligand stoichiometry calculation with only the supernatant or including the precipitate did not 
affect the results. There are other ways to etch the nanoparticles to calculate the ligand ratio 
using 1H-NMR; for example, using cyanide or thermal decomposition. The choice of etchant 
varies with the particle system, and for MUS:OT, the I2-MeOD-d4 approach was chosen 
because of the clarity of the spectrum. If cyanide is used in this system, several side-reactions 
take place and produce peaks difficult to interpret. The main results obtained from the approach 
outlined by Figure M.12 can be found in Figure 2.7 in chapter 2.  
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Figure M.12 Schematic approach to determine the ligand-ratio for MUS:OT nanoparticles used in this thesis. This comes 
from a sample synthesized using the Stucky method,  
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M.2.4.2 Thermogravimetric analysis (TGA) 
TGA is often used to determine the organic content of monolayer-protected gold clusters to 
estimate the number of Au-S bonds and surface coverage110,200. It measures the mass of a sample 
as a function of increasing temperature and can be used to study several phenomena, including 
oxidation and thermal decomposition 201,202. The nanoparticles used in this work are too 
polydisperse to allow a precise, quantitative treatment of the TGA data; however, it offers an 
estimate of the organic content of the sample. It can also be used to estimate the relative 
abundance of the different ligands in our nanoparticles, given they have discernible thermal 
decompositions. Data interpretation from TGA requires understanding of experimental the set 
up: for example, in an open crucible, under N2 flow, a drop in mass cannot be attributed to the 
boiling point, but rather drying, desorption or sublimation. The sample can lose mass well 
before the boiling point, so only a set up with a small hole on the lid that equilibrates the vapor 
phase and the sample can offer a clear boiling point-related mass decay. The equipment we use 
is a TGA 4000 from Perkin Elmer, and Figure M.13 shows TGA’s of recently synthesized 
nanoparticles, and an approach developed to determine ligand ratio, which is compared to the 
1H-NMR determination shown in Figure M.12.  
 
 
Figure M.13 TGA plots of recently one phase synthesized MUS:OT nanoparticles. The three vertical lines on the plots demark 
176°C, 233°C and 833°C. OT thermally leaves the crucible between the first two indicated temperatures, whereas MUS 
degrades at about ~430°C. There is rough agreement between the 1H-NMR determined ratios and that derived from the TGA 
data: the latter reports a higher MUS content. This can result from the thermal degradation of other species in the temperature 
range associated to MUS that over-represents this signal. An experimental setup designed to capture the boiling point would 
have a much sharper drop in mass as a function of time: this type of TGA curve is indicative of drying, desorption and thermal 
degradation. Image and data kindly provided by Zekiye Pelin Guven 
  
 140
M.2.4.3 Representative TEM analysis of nanoparticles 
All TEM images were acquired in a Philips CM12 TEM or an FEI TALOSTM Electron Microscope.  
 
 
Figure M.14 Representative TEM images and size distributions of samples used in this thesis. The size distributions were 
obtained using a threshold based particle analysis in ImageJ, please refer to the discussion in Figure 2.6 for the limitations of 
this approach. 
 
 
Figure M.15 Representative TEM images and size distributions of samples used in this thesis. On the right, an illustration of 
the outcome from sucrose gradient size-fractionation performed on an allMUS Stucky synthesized batch.  
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Ideally, a final characterization should look like the supplemental information of our recent 
publication, discussed in chapter 2.  
 
 
Figure M.16 This image, reproduced from reference 116 summarizes the recommended characterization techniques to describe 
the nanoparticles we produce. This particle was synthesized with the Stucky method, and used in chapter 4 to demonstrate the 
role of nanoparticle size in the discriminative adsorption onto amyloid fibers.  
 
M.3 Preparation of amyloid fiber experiments 
M.3.1 Preparation of A?1-40 and A?1-42 experiments 
Tris Buffer: 12.114g of Trizma base, 2.922g NaCl (50 mM) and 0.2g NaN3 (0.02%) was 
added to 1L, pH 7.4 in MilliQ water. 
NH4OH: 0.1% in MilliQ water 
13mM Basic sodium phosphate buffer (PBS): 184.54 mg of Na2HPO4, 292 mg of NaCl and 
0.02 g of NaN3 were added to 100 mL MilliQ water. The solution was stirred, sonicated, then 
filtered in 50 mL syringe filters through 0.2μm PTFE filters, into a glass bottle. Final 
concentration of 13 mM Na2HPO4 and 50 mM NaCl (0.02% NaN3). 
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13mM Acidic sodium phosphate buffer (PBS): 389.84 mg of NaH2PO4, 730.5 mg and 0.05 
g of NaN3 were added to 250 mL of MilliQ water, stirred and sonicated. The solution was 
filtered through a 50 mL with 0.2μm PTFE syringe filters. Final concentration of 13 mM 
NaH2PO4, 50 mM NaCl, 0.02% NaN3. To achieve pH 7.4 PBS, acidic PBS was added to the 
basic until the target pH was achieved (constant pH monitoring using a Hamilton pH-meter). 
Thioflavin T (ThT): 0.32 g of ThT (1μmol) as added to 10 mL of MilliQ water yielding a 100 
μM solution: it was filtered through a 0.2μm PTFE syringe filter.  
M 3.2 A? sample preparation and kinetic assays  
For a detailed protocol on how to prepare A? samples, refer to 203. 
The A?1-40 and A?1-42 used in this thesis were used as purchased from the Keck Laboratories, 
and then from ChinaPeptides. The lyophilized material was dissolved in a 1:1 mixture of 0.1% 
NH4OH and 100 mM Tris buffer, 0.02 % NaN3 pH 7.4 at roughly 1 mg/mL. 
Solutions were ultracentrifuged for 1 hour at 55 krpm at 4ºC in a Beckman ultracentrifuge- 
The upper half of the supernatant was collected and the peptide concentration was determined 
using its extinction coefficient at 280 nm (1490 M-1cm-1). A Perkin Elmer UV-vis, or the Tecan 
plate-reader were used to perform these measurements.  
The supernatant was then diluted to the desired concentration (usually between 5 to 20 μM) 
with the 13 mM PBS (pH = 7.4) described above.  
Fibers were either grown in a plate reader assay, or inside 1 mL Eppendorf tubes in a 
thermomixer. This approach gives reliable A?1-40 monomeric solution preparation but not A?1-
42. For experiments that rely on A?1-42 we recommend following a protocol that uses size 
exclusion chromatography166,203. 
 
 
Figure M.17 SDS-PAGE of A?1-40 and A?1-42 monomeric solutions prepared using the centrifugation method. The approach 
is reliable for A?1-40 but not A?1-42. On the right, typical ThT kinetic assay curves from multiple wells with the different types 
of nanoparticles show that this sample preparation, for A?1-40 is reliable. Lanes A through G correspond to the remaining 
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monomers after incubation with different nanoparticles. Red curves correspond to cationic allTMA nanoparticles that 
accelerate amyloid formation. Blue curves correspond to allMUS one phase particles and green curves to MUS:OT one phase 
nanoparticles. This phenomenon was widely investigated, and will be further pursued in the future.  
 
Figure M.18 Circular dichroism (CD) of fibers with nanoparticles. On the left, the impact of forming the fibers in the presence 
of different nanoparticles is shown: the red line corresponds to the fast amyloid formation in the presence of allTMA NPs. The 
spectra also confirmed the inhibitory effect of MUS:OT (10% OT) nanoparticles. On the right, we tested the effect of 
nanoparticle addition on the fibers, immediately after adding the NPs (in this case, MUS:OT) and after 2 h at 1000 rpm and 
37°C. No significant changes were detectable by adding the nanoparticles to the mature fibers. This type of experiment is still 
under investigation using also atomic force microscopy to verify changes to the fibers. 
 
 
Figure M.19 Typical ThT kinetic assay with A?1-42 grown in the presence of the different types of nanoparticles. The bar 
graph shows the extracted nucleation times fitted to a sigmoidal curve: all nanoparticles accelerated the fibrillation kinetics of 
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A?1-42 but NPs with an MUS:OT ratio of 9:1 had the same timescale as the controls. A Western Blot was performed after 
centrifugating the samples: it indicates that the allMUS samples consumed all monomeric material, whereas MUS:OT 
nanoparticles stabilized a slightly heavier species.  
The SDS-PAGE in Figure M.17 shows that A?1-40 monomeric solutions can be obtained using 
this approach, but A?1-42 shows higher order complexes. 
Most of the images presented in the thesis were prepared in the absence of ThT, and the 
nanoparticles were added after fiber formation was complete. During the thesis work, several 
kinetic assays to examine the effect of nanoparticle ligand-shell on the nucleation and growth 
were performed in a plate reader. 90 ?l of A? with 200 μM ThT (from a 2mM stock solution 
in water) per well was incubated in the absence or presence of 10 ?l nanoparticles per well at 
37 °C and shaken at 300 rpm in a 96 well black fluorescence plate, GREINER low binding 96-
well plates. Measurements were made at regular intervals of 10 minutes with excitation and 
emission at 440 nm and 480 nm respectively. 
 
M.3.3 ?-synuclein fiber growth  
?-synuclein was purchased from rPeptides and used as received. TBS buffer was prepared (50 
mM Tris, 150 mM NaCl, pH = 7.5) and degassed with argon prior to use. To 1 mg of 
lyophilized powder, 1 mL of TBS buffer was added, the solution was filtered through a 100 
kDa MWCO Microcon Filter (13000 g, 15 min, 4 °C). The concentration was adjusted to 40?M 
using the extinction coefficient at 275 nm of 5974 M-1cm-1. Both plate reader experiments and 
fiber preparations inside a thermomixer were performed. The images shown in the body of the 
thesis correspond to fibers grown over the period of one week at 1000 rpm and 37 °C. The 
sample was considered ready when negatively stained TEM samples showed abundant fibrillar 
material. Plate reader data for ?-synuclein was not reproducible across experiments like 
A?1-40. 
 
M.3.4 Tau fiber growth 
Wild type Tau-441 was kindly provided by Nadine Ait Bouziad from Prof. Hilal Lashuel’s 
group. A solution of 20 ?M Tau-441 was prepared by adding 1.7 mL of 13 mM PBS pH = 7.4 
to 1.6 mg of the lyophilized powder. Five different aliquots of the Tau solution were prepared. 
To the largest 0.9 mL aliquot, heparin was added to a final concentration of 4 ?M, aiming a 
Tau-to-heparin 4:1 ratio. Because our MUS-based nanoparticles are also polyanions, I have 
tested in the other aliquots the fiber formation behavior of Tau, without heparin, but with the 
different nanoparticles used in this project: allMUS, MUS:OT, ZW NPs and allTMA. 
Negatively stained TEM was used to monitor fiber growth, which only occurred in the 
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Eppendorf tube with heparin. No fibers were observed for any of the nanoparticle-Tau mixtures 
over the course of 2 weeks in these conditions.  
To test the adsorptive behavior of different nanoparticles onto grown Tau fibers, aliquots of 90 
?L of the Tau stock were placed in separate Eppendorf tubes. 10 ?L of the nanoparticle stock 
solution was added: allTMA, allMUS, MUS:OT (10 and 30% OT by 1H-NMR) and ZW NPs, 
in addition to fractionated allMUS and MUS:OT (30% OT by 1H-NMR). An experiment to test 
the role of nanoparticle concentration was performed: 10 ?L of 1mg/mL and 10 mg/mL 
MUS:OT (30% OT) were added: the results described in Chapter 4 indicate that first the 
nanoparticles cover small non-fibrillar species. Once such sites are covered, the nanoparticles 
occupy the body of the fibers. 
M.3 Electron microscopy of amyloid nanoparticle samples 
M.3.1 Dry negative staining TEM 
For dry negative staining of amyloid fibers, a droplet of suspended fibers in buffer was 
deposited onto a carbon covered Copper TEM grid (400mesh) (PELCO® TEM grid TedPella, 
INC), washed with MilliQ and finally stained with a freshly prepared and filtered (0.22 μm 
PTFE syringe filter) 2% solution of Uranyl acetate in MilliQ. The dried grid has been imaged 
in an FEI TALOSTM Transmission Electron Microscope. 
M.3.2 Cryo-TEM 
 
 
Figure M.20 Schematic representation of a cryo-EM preparation: a sample in its native hydrated state (a) is deposited onto a 
TEM grid (b), blotted to leave only a very thin layer of liquid (c) that is flash frozen by plunging into a cryogen to be finally 
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imaged under an electron-beam (e). Reprinted with permission from reference 204 Copyright © 2012 Elsevier Ltd. All rights 
reserved. 
 
For cryo electron microscopy a droplet of amyloid fibers suspended in buffer is flash-frozen in 
its native hydrated state. Therefore, a droplet has been deposited on a Quantifoil® holey carbon 
grid and blotted to a thin (100-300nm) layer of liquid that was flash frozen in liquid ethane 
using an FEI vitrobot Marc IV. Imaging was performed in a Gatan single tilt cryo holder with 
an FEI Tecnai Spirit BioTWIN 80kV transmission electron microscope in LowDose Mode to 
visualize the samples at an average exposure of 1-3electrons/Ångström2. 
 
M.4 Experiments omitted from the thesis 
M.4.1 AFM 
Atomic Force Microscopy was performed during this thesis work, but yielded difficult images 
to interpret. Electron microscopy provides good contrast between the metallic core of the gold 
nanoparticles and the carbon-based amyloid fibers. Figure M.21 shows typical dry AFMs 
obtained after preparing A?1-40 in the presence of nanoparticles. Perhaps now that the 
adsorptive behavior of these nanoparticles onto amyloid fibers has been established, AFM can 
be used to investigate mechanical properties of the interaction, the effect of the nanoparticles 
on the fuzzy coat of Tau among other possibilities.  
 
Other techniques were used with varying degree of success: ultimately, no approach was ideal 
for both nanoparticles and amyloid fibers. For example, in this work we discovered that, in the 
presence of buffer and amyloid precursors, our nanoparticles do not flow through the stationary 
phase in size exclusion chromatography (Superdex 200). It has also been difficult to assess the 
affinity of the different nanoparticles to the amyloid fibers. Surface plasmon resonance 
experiments (SPR) showed that the NPs have different affinities to the substrate. 
Deconvoluting affinity to the substrate from possible binding to the fibers is still a challenge, 
but can be achieved with careful controls and calibration.  
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Figure M.21 Dry AFM imaging of A?1-40 grown in the presence of the nanoparticles indicated in each image. AFM is a 
promising technique to study the interaction between these two materials, but clarity to visualize the gold core was needed to 
advance the project: now that the different adsorptive behaviors are well-established, AFM can be used to analyze forces, the 
effect of nanoparticles on mechanical properties of the fibers, among other possibilities. (Bruker Cantilever 40 N/m). 
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